Quiver News

Anastasios Arima, the Chief Executive Officer of $IPX, bought 110,000 shares of the company on 04-28-2026 for an estimated $493,625. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.9%. Following this trade, they now own 12,316,782 shares of this class of $IPX stock.

$IPX Insider Trading Activity

$IPX insiders have traded $IPX stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IPX stock by insiders over the last 6 months:

• TODD HANNIGAN (Executive Chairman) has made 3 purchases buying 705,225 shares for an estimated $2,798,706 and 0 sales.
• ANASTASIOS ARIMA (Chief Executive Officer) has made 3 purchases buying 589,800 shares for an estimated $2,286,735 and 0 sales.
• TOBY EDGCUMBE SYMONDS (President) purchased 11,000 shares for an estimated $262,552
• R TONY TRIPENY purchased 4,187 shares for an estimated $99,463

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$IPX Hedge Fund Activity

We have seen 33 institutional investors add shares of $IPX stock to their portfolio, and 18 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VAN ECK ASSOCIATES CORP added 506,612 shares (+61.0%) to their portfolio in Q4 2025, for an estimated $18,331,755
• SHAY CAPITAL LLC removed 154,303 shares (-53.3%) from their portfolio in Q4 2025, for an estimated $5,583,454
• MILLENNIUM MANAGEMENT LLC added 117,436 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,249,421
• MORGAN STANLEY added 75,034 shares (+135.3%) to their portfolio in Q4 2025, for an estimated $2,715,105
• WOODLINE PARTNERS LP added 68,846 shares (+68.7%) to their portfolio in Q4 2025, for an estimated $2,491,192
• STIFEL FINANCIAL CORP removed 68,369 shares (-7.6%) from their portfolio in Q4 2025, for an estimated $2,473,932
• JANE STREET GROUP, LLC added 49,645 shares (+62.5%) to their portfolio in Q4 2025, for an estimated $1,796,404

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$IPX Analyst Ratings

Wall Street analysts have issued reports on $IPX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 03/27/2026
• Roth Capital issued a "Buy" rating on 01/20/2026
• William Blair issued a "Outperform" rating on 01/13/2026

To track analyst ratings and price targets for $IPX, check out Quiver Quantitative's $IPX forecast page.

$IPX Price Targets

Multiple analysts have issued price targets for $IPX recently. We have seen 3 analysts offer price targets for $IPX in the last 6 months, with a median target of $52.0.

Here are some recent targets:

• Gregory Lewis from BTIG set a target price of $40.0 on 03/27/2026
• Lucas Pipes from B. Riley Securities set a target price of $52.0 on 03/13/2026
• Joe Reagor from Roth Capital set a target price of $74.0 on 01/20/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Representative Debbie Dingell just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Debbie Dingell and other politicians.

The trades in the new disclosure included a:

• Purchase of $PTA stock (COHEN & STEERS TAX-ADVANTAGED PREFERRED SECURITIES AND INCOME FUND COMMON SHARES OF BENEFICIAL INTEREST)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Debbie Dingell

Representative Tim Moore just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Tim Moore and other politicians.

The trades in the new disclosure included a:

• Sale of $CBRL stock (CRACKER BARREL OLD COUNTRY STORE, INC. - COMMON STOCK)
• Sale of $HOG stock (HARLEY-DAVIDSON, INC. COMMON STOCK)
• Sale of $LGIH stock (LGI HOMES, INC. - COMMON STOCK)
• Sale of $NVDA stock (NVIDIA CORPORATION - COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Tim Moore

Philip P Boudreau, the EVP AND CFO of $ABT, bought 2,200 shares of the company on 04-23-2026 for an estimated $201,300. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately inf%. Following this trade, they now own 2,200 shares of this class of $ABT stock.

$ABT Insider Trading Activity

$ABT insiders have traded $ABT stock on the open market 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ABT stock by insiders over the last 6 months:

• ROBERT B FORD (CHAIRMAN AND CEO) purchased 18,800 shares for an estimated $2,013,966
• DANIEL J STARKS has made 2 purchases buying 10,000 shares for an estimated $1,087,331 and 0 sales.
• ERIC SHROFF (Senior Vice President) has made 0 purchases and 2 sales selling 2,295 shares for an estimated $284,988.
• PHILIP P BOUDREAU (EVP AND CFO) purchased 2,200 shares for an estimated $201,300
• LOUIS H. MORRONE (EXECUTIVE VICE PRESIDENT) sold 1,144 shares for an estimated $132,223
• DANIEL GESUA SIVE SALVADORI (EVP AND GROUP PRESIDENT) sold 885 shares for an estimated $102,288
• MARY K MORELAND (EXECUTIVE VICE PRESIDENT) sold 613 shares for an estimated $70,850
• JOHN A. JR. MCCOY (VICE PRESIDENT AND CONTROLLER) sold 585 shares for an estimated $67,614
• ELIZABETH C. CUSHMAN (EVP, GC AND SECRETARY) sold 263 shares for an estimated $30,397

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$ABT Hedge Fund Activity

We have seen 1,231 institutional investors add shares of $ABT stock to their portfolio, and 1,677 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• J. STERN & CO. LLP added 39,005,451 shares (+12439.6%) to their portfolio in Q4 2025, for an estimated $4,886,992,955
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 30,767,022 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $3,854,800,186
• JPMORGAN CHASE & CO removed 7,190,072 shares (-24.5%) from their portfolio in Q4 2025, for an estimated $900,844,120
• ALLIANCEBERNSTEIN L.P. added 6,926,031 shares (+125.3%) to their portfolio in Q4 2025, for an estimated $867,762,423
• BLACKROCK, INC. added 5,348,812 shares (+3.8%) to their portfolio in Q4 2025, for an estimated $670,152,655
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 4,993,343 shares (-28.1%) from their portfolio in Q4 2025, for an estimated $625,615,944
• POLEN CAPITAL MANAGEMENT LLC removed 3,458,374 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $433,299,678

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$ABT Revenue

$ABT had revenues of $11.2B in Q1 2026. This is an increase of 7.78% from the same period in the prior year.

You can track ABT financials on Quiver Quantitative's ABT stock page.

$ABT Congressional Stock Trading

Members of Congress have traded $ABT stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ABT stock by members of Congress over the last 6 months:

• REPRESENTATIVE RICHARD MCCORMICK has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/19, 11/05 and 0 sales.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/18 and 2 sales worth up to $30,000 on 02/10, 12/19.
• REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 01/29.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
• REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 12/08.
• REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

$ABT Analyst Ratings

Wall Street analysts have issued reports on $ABT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 02/02/2026
• BTIG issued a "Buy" rating on 01/23/2026

To track analyst ratings and price targets for $ABT, check out Quiver Quantitative's $ABT forecast page.

$ABT Price Targets

Multiple analysts have issued price targets for $ABT recently. We have seen 12 analysts offer price targets for $ABT in the last 6 months, with a median target of $120.5.

Here are some recent targets:

• Marie Thibault from BTIG set a target price of $131.0 on 04/27/2026
• Matt Miksic from Barclays set a target price of $143.0 on 04/20/2026
• Adam Maeder from Piper Sandler set a target price of $115.0 on 04/17/2026
• Suraj Kalia from Oppenheimer set a target price of $115.0 on 04/17/2026
• Vijay Kumar from Evercore ISI Group set a target price of $120.0 on 04/17/2026
• Bruce D. Jackson from Benchmark set a target price of $120.0 on 04/17/2026
• Shagun Singh from RBC Capital set a target price of $130.0 on 04/17/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Theodore S. Hanson, the Chief Executive Officer of $EFOR, bought 51,965 shares of the company on 04-24-2026 for an estimated $999,785. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 16.0%. Following this trade, they now own 376,843 shares of this class of $EFOR stock.

$EFOR Insider Trading Activity

$EFOR insiders have traded $EFOR stock on the open market 9 times in the past 6 months. Of those trades, 9 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $EFOR stock by insiders over the last 6 months:

• THEODORE S. HANSON (Chief Executive Officer) purchased 51,965 shares for an estimated $999,785
• ARSHAD MATIN purchased 10,000 shares for an estimated $193,462
• MARIA R HAWTHORNE purchased 5,136 shares for an estimated $100,111
• MARK A. FRANTZ purchased 3,800 shares for an estimated $71,896
• JENNIFER HANKES PAINTER (SVP, Chief Legal Officer) purchased 2,500 shares for an estimated $50,077
• JOSEPH WENDELL DYER purchased 2,684 shares for an estimated $50,002
• JONATHAN S HOLMAN purchased 2,000 shares for an estimated $37,739
• SADASIVAM IYER (President) has made 2 purchases buying 1,725 shares for an estimated $33,288 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Jack Jiajia Huang, the Chief Executive Officer of $COE, bought 73,740 shares of the company on 04-23-2026 for an estimated $1,895,855. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.3%. Following this trade, they now own 25,662,900 shares of this class of $COE stock.

$COE Insider Trading Activity

$COE insiders have traded $COE stock on the open market 19 times in the past 6 months. Of those trades, 19 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $COE stock by insiders over the last 6 months:

• JACK JIAJIA HUANG (Chief Executive Officer) has made 19 purchases buying 2,271,600 shares for an estimated $48,534,241 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$COE Hedge Fund Activity

We have seen 3 institutional investors add shares of $COE stock to their portfolio, and 7 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HSG HOLDING LTD removed 192,322 shares (-28.8%) from their portfolio in Q4 2025, for an estimated $6,140,841
• BANK OF AMERICA CORP /DE/ added 143,695 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,588,181
• UBS GROUP AG removed 8,153 shares (-89.5%) from their portfolio in Q4 2025, for an estimated $260,325
• RENAISSANCE TECHNOLOGIES LLC removed 3,000 shares (-6.1%) from their portfolio in Q4 2025, for an estimated $95,790
• MORGAN STANLEY removed 1,915 shares (-98.7%) from their portfolio in Q4 2025, for an estimated $61,145
• EVERSOURCE WEALTH ADVISORS, LLC removed 176 shares (-35.3%) from their portfolio in Q4 2025, for an estimated $5,619
• TOWER RESEARCH CAPITAL LLC (TRC) added 146 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,661

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Petros Panagiotis Panagiotidis, the Chief Executive Officer of $TORO, bought 1,465,990 shares of the company on 04-22-2026 for an estimated $9,456,515. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 7.7%. Following this trade, they now own 20,488,963 shares of this class of $TORO stock.

$TORO Insider Trading Activity

$TORO insiders have traded $TORO stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $TORO stock by insiders over the last 6 months:

• PETROS PANAGIOTIS PANAGIOTIDIS (Chief Executive Officer) has made 4 purchases buying 2,315,971 shares for an estimated $14,254,645 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$TORO Hedge Fund Activity

We have seen 10 institutional investors add shares of $TORO stock to their portfolio, and 7 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CABLE CAR CAPITAL, LP added 520,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,745,600
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 54,581 shares (+inf%) to their portfolio in Q4 2025, for an estimated $288,187
• RENAISSANCE TECHNOLOGIES LLC added 30,100 shares (+19.2%) to their portfolio in Q4 2025, for an estimated $158,928
• JANE STREET GROUP, LLC added 26,421 shares (+inf%) to their portfolio in Q4 2025, for an estimated $139,502
• GROUP ONE TRADING LLC removed 18,304 shares (-82.2%) from their portfolio in Q4 2025, for an estimated $96,645
• CITADEL ADVISORS LLC removed 12,653 shares (-49.8%) from their portfolio in Q4 2025, for an estimated $66,807
• FOUNDERS CAPITAL MANAGEMENT removed 9,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $32,625

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Paul Joachimczyk, the CFO of $SON, bought 8,058 shares of the company on 04-24-2026 for an estimated $399,998. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 39.3%. Following this trade, they now own 28,558 shares of this class of $SON stock.

$SON Insider Trading Activity

$SON insiders have traded $SON stock on the open market 9 times in the past 6 months. Of those trades, 7 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $SON stock by insiders over the last 6 months:

• PAUL JOACHIMCZYK (CFO) has made 6 purchases buying 28,558 shares for an estimated $1,209,744 and 0 sales.
• JOHN R HALEY purchased 2,506 shares for an estimated $99,914
• ERNEST D III HAYNES (Pres. Consumer Pkg Americas) sold 1,581 shares for an estimated $89,152
• JAMES A. III HARRELL (Pres. Global Ind. Paper Pkg.) sold 20 shares for an estimated $1,156

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$SON Hedge Fund Activity

We have seen 215 institutional investors add shares of $SON stock to their portfolio, and 254 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FULLER & THALER ASSET MANAGEMENT, INC. added 4,880,438 shares (+477.8%) to their portfolio in Q4 2025, for an estimated $212,982,314
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 933,869 shares (-75.7%) from their portfolio in Q4 2025, for an estimated $40,754,043
• SQUAREPOINT OPS LLC added 846,794 shares (+2813.2%) to their portfolio in Q4 2025, for an estimated $36,954,090
• LSV ASSET MANAGEMENT added 764,590 shares (+95.7%) to their portfolio in Q4 2025, for an estimated $33,366,707
• DEPRINCE RACE & ZOLLO INC removed 655,339 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $35,447,286
• NORDEA INVESTMENT MANAGEMENT AB removed 652,692 shares (-24.0%) from their portfolio in Q4 2025, for an estimated $28,483,478
• MACQUARIE GROUP LTD removed 594,592 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $25,947,994

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$SON Revenue

$SON had revenues of $1.7B in Q1 2026. This is a decrease of -1.92% from the same period in the prior year.

You can track SON financials on Quiver Quantitative's SON stock page.

$SON Analyst Ratings

Wall Street analysts have issued reports on $SON in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Truist Securities issued a "Buy" rating on 01/06/2026

To track analyst ratings and price targets for $SON, check out Quiver Quantitative's $SON forecast page.

$SON Price Targets

Multiple analysts have issued price targets for $SON recently. We have seen 7 analysts offer price targets for $SON in the last 6 months, with a median target of $60.0.

Here are some recent targets:

• Ghansham Panjabi from Baird set a target price of $55.0 on 04/23/2026
• Anthony Pettinari from Citigroup set a target price of $63.0 on 04/23/2026
• Michael Roxland from Truist Securities set a target price of $68.0 on 04/15/2026
• Anojja Shah from UBS set a target price of $59.0 on 04/10/2026
• Hillary Cacanando from Deutsche Bank set a target price of $63.0 on 04/01/2026
• Gabe Hajde from Wells Fargo set a target price of $56.0 on 03/20/2026
• George Staphos from B of A Securities set a target price of $60.0 on 01/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Representative Robert E. Latta just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Robert E. Latta and other politicians.

The trades in the new disclosure included a:

• Purchase of $FMAO stock (FARMERS & MERCHANTS BANCORP, INC.)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Robert E. Latta

Representative Maria Elvira Salazar just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Maria Elvira Salazar and other politicians.

The trades in the new disclosure included a:

• Purchase of $C stock (CITIGROUP, INC. COMMON STOCK)
• Purchase of $FDX stock (FEDEX CORPORATION COMMON STOCK)
• Purchase of $PTON stock (PELOTON INTERACTIVE, INC. - COMMON STOCK)
• Purchase of $URI stock (UNITED RENTALS, INC. COMMON STOCK)
• Purchase of $VG stock (VENTURE GLOBAL, INC. CLASS A COMMON STOCK)
• Purchase of $AMGN stock (AMGEN INC. - COMMON STOCK)
• Purchase of $BA stock (BOEING COMPANY)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Maria Elvira Salazar

Representative Dwight Evans just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Dwight Evans and other politicians.

The trades in the new disclosure included a:

• Sale of $MU stock (MICRON TECHNOLOGY, INC. - COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Dwight Evans

Representative Terri A. Sewell just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Terri A. Sewell and other politicians.

The trades in the new disclosure included a:

• Sale of $GEHC stock (GE HEALTHCARE TECHNOLOGIES INC. - COMMON STOCK)
• Sale of $TPR stock (TAPESTRY, INC. COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Terri A. Sewell

Representative Daniel Meuser just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Daniel Meuser and other politicians.

The trades in the new disclosure included a:

• Sale of $NVDA stock (NVIDIA CORPORATION - COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Daniel Meuser

$11,380,000 of GENERAL MOTORS COMPANY lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Industrial loan charters, issues generally, auto finance issues; One Big Beautiful Bill Act implementation S. 1379, H.R. 1566, REPAIR Act and related issues to safety, intellectual property, cybersecurity, privacy and China; H.R. 6687 DRIVER Act and related issues to safety, intellectual property, cybersecurity, and privacy Tax sections 45X, One Big Beautiful Bill Act implementation Defense authorization and appropriations for Fiscal Year 2027, propulsion programs, infantry squad vehicle authorization; Armored vehicle procurement, acquisition reform Fuel economy/GHG rule/CAFE; One Big Beautiful Bill Act implementation; Permitting Reform. MY2030-35 Corporate Average Fuel Consumption (CAFC) Vehicle fuel economy; connected vehicles, global competitiveness; auto manufacturing supply chain; One Big Beautiful Bill Act implementation; H.R. 6688, ADAS Functionality and Integrity Act; S.1711, the Stop China Act and related issues concerning China and the U.S. Auto industry; H.R. 5221, PART Act; H.R. 7389, Motor Vehicle Modernization Act; H.R. 7372, Safety is Not for Sale Act; H.R. 3360, Driver Technology and Pedestrian Safety Act; H.R. 2110, Safe Access for Survivors Act; H.R. 7353, Magnus White and Safe Streets for Everyone Act; H.R., 6947, SAFE Exit Act; H.R. 7377, Know Before You Drive Act; legislation related to autonomous vehicles Defense appropriations for Fiscal Year 2026; infantry squad vehicle funding, tactical electrification initiatives; Department of defense budget request for Fiscal Year 2026; One Big Beautiful Bill Act implementation; H.R. 5166, Financial Services, General Government Appropriations Act, 2026; H.R. 4249, Legislative Branch Appropriations Act, 2026 Fuel economy/GHG rule/CAFE; One Big Beautiful Bill Act implementation One Big Beautiful Bill Act implementation Global market access; non-tariff trade barriers; tariffs; USMCA review"

You can find more data on corporate lobbying on Quiver Quantitative.

GM Congressional Stock Trading

Members of Congress have traded $GM stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $GM stock by members of Congress over the last 6 months:

• REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $15,000 on 01/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GM Insider Trading Activity

GM insiders have traded $GM stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $GM stock by insiders over the last 6 months:

• MARK L REUSS (President) has made 0 purchases and 7 sales selling 741,324 shares for an estimated $56,026,288.
• CHRISTOPHER HATTO (Vice President & CAO) has made 0 purchases and 2 sales selling 23,421 shares for an estimated $1,654,918.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GM Hedge Fund Activity

We have seen 686 institutional investors add shares of GM stock to their portfolio, and 666 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 19,014,851 shares (-69.8%) from their portfolio in Q4 2025, for an estimated $1,546,287,683
• VIKING GLOBAL INVESTORS LP removed 6,221,044 shares (-47.8%) from their portfolio in Q4 2025, for an estimated $505,895,298
• FMR LLC added 5,119,814 shares (+47.6%) to their portfolio in Q4 2025, for an estimated $416,343,274
• DIAMOND HILL CAPITAL MANAGEMENT INC removed 4,103,036 shares (-64.0%) from their portfolio in Q4 2025, for an estimated $333,658,887
• HOLOCENE ADVISORS, LP added 3,668,197 shares (+inf%) to their portfolio in Q4 2025, for an estimated $298,297,780
• HARRIS ASSOCIATES L P removed 3,642,979 shares (-17.3%) from their portfolio in Q4 2025, for an estimated $296,247,052
• AQR CAPITAL MANAGEMENT LLC removed 3,368,900 shares (-23.6%) from their portfolio in Q4 2025, for an estimated $273,958,948

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GM Analyst Ratings

Wall Street analysts have issued reports on $GM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 01/28/2026
• Barclays issued a "Overweight" rating on 01/28/2026
• Wells Fargo issued a "Underweight" rating on 01/28/2026
• Citigroup issued a "Buy" rating on 01/12/2026
• Evercore ISI Group issued a "Outperform" rating on 11/24/2025
• Tigress Financial issued a "Strong Buy" rating on 10/24/2025

To track analyst ratings and price targets for GM, check out Quiver Quantitative's $GM forecast page.

GM Price Targets

Multiple analysts have issued price targets for $GM recently. We have seen 18 analysts offer price targets for $GM in the last 6 months, with a median target of $95.5.

Here are some recent targets:

• Edison Yu from Deutsche Bank set a target price of $90.0 on 04/14/2026
• Joseph Spak from UBS set a target price of $105.0 on 04/14/2026
• Mark Delaney from Goldman Sachs set a target price of $91.0 on 04/14/2026
• Dan Levy from Barclays set a target price of $105.0 on 03/30/2026
• Emmanuel Rosner from Wolfe Research set a target price of $96.0 on 03/25/2026
• Mickey Legg from Benchmark set a target price of $90.0 on 02/10/2026
• George Galliers from Evercore ISI Group set a target price of $95.0 on 02/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$7,080,000 of META PLATFORMS INC. AND VARIOUS SUBSIDIARIES lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Discussions regarding cybersecurity, data security, encryption, platform integrity, election integrity, content policy, and terrorism; Issues related to voter suppression/interference, political ads and misinformation policies Education regarding internet security policy and internet privacy issues, federal privacy legislation, and freedom of expression on the internet, including connectivity, spectrum and access issues, local media issues Issues related to Digital Services Taxes (DSTs); Discussions regarding corporate tax issues and international tax policy Discussions regarding free trade agreements; Data localization and cross-border trade flows; Trade promotion authority and digital trade; Commerce export regulations - emerging technology; EU/US data flow; China; Intermediary liability; US-India trade negotiations; Export controls Issues and discussions related to technology and the Internet including privacy, security, competition, research, trademark counterfeiting and copyright piracy issues; online advertising, content and platform transparency efforts; technology and engineering; protecting children, bullying prevention and online safety; youth safety and federal parental approval; human trafficking issues; data portability and interoperability; data breach; connectivity and network usage issues; platform integrity and cybersecurity; storage and access to electronic communications and encryption; manipulated media; continued conversations on Artificial Intelligence; Section 230 of the Communications Decency Act; youth restrictions on social media; issues related to online platform content in the EU; issues related to fraud and scams online; issues related to AI Wearables; Congressional Review Act and other activity related to the CFPBs rulemaking on payment system plans and nonbank larger participants"; S. 1829, STOP CSAM Act of 2025; EARN It Act; S. 146, TAKE IT DOWN Act; H.R. 3149/S. 1586, App Store Accountability Act; S. 1748/H.R. 6484, Kids Online Safety Act (KOSA); S. 836/H.R. 6291, Children and Teens Online Privacy Protection Act; S. 1367, NO FAKES Act of 2025; S. 1792, AI Whistleblower Protection Act; Issues related to the CLOUD Act; S. 2081, Responsible Innovation and Safe Expertise (RISE) Act of 2025; S. 2019, Taskforce for Recognizing and Averting Payment Scams (TRAPS) Act; S. 2750, Strengthening Artificial intelligence Normalization and Diffusion By Oversight and eXperimentation Act (SANDBOX) Act; H.R. 3209, App Store Freedom Act; H.R. 2657, Sammys Law; H.R. 6273, Stop Profiling Youth and Kids Act; H.R. 6253, Algorithmic Transparency and Choice Act; H.R. 6489, Safeguarding Adolescents From Exploitative (SAFE) BOTs Act; H.R. 1623, Shielding Children's Retinas from Egregious Exposure on the Net (SCREEN) Act; H.R. 6257, Safe Messaging for Kids Act of 2025; H.R. 6333, Parents Over Platforms Act; H.R. 6048, NDO Fairness Act; Issues related to the Communications, Video, and Technology Accessibility (CVTA) Act; H.R. 6265, Safer Guarding of Adolescents from Malicious Interactions on Network Games (GAMING) Act; H.R. 5360, AI Warnings And Resources for Education (AWARE) Act; H.R. 6499, Assessing Safety Tools for Parents and Minors Act; H.R. 6437, Kids Internet Safety Partnership Act; H.R. 6289, Promoting a Safe Internet for Minors Act; H.R. 6259, No Fentanyl on Social Media Act; H.R. 6290, Safe Social Media Act; H.R. 6488, Reducing Exploitative Social Media Exposure for Teens (RESET) Act; S. 3150, Guaranteeing Access and Innovation for National Artificial Intelligence (GAIN AI) Act of 2025; H.R. 7757, Kids Internet and Digital Safety (KIDS) Act; S. 3774, Safeguarding Consumers from Advertising Misconduct (SCAM) Act; S. 3947, Reconductoring Existing Wires for Infrastructure Reliability and Expansion (REWIRE) Act; H.R. 5764, AI for Main Street Act; S. 3397, Ending Coercion of Children and Harm Online (ECCHO) Act; S. 1885, Stop the Scroll Act; S. 4046, Economy of the Future Commission Act of 2026; S. 3982, AI Fraud Accountability Act of 2026 Issues related to infrastructure and subsea cable systems in the US and globally; H.R. 261, Undersea Cable Protection Act of 2025 Issues related to Meta's Community Standards; Update on civil rights issues related to advertising practices; Issues related to human rights Issues related to encryption; Issues related to EU/US data flow; India and other data localization issues; Issues related to intermediary liability, both civil and criminal Discussions regarding temporary high-tech worker visas and employment based permanent residency Issues related to energy policy and permitting reforms; H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act; H.R. 6983, Preventing Rate Inflation in Consumer Energy (PRICE) Act"

You can find more data on corporate lobbying on Quiver Quantitative.

META Congressional Stock Trading

Members of Congress have traded $META stock 14 times in the past 6 months. Of those trades, 9 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $META stock by members of Congress over the last 6 months:

• SENATOR ANGUS S. KING JR. sold up to $15,000 on 02/13.
• REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 02/12.
• REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $350,000 on 02/03, 01/20 and 0 sales.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/30 and 1 sale worth up to $15,000 on 12/24.
• REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 01/07.
• SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 12/29.
• SENATOR SHELLEY MOORE CAPITO purchased up to $15,000 on 11/13.
• REPRESENTATIVE JONATHAN L. JACKSON sold up to $15,000 on 11/11.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 10/31.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

META Insider Trading Activity

META insiders have traded $META stock on the open market 124 times in the past 6 months. Of those trades, 0 have been purchases and 124 have been sales.

Here’s a breakdown of recent trading of $META stock by insiders over the last 6 months:

• SUSAN J LI (Chief Financial Officer) has made 0 purchases and 24 sales selling 144,355 shares for an estimated $92,273,250.
• JAVIER OLIVAN (Chief Operating Officer) has made 0 purchases and 69 sales selling 27,101 shares for an estimated $17,315,739.
• ANDREW BOSWORTH (Chief Technology Officer) has made 0 purchases and 11 sales selling 24,842 shares for an estimated $15,127,520.
• JENNIFER NEWSTEAD (Chief Legal Officer) has made 0 purchases and 11 sales selling 5,706 shares for an estimated $3,751,406.
• ROBERT M KIMMITT has made 0 purchases and 6 sales selling 3,500 shares for an estimated $2,223,048.
• PEGGY ALFORD has made 0 purchases and 2 sales selling 993 shares for an estimated $657,370.
• AARON ANDERSON (Chief Accounting Officer) sold 726 shares for an estimated $429,501

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

META Hedge Fund Activity

We have seen 2,610 institutional investors add shares of META stock to their portfolio, and 1,958 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AUTO-OWNERS INSURANCE CO removed 105,132,784 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $58,898,539,580
• J. STERN & CO. LLP added 69,519,638 shares (+53305.2%) to their portfolio in Q4 2025, for an estimated $45,889,217,847
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 35,184,915 shares (-72.9%) from their portfolio in Q4 2025, for an estimated $23,225,210,542
• JPMORGAN CHASE & CO removed 10,859,259 shares (-19.8%) from their portfolio in Q4 2025, for an estimated $7,168,088,273
• FMR LLC removed 7,659,737 shares (-5.9%) from their portfolio in Q4 2025, for an estimated $5,056,115,796
• VANGUARD GROUP INC added 7,269,279 shares (+3.8%) to their portfolio in Q4 2025, for an estimated $4,798,378,375
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 6,101,761 shares (-99.0%) from their portfolio in Q4 2025, for an estimated $4,027,711,418

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

META Analyst Ratings

Wall Street analysts have issued reports on $META in the last several months. We have seen 22 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Argus Research issued a "Buy" rating on 02/02/2026
• DA Davidson issued a "Buy" rating on 01/29/2026
• Morgan Stanley issued a "Overweight" rating on 01/29/2026
• Mizuho issued a "Outperform" rating on 01/29/2026
• Stifel issued a "Buy" rating on 01/29/2026
• Truist Securities issued a "Buy" rating on 01/29/2026
• B of A Securities issued a "Buy" rating on 01/29/2026

To track analyst ratings and price targets for META, check out Quiver Quantitative's $META forecast page.

META Price Targets

Multiple analysts have issued price targets for $META recently. We have seen 31 analysts offer price targets for $META in the last 6 months, with a median target of $825.0.

Here are some recent targets:

• Justin Post from B of A Securities set a target price of $820.0 on 04/20/2026
• John Blackledge from TD Cowen set a target price of $820.0 on 04/16/2026
• Mark Kelley from Stifel set a target price of $805.0 on 04/13/2026
• Barton Crockett from Rosenblatt set a target price of $1015.0 on 04/09/2026
• Justin Patterson from Keybanc set a target price of $760.0 on 04/09/2026
• Ken Gawrelski from Wells Fargo set a target price of $765.0 on 04/02/2026
• Brian Nowak from Morgan Stanley set a target price of $775.0 on 03/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,130,000 of AMERICAN TOWER CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to international and domestic tax provisions as applied to real estate investment trusts, including discussion of OECD Pillar 2 implementation and provisions in Public Law No: 119-21, the One Big Beautiful Bill Act (OBBBA) Issues pertaining to telecommunications towers, other infrastructure and real estate (no specific legislation) Issues related to global telecommunications policy (no specific legislation) Spectrum policy and other related issues in Public Law No: 119-21, the One Big Beautiful Bill Act (OBBBA) Issues related to data centers (no specific legislation) Telecommunications infrastructure issues - including any related provisions in Public Law No: 119-21, the One Big Beautiful Bill Act (OBBBA) Issues related to NTIA, including broadband funding programs Issues related to 5G and wireless communications deployment, including the American Broadband Deployment Act, HR 2289 Issues related to the definition of eligible project costs (no specific legislation) Issues related to corporate disclosures (no specific legislation)"

You can find more data on corporate lobbying on Quiver Quantitative.

AMT Insider Trading Activity

AMT insiders have traded $AMT stock on the open market 14 times in the past 6 months. Of those trades, 2 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $AMT stock by insiders over the last 6 months:

• EUGENE M NOEL (EVP & Chief Operating Officer) has made 0 purchases and 4 sales selling 41,209 shares for an estimated $7,872,919.
• RODNEY M SMITH (EVP, CFO & Treasurer) has made 0 purchases and 4 sales selling 34,341 shares for an estimated $6,596,527.
• STEVEN O VONDRAN (President and CEO) has made 0 purchases and 3 sales selling 33,482 shares for an estimated $6,309,966.
• EUGENE F REILLY purchased 5,554 shares for an estimated $994,110
• RAJESH KALATHUR purchased 2,671 shares for an estimated $494,936
• RUTH T DOWLING (EVP, Chief Admin Ofr, GC & Sec) sold 682 shares for an estimated $128,563

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AMT Hedge Fund Activity

We have seen 708 institutional investors add shares of AMT stock to their portfolio, and 965 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• J. STERN & CO. LLP added 37,553,436 shares (+28121.1%) to their portfolio in Q4 2025, for an estimated $6,593,256,758
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,467,997 shares (-76.0%) from their portfolio in Q4 2025, for an estimated $2,364,576,233
• NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 9,666,025 shares (+20721.6%) to their portfolio in Q4 2025, for an estimated $1,697,064,009
• CAPITAL INTERNATIONAL INVESTORS added 2,364,898 shares (+157.0%) to their portfolio in Q4 2025, for an estimated $415,205,141
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,943,111 shares (-64.4%) from their portfolio in Q4 2025, for an estimated $341,151,998
• WELLINGTON MANAGEMENT GROUP LLP removed 1,865,771 shares (-71.8%) from their portfolio in Q4 2025, for an estimated $327,573,414
• LAZARD ASSET MANAGEMENT LLC added 1,620,781 shares (+36.3%) to their portfolio in Q4 2025, for an estimated $284,560,520

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMT Analyst Ratings

Wall Street analysts have issued reports on $AMT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 10/29/2025

To track analyst ratings and price targets for AMT, check out Quiver Quantitative's $AMT forecast page.

AMT Price Targets

Multiple analysts have issued price targets for $AMT recently. We have seen 12 analysts offer price targets for $AMT in the last 6 months, with a median target of $209.5.

Here are some recent targets:

• Tim Long from Barclays set a target price of $195.0 on 04/16/2026
• Vikram Malhorta from Mizuho set a target price of $205.0 on 04/15/2026
• Matthew Niknam from Truist Securities set a target price of $205.0 on 03/31/2026
• Madison Rezaei from Bernstein set a target price of $205.0 on 03/05/2026
• Maher Yaghi from Scotiabank set a target price of $214.0 on 02/25/2026
• Simon Flannery from Morgan Stanley set a target price of $220.0 on 02/25/2026
• Batya Levi from UBS set a target price of $248.0 on 02/25/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,050,000 of DUKE ENERGY CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 5301, the Promoting Innovation in Pipeline Efficiency and Safety (PIPES) Act of 2025 No specific legislation: Surface transportation reauthorization generally. No specific legislation: Spectrum issues generally H.R. 4553 & S.3293 - Energy & Water Development and Related Agencies Appropriations Act, 2027 (specifically loan programs office, advanced nuclear, SMR, grid resiliency, nuclear fuels reprocessing, and siting of energy projects on Department of Energy sites). H.R. 6938 - Energy & Water Development and Related Agencies Appropriations Act, 2026 (specifically loan programs office, advanced nuclear, SMR, grid resiliency, nuclear fuels reprocessing, and siting of energy projects on Department of Energy sites). H.R.4121 & S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 (U.S. forest service permitting staff). H.R. 4754 & S. 2431 - House and Senate Department of the Interior, Environment, and Related Agencies Appropriations bills for FY27 (specifically funding for national parks, national forests & support for permitting staff at U.S. Fish & Wildlife and BOEM). H.R.4016 & S. 2572 - Department of Defense Appropriations Act, 2027 (specifically funding for energy programs, siting of energy projects on military bases and base resiliency). H.R.5304 & S.2587 House and Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies bills for FY27 (specifically funding for LIHEAP). H.R. 7148 - LIHEAP funding and siting of energy projects on military bases in the consolidated Defense, LHHSED, National Security-State, THUD, FSGG Appropriations Act for FY26 funding. H.R.4213, and Senate bill Department of Homeland Security Act of 2027 (specifically TSA support for pipeline safety technical and permitting personnel, and cybersecurity). H.R.3944 - Military Construction, Veterans Affairs, and Related Agencies Act, 2027 (specifically to support storm hardening and resiliency efforts at military bases and veterans hospitals). H.R. 5342 & S. 2354 - House and Senate, Commerce, Justice, Science, and Related Agencies bills for FY27 (specifically for energy trade issues). No specific legislation: Hydro programs (completed and ongoing repairs to hydro facilities impacted by Hurricane Helene). H.R. 1047 & S. 465 - Guaranteeing Reliability through the Interconnection of Dispatchable (GRID) Power Act (transmission and siting of large transmission infrastructure). H.R. 5600 - Streamlining Powerlines Essential to Electric Demand (SPEED) and Reliability Act (transmission market reform, siting of large transmission infrastructure, and interconnection queue reform). H.R. 3657 - The Hydropower Relicensing Transparency Act (uprating and approvals of hydropower turbine replacement). H.R. 3617 - Securing Americas Critical Materials Supply Act (uranium classification as a critical material). E.O. 14179 Removing Barriers to American Leadership in Artificial Intelligence H.R. 6529 - Protecting Families from AI Data Center Energy Costs Act H.R.3898 - Promoting Efficient Review for Modern Infrastructure Today (PERMIT) Act H.R. 7329 - Fighting for Reliable Energy and Ending Doubt for Open Markets (FREEDOM) Act S. 1327 - Advancing GETs Act of 2025 S. 3034 - Reliable Power Act S. 3947 - REWIRE Act H.R. 3616 - The Reliable Power Act S.3585 DATA Act of 2026 Create Expedited Reviews to Transform American Infrastructure Now (CERTAIN) - discussion draft No specific legislation: Artificial intelligence resource adequacy. Load growth. Data center issues. Energy security issues. Nuclear energy - used fuels. DoD use of nuclear energy. Resiliency. Project permitting certainty. Senate permitting reform. Executive action grid executive orders. DOE/FERC regulations on load interconnection H.R. 4776 - Standardizing Permitting and Expediting Economic Development (SPEED) Act (reforming NEPA and section 401 and 404 of the Clean Water Act). P.L. 91-190 National Environmental Policy Act (categorical exclusions). P.L. 93-205 Endangered Species Act (migratory bird issues). H.R.161 - New Source Review Permitting Improvement Act No specific legislation: EPA regulations on Clean Air Act Section 111 d and b. Coal combustion residuals regulations Regulations on Effluent Limitation Guidelines (ELGs) Emission Standards for Hazardous Air Pollutants for Coal- and Oil-Fired Electric Utility Steam Generating Units (MATS). Draft legislation related to the Federal Permitting Improvement - rights-of-way and siting and permitting. Power demand resource adequacy. Good Neighbor Rule. P.L. 117-169 - Inflation Reduction Act Clean Energy Credits Implementation; P.L. 119-21 - One Big Beautiful Bill Act: issues including interest deductibility, 45U, 48E, 48Y, transferability, and qualifying bonus credits associated with 48E S. 3605 /H.R. 7450 Disaster Zone Energy Affordability and Investment Act No specific legislation: Corporate Alternative Minimum Tax repairs 45U Gross Receipts definition Debt Issuance Guidance S. 1337 - Reauthorization of Cybersecurity Information Sharing Act of 2015 No specific legislation: Issues related to energy grid supply chain. Cyber and physical security draft legislation. Counter UAS legislation. UAS Beyond Visual Line of Sight. Cyber incident reporting generally."

You can find more data on corporate lobbying on Quiver Quantitative.

DUK Congressional Stock Trading

Members of Congress have traded $DUK stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $DUK stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

DUK Insider Trading Activity

DUK insiders have traded $DUK stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $DUK stock by insiders over the last 6 months:

• BRIAN D SAVOY (EVP & CFO) has made 0 purchases and 2 sales selling 12,000 shares for an estimated $1,532,319.
• ROBERT ALEXANDER GLENN (EVP & Chief Legal Officer) sold 8,200 shares for an estimated $1,015,160
• LOUIS E. RENJEL (EVP&CEO DEF&MW&ChiefCorpAffOff) has made 0 purchases and 2 sales selling 7,600 shares for an estimated $968,676.
• REGIS T. REPKO (SVP, System Planning&Construct) has made 0 purchases and 2 sales selling 5,338 shares for an estimated $679,541.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DUK Hedge Fund Activity

We have seen 1,138 institutional investors add shares of DUK stock to their portfolio, and 967 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,349,491 shares (-76.9%) from their portfolio in Q4 2025, for an estimated $1,564,693,840
• CITADEL ADVISORS LLC added 2,008,970 shares (+1252.2%) to their portfolio in Q4 2025, for an estimated $235,471,373
• VANGUARD GROUP INC added 1,957,592 shares (+2.6%) to their portfolio in Q4 2025, for an estimated $229,449,358
• STATE STREET CORP added 1,695,638 shares (+4.0%) to their portfolio in Q4 2025, for an estimated $198,745,729
• BLACKROCK, INC. added 1,645,544 shares (+2.4%) to their portfolio in Q4 2025, for an estimated $192,874,212
• OMERS ADMINISTRATION CORP removed 1,157,469 shares (-48.9%) from their portfolio in Q4 2025, for an estimated $135,666,941
• SARASIN & PARTNERS LLP added 1,112,513 shares (+inf%) to their portfolio in Q1 2026, for an estimated $145,683,577

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DUK Analyst Ratings

Wall Street analysts have issued reports on $DUK in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 01/15/2026
• Mizuho issued a "Outperform" rating on 10/27/2025

To track analyst ratings and price targets for DUK, check out Quiver Quantitative's $DUK forecast page.

DUK Price Targets

Multiple analysts have issued price targets for $DUK recently. We have seen 8 analysts offer price targets for $DUK in the last 6 months, with a median target of $139.5.

Here are some recent targets:

• James Thalacker from BMO Capital set a target price of $143.0 on 04/13/2026
• Nicholas Campanella from Barclays set a target price of $143.0 on 04/08/2026
• Nicholas Amicucci from Evercore ISI Group set a target price of $139.0 on 03/05/2026
• Shahriar Pourreza from Wells Fargo set a target price of $135.0 on 03/04/2026
• Ross Fowler from UBS set a target price of $126.0 on 12/17/2025
• Jeremy Tonet from JP Morgan set a target price of $126.0 on 12/11/2025
• Stephen D'Ambrisi from RBC Capital set a target price of $143.0 on 10/28/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,640,000 of T-MOBILE USA INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to: spectrum policy, accessibility, BEAD funding and deployment, auction authority, FirstNet oversight, public safety communications, 4.9 GHz, 4.7 GHz, wireless emergency alerts, cybersecurity, drones, contraband prison phones, the deployment of broadband, oversight of the Federal Communications Commission, FAA reauthorization, E911/NG911 oversight of the National Telecommunications and Information Administration, oversight of the Federal Communications Commission, oversight of the Universal Service Fund, network resiliency, comprehensive privacy protections, net neutrality, robocalls, artificial intelligence, privacy protections, broadband mapping, USF reform, 2027 World Radio Conference, wireless emergency alerts, NDAA provisions, fixed wireless Issues and bills related to: Tax Reform, Bonus depreciation, Book Minimum Tax, Tax Extenders and spectrum swaps"

You can find more data on corporate lobbying on Quiver Quantitative.

TMUS Congressional Stock Trading

Members of Congress have traded $TMUS stock 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $TMUS stock by members of Congress over the last 6 months:

• REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $115,000 on 01/13, 11/11.
• REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/11.
• SENATOR MARKWAYNE MULLIN sold up to $100,000 on 11/03.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TMUS Insider Trading Activity

TMUS insiders have traded $TMUS stock on the open market 46 times in the past 6 months. Of those trades, 1 have been purchases and 45 have been sales.

Here’s a breakdown of recent trading of $TMUS stock by insiders over the last 6 months:

• RAUL MARCELO CLAURE sold 550,000 shares for an estimated $119,663,500
• TELEKOM AG DEUTSCHE has made 0 purchases and 31 sales selling 537,832 shares for an estimated $109,706,893.
• G MICHAEL SIEVERT has made 0 purchases and 5 sales selling 140,000 shares for an estimated $30,200,638.
• PETER OSVALDIK (Chief Financial Officer) sold 27,000 shares for an estimated $5,801,220
• MARK WOLFE NELSON (Chief Legal Officer & GC) has made 0 purchases and 3 sales selling 18,843 shares for an estimated $4,157,295.
• SRINI GOPALAN (President and CEO) purchased 9,800 shares for an estimated $1,977,836
• SRIKANT M. DATAR has made 0 purchases and 2 sales selling 4,291 shares for an estimated $945,890.
• MICHAEL J. KATZ (Pres, Mkting Stgy & Prods) sold 2,500 shares for an estimated $539,775
• LETITIA A LONG sold 1,457 shares for an estimated $306,436

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TMUS Hedge Fund Activity

We have seen 752 institutional investors add shares of TMUS stock to their portfolio, and 877 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SOFTBANK GROUP CORP. removed 16,671,036 shares (-36.9%) from their portfolio in Q4 2025, for an estimated $3,384,887,149
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 12,543,974 shares (-71.7%) from their portfolio in Q4 2025, for an estimated $2,546,928,480
• PRICE T ROWE ASSOCIATES INC /MD/ added 6,516,968 shares (+30.6%) to their portfolio in Q4 2025, for an estimated $1,323,205,182
• WELLINGTON MANAGEMENT GROUP LLP added 3,121,759 shares (+23.2%) to their portfolio in Q4 2025, for an estimated $633,841,947
• DODGE & COX added 2,442,450 shares (+65.2%) to their portfolio in Q4 2025, for an estimated $495,915,048
• AMUNDI removed 1,491,932 shares (-36.3%) from their portfolio in Q4 2025, for an estimated $302,921,873
• JPMORGAN CHASE & CO removed 1,411,393 shares (-31.0%) from their portfolio in Q4 2025, for an estimated $286,569,234

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TMUS Analyst Ratings

Wall Street analysts have issued reports on $TMUS in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 12/10/2025
• Argus Research issued a "Buy" rating on 12/09/2025
• Tigress Financial issued a "Buy" rating on 11/11/2025
• Barclays issued a "Overweight" rating on 10/24/2025
• TD Cowen issued a "Buy" rating on 10/24/2025

To track analyst ratings and price targets for TMUS, check out Quiver Quantitative's $TMUS forecast page.

TMUS Price Targets

Multiple analysts have issued price targets for $TMUS recently. We have seen 13 analysts offer price targets for $TMUS in the last 6 months, with a median target of $251.0.

Here are some recent targets:

• Lyaysyan Sedova from Freedom Broker set a target price of $270.0 on 04/17/2026
• Brandon Nispel from Keybanc set a target price of $260.0 on 04/13/2026
• Michael Rollins from Citigroup set a target price of $225.0 on 03/17/2026
• Jonathan Kees from Daiwa Capital set a target price of $240.0 on 02/19/2026
• Eric Luebchow from Wells Fargo set a target price of $235.0 on 02/13/2026
• Maher Yaghi from Scotiabank set a target price of $266.0 on 02/12/2026
• Kannan Venkateshwar from Barclays set a target price of $245.0 on 02/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$4,140,000 of LOCKHEED MARTIN CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"S 2572/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to space, missile defense, classified and strategic programs; S (not yet introduced/HR (not yet introduced) - National Defense Authorization Act for Fiscal Year 2027 including issues related to aircraft, acquisition policy, procurement, small business, critical minerals, tactical aircraft, transport aircraft, classified programs, helicopters, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, strategic programs, missile defense, cyber, technology, intelligence, spectrum, Army, Navy, Missile Defense Agency procurement, RDTE, helicopters, hypersonic weapons; S (not yet introduced/HR (not yet introduced) - Department of Defense Appropriations Act, 2027, P.L. 119-75, including issues related to aircraft, acquisition policy, procurement, tactical aircraft, transport aircraft, classified programs, helicopters, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, strategic programs, missile defense, cyber, technology, intelligence, spectrum, helicopters; S (not yet introduced/HR (not yet introduced) - Spectrum Relocation and Enhancement Act including issues related to spectrum sharing, deployment of systems, operation requirements; HR 7148 - Consolidated Appropriations Act, 2026 including issues related to space, strategic missile defense programs, intelligence S 2354/HR 5342 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 including issues related to civil space, aeronautics; S 933 - NASA Transition Authorization Act of 2025 including issues related to civil space, aeronautics; HR 6938 - Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 including issues related to space programs; S (not yet introduced)/HR (not yet introduced) - Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2027 including issues related to space programs S 2342/HR 5167 - Intelligence Authorization Act for Fiscal Year 2026 including issues related to intelligence matters S 1173/HR 2199 - Restore Protections for Dialysis Patients Act including issues related to Medicare and secondary payer; HR 4317 - PBM Reform Act of 2025 including issues related to healthcare; HR 7148 - Consolidated Appropriations Act, 2026 including issues related to Pharmacy Benefit Manager issues Discussions related to the Corporate Alternative Minimum Tax Congressional Notifications for Lockheed Martin Corp. platforms S 2572/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to Army, Navy and Missile Defense Agency procurement, Research Development Test and Evaluation (RDTE), tactical aircraft, hypersonic weapons programs; HR 7148 - Consolidated Appropriations Act, 2026 including issues related to procurement, RDTE tiles for Army, Navy, Air Force and Missile Defense Agency; S (not yet introduced/HR (not yet introduced) - Department of Defense Appropriations Act, 2027 including issues related to Army, Navy and Missile Defense Agency procurement, Research Development Test and Evaluation (RDTE), tactical aircraft, intelligence and reconnaissance aircraft, acquisition policy; S (not yet introduced/HR (not yet introduced) - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027 including issues related to wildfires and innovation technology for prevention, suppression, and mitigation"

You can find more data on corporate lobbying on Quiver Quantitative.

LMT Congressional Stock Trading

Members of Congress have traded $LMT stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $LMT stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 11/18 and 1 sale worth up to $15,000 on 12/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

LMT Insider Trading Activity

LMT insiders have traded $LMT stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $LMT stock by insiders over the last 6 months:

• JOHN FRANK A ST (Chief Operating Officer) has made 0 purchases and 3 sales selling 7,792 shares for an estimated $3,826,166.
• STEPHANIE C. HILL (Pres. Rotary & Mission Systems) has made 0 purchases and 2 sales selling 2,410 shares for an estimated $6,660.
• GREGORY M ULMER (President Aeronautics) has made 0 purchases and 2 sales selling 2,840 shares for an estimated $0.
• TIMOTHY S CAHILL (Pres. Missiles & Fire Control) has made 0 purchases and 8 sales selling 4,620 shares for an estimated $0.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LMT Hedge Fund Activity

We have seen 1,187 institutional investors add shares of LMT stock to their portfolio, and 1,185 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,509,057 shares (-77.5%) from their portfolio in Q4 2025, for an estimated $729,885,599
• CAPITAL WORLD INVESTORS removed 1,035,763 shares (-36.3%) from their portfolio in Q4 2025, for an estimated $500,967,490
• BLACKROCK, INC. added 851,976 shares (+5.1%) to their portfolio in Q4 2025, for an estimated $412,075,231
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 828,827 shares (-96.0%) from their portfolio in Q4 2025, for an estimated $400,878,755
• D. E. SHAW & CO., INC. added 699,458 shares (+109.1%) to their portfolio in Q4 2025, for an estimated $338,306,850
• AQR CAPITAL MANAGEMENT LLC added 669,604 shares (+107.3%) to their portfolio in Q4 2025, for an estimated $323,867,366
• BALYASNY ASSET MANAGEMENT L.P. removed 659,551 shares (-98.2%) from their portfolio in Q4 2025, for an estimated $319,005,032

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

LMT Analyst Ratings

Wall Street analysts have issued reports on $LMT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Truist Securities issued a "Buy" rating on 01/09/2026

To track analyst ratings and price targets for LMT, check out Quiver Quantitative's $LMT forecast page.

LMT Price Targets

Multiple analysts have issued price targets for $LMT recently. We have seen 11 analysts offer price targets for $LMT in the last 6 months, with a median target of $650.0.

Here are some recent targets:

• Sheila Kahyaoglu from Jefferies set a target price of $640.0 on 04/07/2026
• John Godyn from Citigroup set a target price of $675.0 on 04/02/2026
• David Strauss from Wells Fargo set a target price of $650.0 on 04/01/2026
• Charles Minervino from Susquehanna set a target price of $740.0 on 03/18/2026
• Noah Poponak from Goldman Sachs set a target price of $517.0 on 02/02/2026
• Gavin Parsons from UBS set a target price of $663.0 on 02/02/2026
• Gautam Khanna from TD Cowen set a target price of $670.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$4,380,000 of AMAZON.COM SERVICES LLC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to IT systems improvements and cloud computing technology, including the Intelligence Authorization Act (IAA) for Fiscal Year 2027 (draft bill - no numbers) and implementation of the FY26 National Defense Authorization Act (P.L. 119-60). Issues related to drones and air cargo, including implementation of the Federal Aviation Administration Reauthorization Act of 2024 (P.L. 118-63). Issues related to job training in the CHIPS and Science Act of 2022 (P.L. 117-167), and implementation of the National Defense Authorization Act for Fiscal Year 2024 (P.L. 118-31) and the National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159.) Issues related to Amazon's Climate Pledge, including development of carbon-free energy sources, renewable energy deployment, grid infrastructure, stability, and storage; energy efficient standards; and the Standardizing Permitting and Expediting Economic Development Act (SPEED Act) (H.R. 4776). Issues related to broadband access and affordability, satellite communications, space safety, device accessibility, Section 230 reform, content moderation, online video, and the Universal Service Fund (USF). Issues related to cybersecurity, including critical infrastructure protection, payments security, cloud security, authentication, government procurement, cybersecurity incident reporting, and artificial intelligence, including implementation of the FY26 National Defense Authorization Act (P.L. 119-60), and the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159). Issues related to postal rates, service performance, and the transportation of hazardous materials. Issues related to intellectual property, including the NO FAKES Act (S. 1367), counterfeits, music licensing, and issues related to patent reform, International Trade Commission patent investigations, intermediary liability, and patent reform, including the RESTORE Patents Act (H.R. 1574 / S. 708), the Patent Eligibility Restoration (PERA) Act (H.R. 3152 / S. 1546), and the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R. 3160 / S. 1553). Issues related to taxes, digital goods and services, renewable energy tax credits, and international and corporate taxation, including H.R. 1 - To provide for reconciliation pursuant to title II of H. Con. Res. 14. (P.L. 119-21), the United States-Taiwan Expedited Double Tax Relief Act (H.R. 33 / S. 199), and implementation of the Tax Cut and Jobs Act (P.L. 115-97). Issues related to data protection, encryption, data retention, data breach notification, data security, cross border data flows, privacy, law enforcement access, fraud prevention, product safety related to the sale of counterfeit and/or stolen products, including the Combating Organized Retail Crime Act (S. 1404 / H.R. 2853), and cloud computing. Issues related to artificial intelligence safety and research and development, including the CREATE AI Act (H.R. 2385). Issues related to cybersecurity, cloud security, IT modernization, and government procurement, including implementation of the FY26 National Defense Authorization Act (P.L. 119-60), the Strengthening Agency Management and Oversight of Software Assets Act (H.R. 1695 / S. 931), the Protecting AI and Cloud Competition in Defense Act of 2025 (H.R. 3434 / S. 1775), implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159), and the Federal Improvement in Technology (FIT) Procurement Act (H.R. 4123). Issues related to immigration, high-skilled immigration, and non-immigrant visas, including issues related to employment-based visas, green card backlog, and the STEM visa exemption provision. Issues related to US trade policy, including USMCA, the World Trade Organization, the World Customs Organization, China, country of origin labeling, US customs policy and procedures, US tariffs, foreign direct investment, issues related to domestic semiconductor manufacturing and research, export controls, sanctions, and supply chain, and other trade practices, including the COOL Online Act (S.294), and the ENFORCE Act (draft bill - no numbers). Issues related to technology, procurement, and space policy, including the National Defense Authorization Act (draft bill - no numbers), and the FoRGED Act (S. 5618), and implementation of the FY26 National Defense Authorization Act (P.L. 119-60). Issues related to payment processing, corporate governance, debit reforms, financial innovation and technology, lending, gift cards, money transmission licensing, fraud prevention, payment authentication, data security, the CFPB open banking rule, the Credit Card Competition Act (draft bill - no numbers), implementation of the Consolidated Appropriations Act 2026 (P.L. 119-75), and financial inclusion. Issues related to surface transportation, including autonomous vehicles, community infrastructure investments, hazardous materials, U.S. internal supply chain and goods movement, and maritime transportation; issues related to infrastructure. Issues related to USDA SNAP online purchasing, including reauthorization of the Agricultural Improvement Act of 2018 (P.L. 115-334), Electronic Benefit Transfer, the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), and food safety. Issues related to e-commerce opportunities for small businesses. Issues related to veterans hiring and training, employee compensation and benefits, workplace safety, competition, contracting, and minimum wage, including the Warehouse Worker Protection Act (S. 2613). Issues related to IT modernization, cybersecurity, FedRAMP, open data, and government procurement, including implementation of the National Defense Authorization Act for Fiscal Year 2024 (P.L. 118-31, implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159), implementation of Federal Acquisition Reform; implementation of the Foundations for Evidence-Based Policymaking Act of 2018 (P.L. 115-435), the Continuing Appropriations and Extensions Act of 2025 (H.R. 9747), the Strengthening Agency Management and Oversight of Software Assets Act (H.R. 5457 / S. 1956), implementation of the Federal Information Security Management Act (P.L. 107-347), the Federal Improvement in Technology (FIT) Procurement Act (H.R. 4123), and implementation of the Federal Artificial Intelligence Risk Management Act of 2023 (P.L. 117-263). Issues related to IT modernization, cloud computing, and IP in general appropriations and the federal budget. Issues related to health information technology, Medicare, healthcare, pharmacy policy, and telehealth, the CONNECT for Health Act (S. 1261), and the Telehealth Modernization Act (H.R. 5081 / S. 2709). Issues related to Amazons Climate Pledge, including carbon-free energy development, grid modernization, energy and grid reliability, Standardizing Permitting and Expediting Economic Development Act (SPEED Act) (H.R.4776), and Energy and Water Development and Related Agencies Appropriations Act, 2026 (H.R. 4553/S.3293)"

You can find more data on corporate lobbying on Quiver Quantitative.

AMZN Congressional Stock Trading

Members of Congress have traded $AMZN stock 24 times in the past 6 months. Of those trades, 14 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by members of Congress over the last 6 months:

• SENATOR JOHN FETTERMAN purchased up to $15,000 on 03/30.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 9 times. They made 5 purchases worth up to $110,000 on 03/16, 02/10, 01/30, 11/18 and 4 sales worth up to $60,000 on 03/16, 03/13, 12/24, 12/19.
• REPRESENTATIVE MARK ALFORD sold up to $15,000 on 03/16.
• REPRESENTATIVE JONATHAN L. JACKSON has traded it 3 times. They made 1 purchase worth up to $15,000 on 02/05 and 2 sales worth up to $30,000 on 03/09, 02/11.
• REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 3 purchases worth up to $45,000 on 02/26, 02/09, 01/29 and 0 sales.
• REPRESENTATIVE NANCY PELOSI has traded it 2 times. They made 1 purchase worth up to $1,000,000 on 01/16 and 1 sale worth up to $5,000,000 on 12/24.
• SENATOR MARKWAYNE MULLIN purchased up to $250,000 on 12/29.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 11/13.
• SENATOR KATIE BOYD BRITT sold up to $15,000 on 11/07.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
• REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 10/22.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AMZN Insider Trading Activity

AMZN insiders have traded $AMZN stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by insiders over the last 6 months:

• DOUGLAS J HERRINGTON (CEO Worldwide Amazon Stores) has made 0 purchases and 23 sales selling 73,738 shares for an estimated $17,315,696.
• ANDREW R JASSY (President and CEO) has made 0 purchases and 10 sales selling 39,744 shares for an estimated $8,388,329.
• DAVID ZAPOLSKY (Senior Vice President) has made 0 purchases and 12 sales selling 38,419 shares for an estimated $8,205,080.
• MATTHEW S GARMAN (CEO Amazon Web Services) has made 0 purchases and 10 sales selling 35,519 shares for an estimated $7,496,787.
• JONATHAN RUBINSTEIN sold 8,173 shares for an estimated $2,043,495
• SHELLEY REYNOLDS (Vice President) has made 0 purchases and 4 sales selling 2,695 shares for an estimated $554,892.
• KEITH BRIAN ALEXANDER has made 0 purchases and 2 sales selling 1,800 shares for an estimated $393,192.
• DANIEL P HUTTENLOCHER sold 1,237 shares for an estimated $280,316

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AMZN Hedge Fund Activity

We have seen 3,033 institutional investors add shares of AMZN stock to their portfolio, and 2,215 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 207,149,000 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $47,814,132,180
• AUTO-OWNERS INSURANCE CO removed 98,022,377 shares (-99.6%) from their portfolio in Q1 2026, for an estimated $20,198,491,004
• J. STERN & CO. LLP added 87,557,736 shares (+20598.0%) to their portfolio in Q4 2025, for an estimated $20,210,076,623
• CARDANO RISK MANAGEMENT B.V. removed 24,954,963 shares (-89.6%) from their portfolio in Q1 2026, for an estimated $5,142,219,675
• JPMORGAN CHASE & CO removed 22,614,647 shares (-12.4%) from their portfolio in Q4 2025, for an estimated $5,219,912,820
• NORGES BANK added 17,334,851 shares (+13.9%) to their portfolio in Q4 2025, for an estimated $4,001,230,307
• PRICE T ROWE ASSOCIATES INC /MD/ removed 12,041,421 shares (-8.4%) from their portfolio in Q4 2025, for an estimated $2,779,400,795

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMZN Analyst Ratings

Wall Street analysts have issued reports on $AMZN in the last several months. We have seen 20 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citizens issued a "Market Outperform" rating on 02/02/2026
• TD Cowen issued a "Buy" rating on 01/13/2026
• Guggenheim issued a "Buy" rating on 12/10/2025
• Oppenheimer issued a "Outperform" rating on 12/01/2025
• Rosenblatt issued a "Buy" rating on 11/25/2025
• Mizuho issued a "Outperform" rating on 11/04/2025
• JP Morgan issued a "Overweight" rating on 10/31/2025

To track analyst ratings and price targets for AMZN, check out Quiver Quantitative's $AMZN forecast page.

AMZN Price Targets

Multiple analysts have issued price targets for $AMZN recently. We have seen 34 analysts offer price targets for $AMZN in the last 6 months, with a median target of $300.0.

Here are some recent targets:

• Justin Post from B of A Securities set a target price of $298.0 on 04/20/2026
• Justin Patterson from Keybanc set a target price of $325.0 on 04/20/2026
• Youssef Squali from Truist Securities set a target price of $285.0 on 04/17/2026
• John Blackledge from TD Cowen set a target price of $300.0 on 04/16/2026
• Barton Crockett from Rosenblatt set a target price of $296.0 on 04/15/2026
• Andrew Boone from Citizens set a target price of $315.0 on 04/15/2026
• Mark Kelley from Stifel set a target price of $294.0 on 04/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,070,000 of ELEVANCE HEALTH INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"ACA Exchanges & Enrollment Enhanced Premium Tax Credits The Lower Health Care Premiums for All Americans Act (H.R. 6703) Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) Veterans Affairs Community Cares program GUARD Veterans Health Care Act (H.R. 4077) Provider Directories Transparency in Coverage and Machine-Readable Files Patients Deserve Price Tags Act (H.R. 5582 & S. 2355) No Surprises Act Implementation No Suprises Act Enforcement Act (H.R. 4710) Physician Led and Rural Access to Quality Care Act (H.R. 2191) One Big Beautiful Bill Act (H.R. 1) Consolidated Appropriations Act of 2026 (H.R.7148) ACA Exchanges & Enrollment Enhanced Premium Tax Credits The Lower Health Care Premiums for All Americans Act (H.R. 6703) Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) Veterans Affairs Community Cares program GUARD Veterans Health Care Act (H.R. 4077) Provider Directories Transparency in Coverage and Machine-Readable Files Patients Deserve Price Tags Act (H.R. 5582 & S. 2355) No Surprises Act Implementation No Suprises Act Enforcement Act (H.R. 4710) Physician Led and Rural Access to Quality Care Act (H.R. 2191) One Big Beautiful Bill Act (H.R. 1) Consolidated Appropriations Act of 2026 (H.R.7148) Medicare Advantage Supplemental Benefits In-Home Health Risk Assessments and Chart Review The Apples-to-Apples Comparison Act (H.R. 4093 & S. 3848) No UPCODE Act Puerto Rico Medicaid Program Funding - Federal Matching Assistance Percentage (FMAP) Puerto Rico Medicare Program Funding Medicare Advantage & Medicare Part D Prescription Drug Program Medicaid Managed Care Medicaid Eligibility and Redetermination Medicare Site Neutrality Medicare & Medicaid Social Determinants of Health (SDOH) Medicare Advantage - 2027 CMS Advance Rate Notice for MA and Parts D program Medicare Administrative Contractor Local Coverage Determination (LCD) Process One Big Beautiful Bill Act (H.R. 1) Drug Patent Reform Pharmacy Benefit Manager (PBM) operations and practices, Spread Pricing, Rebates, Delinking Drug Act (H.R. 2214) Robinson-Patman Act Reform Modernizing and Ensuring PBM Accountability (MEPA) Act (118th Congress) Pharmacy Benefit Manager Transparency Act of 2025 (S. 526) Pharmacy Benefit Manager Reform Act (118th Congress) Patients Before Middlemen Act (S.882) Prescription Drug Transparency and Affordability Act (H.R. 2450) Pharmacists Fight Back Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) One Big Beautiful Bill Act (H.R. 1) Consolidated Appropriations Act of 2026 (H.R.7148)"

You can find more data on corporate lobbying on Quiver Quantitative.

ELV Congressional Stock Trading

Members of Congress have traded $ELV stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ELV stock by members of Congress over the last 6 months:

• SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ELV Insider Trading Activity

ELV insiders have traded $ELV stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $ELV stock by insiders over the last 6 months:

• CHARLES MORGAN JR KENDRICK (EVP & President, Commercial) sold 3,196 shares for an estimated $910,604
• STEVEN H COLLIS purchased 3,000 shares for an estimated $869,519
• AMY W SCHULMAN sold 26 shares for an estimated $7,475

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ELV Hedge Fund Activity

We have seen 630 institutional investors add shares of ELV stock to their portfolio, and 778 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,196,465 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $2,522,720,805
• WELLINGTON MANAGEMENT GROUP LLP added 1,668,679 shares (+25.2%) to their portfolio in Q4 2025, for an estimated $584,955,423
• PRICE T ROWE ASSOCIATES INC /MD/ added 1,607,274 shares (+27.5%) to their portfolio in Q4 2025, for an estimated $563,429,900
• HARRIS ASSOCIATES L P added 1,604,821 shares (+50.3%) to their portfolio in Q4 2025, for an estimated $562,570,001
• CAPITAL INTERNATIONAL INVESTORS removed 1,367,274 shares (-46.3%) from their portfolio in Q4 2025, for an estimated $479,297,900
• INVESCO LTD. added 1,306,390 shares (+50.3%) to their portfolio in Q4 2025, for an estimated $457,955,014
• CITADEL ADVISORS LLC added 1,244,783 shares (+294.1%) to their portfolio in Q4 2025, for an estimated $436,358,680

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ELV Analyst Ratings

Wall Street analysts have issued reports on $ELV in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 01/30/2026
• Wells Fargo issued a "Overweight" rating on 01/30/2026
• TD Cowen issued a "Buy" rating on 11/26/2025
• Mizuho issued a "Outperform" rating on 11/04/2025
• JP Morgan issued a "Overweight" rating on 10/28/2025

To track analyst ratings and price targets for ELV, check out Quiver Quantitative's $ELV forecast page.

ELV Price Targets

Multiple analysts have issued price targets for $ELV recently. We have seen 12 analysts offer price targets for $ELV in the last 6 months, with a median target of $391.0.

Here are some recent targets:

• David Windley from Jefferies set a target price of $391.0 on 04/20/2026
• David Macdonald from Truist Securities set a target price of $375.0 on 04/13/2026
• Elizabeth Anderson from Evercore ISI Group set a target price of $345.0 on 04/08/2026
• Ann Hynes from Mizuho set a target price of $350.0 on 03/11/2026
• Lisa Gill from JP Morgan set a target price of $397.0 on 02/02/2026
• Andrew Mok from Barclays set a target price of $393.0 on 01/30/2026
• Stephen Baxter from Wells Fargo set a target price of $391.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,400,000 of VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General discussions related to the 119th Congress Budget Reconciliation H.R. 46: Rural Broadband Window of Opportunity Act; all provisions H.R. 278: BROADBAND Leadership Act; all provisions H.R. 651: Spectrum Pipeline Act of 2025; all provisions H.R. 791: Foreign Anti-Digital Piracy Act; provisions related to Internet Service Providers H.R. 1519: Public Safety Communications Act; all provisions H.R. 1665: DIGITAL Applications Act; all provisions H.R. 1870: SPEED for BEAD Act; all provisions H.R. 2399: Rural Broadband Protection Act of 2025; all provisions H.R. 2449: FUTURE Networks Act; all provisions H.R. 2482: NTIA Reauthorization Act of 2025; all provisions H.R. 2794: NO FAKES Act of 2025; provisions related to Internet Service Providers H.R. 2975: Broadband Incentives for Communities Act; all provisions H.R. 3149: App Store Accountability Act; all provisions H.R. 3562: DEFIANCE Act of 2025; provisions related to Internet Service Providers H.R. 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions related to cybersecurity, privacy, and spectrum H.R. 5061: Counter-UAS Authority Security, Safety, and Reauthorization Act; all provisions H.R. 5079: Widespread Information Management for the Welfare of Infrastructure and Government Act; provisions and amendments related to telecommunications H.R. 6046: Broadband and Telecommunications RAIL Act: all provisions H.R. 6333 - Parents Over Platforms Act; all provisions H.R. 7022: Mystic Alerts Act; all provisions H.R. 7294: AI for Secure Networks Act; all provisions H.R. 7386: First Responder Network Authority Reauthorization Act of 2026; all provisions S. 98: Rural Broadband Protection Act of 2025; all provisions S. 792: Government Spectrum Valuation Act; all provisions S. 836: The Children and Teens' Online Privacy Protection Act (COPPA 2.0); all provisions S. 1748: Kids Online Safety Act (KOSA) (not yet introduced); all provisions S. 1829 : STOP CSAM Act of 2025; all provisions S. 1837: DEFIANCE Act of 2025; provisions related to Internet Service Providers S. 1875: Streamlining Federal Cybersecurity Regulations Act of 2025; all provisions S. 2296: National Defense Authorization Act for Fiscal Year 2026; provisions related to cybersecurity, privacy, and spectrum S. 3268: Broadband and Telecommunications RAIL Act: all provisions S. 3813: Copyright Labeling and Ethical AI Reporting (CLEAR) Act; all provisions (Senate discussion draft) Block Bad Electronic Art and Recording Distributors (Block BEARD) Act of 2025; all provisions Sens. Cruz and Warner draft legislation to establish a public-private working group regarding cybersecurity practices; all provisions of the draft Advanced, Local Emergency Response Telecommunications (ALERT) Parity Act (draft); all provisions of the draft FCC Merger Act (draft); all provisions of the draft Discussions related to (draft) Communications, Video, and Technology Accessibility Act of 2025; all provisions of the draft Discussions on draft Sen. Lujan legislation Outage Refund Protection Act on customer reimbursements after network outages Discussions related to Universal Service Fund Program reform and oversight; provisions regarding program contribution Discussions related to pole attachments Discussions related to FirstNet oversight and reauthorization, public safety communications, 4.9 GHz, and wireless emergency alerts Discussions related to rural broadband, National Telecommunications and Information Administration (NTIA) regarding oversight and the Broadband, Equity, Access, and Deployment (BEAD) program Discussions related to broadband regulation Discussions related to network resiliency Discussions related to device unlocking Discussions related to data privacy protection and comprehensive federal privacy policy Discussions related to cyber security Discussions related to the Frontier Transaction and FCC Approval Discussions related to intellectual property and site blocking Discussions related to AI moratorium and other miscellaneous AI policies Discussions related to restrictions on certain patent enforcement Discussions related to illegal calls and texts Discussions related to permitting and permitting reform Discussions related to spectrum policy and implementation of the Spectrum Pipeline Act Discussions related to Arctic Frost investigation related to subpoena notification and Non-disclosure Orders (NDOs) Discussions related to Senate Sergeant at Arms (SAA) records requests Discussions related to SIM boxes and consumer fraud Discussions related to AI legislation, including a study on how AI impacts telecom security Discussion related to data centers Discussions related to World Radio Conference and US spectrum policy Discussions on addressing Copper Theft Discussions related to 100% expensing bonus depreciation, and research and experimentation costs Discussions related to corporate income tax rate Discussions related to the taxation of spectrum licenses Discussions related to the Corporate Minimum Tax"

You can find more data on corporate lobbying on Quiver Quantitative.

VZ Congressional Stock Trading

Members of Congress have traded $VZ stock 10 times in the past 6 months. Of those trades, 4 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $VZ stock by members of Congress over the last 6 months:

• REPRESENTATIVE JENNIFER L. MCCLELLAN sold up to $250,000 on 04/07.
• REPRESENTATIVE PETE SESSIONS sold up to $15,000 on 03/09.
• SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 02/23.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
• SENATOR GARY C. PETERS purchased up to $15,000 on 12/12.
• REPRESENTATIVE TIM MOORE has traded it 4 times. They made 3 purchases worth up to $150,000 on 12/10, 11/05, 10/31 and 1 sale worth up to $250,000 on 11/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

VZ Insider Trading Activity

VZ insiders have traded $VZ stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $VZ stock by insiders over the last 6 months:

• HANS ERIK VESTBERG has made 0 purchases and 3 sales selling 225,000 shares for an estimated $11,163,150.
• JOSEPH J. RUSSO (EVP&Pres-Global Networks&Tech) sold 9,579 shares for an estimated $429,905
• MARY-LEE STILLWELL (SVP and Controller) sold 8,569 shares for an estimated $428,450

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

VZ Hedge Fund Activity

We have seen 1,328 institutional investors add shares of VZ stock to their portfolio, and 1,589 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 112,402,235 shares (-75.9%) from their portfolio in Q4 2025, for an estimated $4,578,143,031
• MORGAN STANLEY removed 12,312,908 shares (-15.9%) from their portfolio in Q4 2025, for an estimated $501,504,742
• JPMORGAN CHASE & CO removed 11,992,540 shares (-28.1%) from their portfolio in Q4 2025, for an estimated $488,456,154
• AMERIPRISE FINANCIAL INC added 10,569,162 shares (+69.7%) to their portfolio in Q4 2025, for an estimated $430,481,968
• GQG PARTNERS LLC removed 9,124,130 shares (-17.2%) from their portfolio in Q4 2025, for an estimated $371,625,814
• BLACKROCK, INC. added 8,230,971 shares (+2.3%) to their portfolio in Q4 2025, for an estimated $335,247,448
• BANK OF NEW YORK MELLON CORP added 7,509,055 shares (+31.2%) to their portfolio in Q4 2025, for an estimated $305,843,810

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

VZ Analyst Ratings

Wall Street analysts have issued reports on $VZ in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 10/30/2025

To track analyst ratings and price targets for VZ, check out Quiver Quantitative's $VZ forecast page.

VZ Price Targets

Multiple analysts have issued price targets for $VZ recently. We have seen 11 analysts offer price targets for $VZ in the last 6 months, with a median target of $49.0.

Here are some recent targets:

• Kannan Venkateshwar from Barclays set a target price of $47.0 on 03/31/2026
• Michael Rollins from Citigroup set a target price of $55.0 on 03/20/2026
• Maher Yaghi from Scotiabank set a target price of $54.5 on 03/09/2026
• Jonathan Kees from Daiwa Capital set a target price of $58.0 on 02/19/2026
• Jonathan Atkin from RBC Capital set a target price of $48.0 on 02/03/2026
• Sebastiano Petti from JP Morgan set a target price of $49.0 on 02/03/2026
• Benjamin Swinburne from Morgan Stanley set a target price of $49.0 on 02/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,480,000 of APPLE INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Providing information related to Apples efforts around financial services Issues related to open banking and financial technology General tax issues, including expiring tax provisions Providing information regarding Apple's tax posture Issues related to health-related tax provisions Issues related to encryption and cybersecurity, including operation of the CLOUD Act General patent policy, including issues related to the Patent Trial and Appeal Board, S. 1553/H.R. 3160 the PREVAIL Act, and S. 708/H.R. 1574 the RESTORE Patent Rights Act Issues related to standard essential patents Issues related to anti-counterfeit policy General trademark and copyright policy Issues related to patent proceedings and the International Trade Commission, including the Advancing Americas Interests Act General overview of music licensing legal framework Providing information on Apples commitment to the environment, including recycling efforts Issues related to environmental policy, including critical minerals and renewable energy Issues related to the U.S. - EU Privacy Shield Issues related to anti-counterfeit and anti-piracy policy Issues related to the trade impacts of intellectual property disputes Issues related to U.S. competitiveness in global markets Issues related to tariff and non-tariff trade barriers General consumer privacy issues Providing information relevant to online child safety, including potential legislation, regulatory policy, H.R. 3149/S. 1586 the App Store Accountability Act, H.R. 6333 the Parents Over Platforms Act, and S. 1748 the Kids Online Safety Act Encouraging the development and adoption of strong consumer data privacy protections via legislation and/or regulatory policy Providing information on App Store policies and procedures Providing information related to Apple product features and functionality Issues related to privacy and security practices in the app ecosystem Providing information related to Apple's artificial intelligence offerings including consumer protections Providing information related to the health features of Apples products, including health data privacy Providing information related to consumer wearable devices and H.R. 4203 the WEAR IT Act Issues related to competition in digital markets and the app marketplace, including privacy, security, and competitiveness issues related to the American Innovation and Choice Online Act (pre-introduction), S. 2153 the Open App Markets Act, and H.R. 3209 the App Store Freedom Act Educating policymakers about Apples employee base in their states Providing information to policymakers about global regulations impacting competition in digital markets Issues related to immigration reform Issues related to the domestic manufacturing of semiconductors Providing information related to Apples supply chain Providing information related to artificial intelligence and domestic manufacturing Issues related to general spectrum management and policy, including issues related to ultra wideband uses Issues related to telecommunications and accessibility"

You can find more data on corporate lobbying on Quiver Quantitative.

AAPL Congressional Stock Trading

Members of Congress have traded $AAPL stock 29 times in the past 6 months. Of those trades, 15 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARK ALFORD sold up to $15,000 on 03/16.
• REPRESENTATIVE DAVID TAYLOR has traded it 5 times. They made 2 purchases worth up to $30,000 on 01/16 and 3 sales worth up to $45,000 on 02/26, 10/30.
• REPRESENTATIVE THOMAS R. SUOZZI sold up to $50,000 on 02/18.
• REPRESENTATIVE CLEO FIELDS has traded it 4 times. They made 4 purchases worth up to $780,000 on 02/12, 11/13, 10/30, 10/23 and 0 sales.
• REPRESENTATIVE ED CASE has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/12, 11/13 and 0 sales.
• REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 02/02.
• SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/15, 12/17 and 0 sales.
• REPRESENTATIVE NANCY PELOSI has traded it 3 times. They made 0 purchases and 3 sales worth up to $50,250,000 on 12/30, 12/24, 10/22.
• SENATOR MARKWAYNE MULLIN purchased up to $250,000 on 12/29.
• SENATOR TOMMY TUBERVILLE sold up to $100,000 on 12/17.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 12/16.
• REPRESENTATIVE DEBBIE DINGELL sold up to $100,000 on 11/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
• SENATOR KATIE BOYD BRITT sold up to $15,000 on 11/07.
• REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $50,000 on 10/30 and 2 sales worth up to $100,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AAPL Insider Trading Activity

AAPL insiders have traded $AAPL stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by insiders over the last 6 months:

• TIMOTHY D COOK (Chief Executive Officer) has made 0 purchases and 6 sales selling 64,949 shares for an estimated $16,512,197.
• DEIRDRE O'BRIEN (Senior Vice President) has made 0 purchases and 2 sales selling 30,002 shares for an estimated $7,660,875.
• CHRIS KONDO (Principal Accounting Officer) sold 3,752 shares for an estimated $1,017,654

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AAPL Hedge Fund Activity

We have seen 2,253 institutional investors add shares of AAPL stock to their portfolio, and 3,035 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 315,640,616 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $85,810,057,865
• CARDANO RISK MANAGEMENT B.V. removed 37,596,848 shares (-89.5%) from their portfolio in Q1 2026, for an estimated $9,411,994,928
• VANGUARD GROUP INC added 26,856,752 shares (+1.9%) to their portfolio in Q4 2025, for an estimated $7,301,276,598
• CORIENT PRIVATE WEALTH LLC added 20,955,821 shares (+226.4%) to their portfolio in Q4 2025, for an estimated $5,697,049,497
• CAPITAL INTERNATIONAL INVESTORS added 15,780,633 shares (+28.2%) to their portfolio in Q4 2025, for an estimated $4,290,122,887
• ALLIANCEBERNSTEIN L.P. added 11,632,482 shares (+40.0%) to their portfolio in Q4 2025, for an estimated $3,162,406,556
• AXXCESS WEALTH MANAGEMENT, LLC added 11,253,173 shares (+2039.5%) to their portfolio in Q4 2025, for an estimated $3,059,287,611

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AAPL Analyst Ratings

Wall Street analysts have issued reports on $AAPL in the last several months. We have seen 14 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 01/30/2026
• Maxim Group issued a "Buy" rating on 01/30/2026
• Wedbush issued a "Outperform" rating on 01/30/2026
• Barclays issued a "Underweight" rating on 01/30/2026
• Citigroup issued a "Buy" rating on 01/20/2026
• Evercore ISI Group issued a "Outperform" rating on 01/20/2026
• Morgan Stanley issued a "Overweight" rating on 12/17/2025

To track analyst ratings and price targets for AAPL, check out Quiver Quantitative's $AAPL forecast page.

AAPL Price Targets

Multiple analysts have issued price targets for $AAPL recently. We have seen 21 analysts offer price targets for $AAPL in the last 6 months, with a median target of $315.0.

Here are some recent targets:

• David O'Connor from BNP Paribas set a target price of $300.0 on 04/17/2026
• Wamsi Mohan from B of A Securities set a target price of $325.0 on 04/14/2026
• Dan Ives from Wedbush set a target price of $350.0 on 03/31/2026
• Erik Woodring from Morgan Stanley set a target price of $315.0 on 03/23/2026
• Barton Crockett from Rosenblatt set a target price of $268.0 on 03/05/2026
• Tim Long from Barclays set a target price of $248.0 on 03/03/2026
• Gil Luria from DA Davidson set a target price of $270.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,950,000 of ALTRIA CLIENT SERVICES LLC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products Department of Homeland Security Appropriations Act 2027; potential provisions related to tobacco and nicotine products Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products Commerce Justice Science and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products HR 7148: FY2026 Consolidated Defense, Labor-HHS, Nat. Sec.-State, Transportation Housing and Urban Development, Financial Services and General Government Appropriations Act; provisions related to tobacco and nicotine products HR 6938: FY2026 Consolidated Commerce Justice Science, Energy & Water, Interior Appropriations Act; provisions related to contraband vapor products and the Organized Crime Drug Enforcement Task Force HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill"

You can find more data on corporate lobbying on Quiver Quantitative.

MO Insider Trading Activity

MO insiders have traded $MO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MO stock by insiders over the last 6 months:

• CHARLES N. WHITAKER (SVP, Chief HR Off. & CCO) sold 27,908 shares for an estimated $1,885,718

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MO Hedge Fund Activity

We have seen 1,112 institutional investors add shares of MO stock to their portfolio, and 1,010 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 18,349,454 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $1,058,029,517
• PACER ADVISORS, INC. removed 7,078,893 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $408,168,970
• CAPITAL WORLD INVESTORS removed 6,590,723 shares (-26.3%) from their portfolio in Q4 2025, for an estimated $380,021,088
• CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 6,265,780 shares (+10.6%) to their portfolio in Q4 2025, for an estimated $361,284,874
• BLACKROCK, INC. added 4,062,887 shares (+3.2%) to their portfolio in Q4 2025, for an estimated $234,266,064
• JPMORGAN CHASE & CO removed 2,653,857 shares (-22.0%) from their portfolio in Q4 2025, for an estimated $153,021,394
• AMERIPRISE FINANCIAL INC added 2,230,517 shares (+11.4%) to their portfolio in Q4 2025, for an estimated $128,611,610

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MO Analyst Ratings

Wall Street analysts have issued reports on $MO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Stifel issued a "Buy" rating on 01/30/2026

To track analyst ratings and price targets for MO, check out Quiver Quantitative's $MO forecast page.

MO Price Targets

Multiple analysts have issued price targets for $MO recently. We have seen 5 analysts offer price targets for $MO in the last 6 months, with a median target of $68.0.

Here are some recent targets:

• Lisa Lewandowski from B of A Securities set a target price of $73.0 on 04/10/2026
• Faham Baig from UBS set a target price of $74.0 on 03/09/2026
• Gaurav Jain from Barclays set a target price of $63.0 on 02/23/2026
• Simon Hales from Citigroup set a target price of $65.0 on 02/09/2026
• Matthew Smith from Stifel set a target price of $68.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,320,000 of CVS HEALTH (AND SUBSIDIARIES) lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act S. 2068 - The End Prescription Drug Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025 Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act H.R. 5031, The Preserving Patient Access to Long-Term Care Pharmacies Act Issues related to corporate tax. H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act S. 3345, The PBM Price Transparency and Accountability Act H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act H.R. 4093, Apple to Apples Comparison Act H.R. 6575, CommonGround for Affordable Health Care Act H.R. 6703, The Lower Healthcare Premiums for All Americans Act H.R.6609, Pharmacists Fight Back in Medicare and Medicaid Act Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025 H.R. 6703, Lower Healthcare Premiums for All Americans Act H.R. 6610, The Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] S. 3822, Break Up Big Medicine Act Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. S. 2099, The Restore Prescription Drugs Discount Act"

You can find more data on corporate lobbying on Quiver Quantitative.

CVS Congressional Stock Trading

Members of Congress have traded $CVS stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CVS stock by members of Congress over the last 6 months:

• SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/29.
• REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 11/21.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CVS Hedge Fund Activity

We have seen 844 institutional investors add shares of CVS stock to their portfolio, and 875 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 23,387,155 shares (-73.8%) from their portfolio in Q4 2025, for an estimated $1,856,004,620
• WELLINGTON MANAGEMENT GROUP LLP added 12,233,675 shares (+193.2%) to their portfolio in Q4 2025, for an estimated $970,864,448
• DODGE & COX removed 10,666,598 shares (-14.6%) from their portfolio in Q4 2025, for an estimated $846,501,217
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 8,355,230 shares (+822.1%) to their portfolio in Q4 2025, for an estimated $663,071,052
• JPMORGAN CHASE & CO removed 4,072,568 shares (-11.5%) from their portfolio in Q4 2025, for an estimated $323,198,996
• MARSHALL WACE, LLP removed 3,649,256 shares (-99.6%) from their portfolio in Q4 2025, for an estimated $289,604,956
• FRANKLIN RESOURCES INC removed 3,438,834 shares (-47.8%) from their portfolio in Q4 2025, for an estimated $272,905,866

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CVS Analyst Ratings

Wall Street analysts have issued reports on $CVS in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 12/10/2025
• Barclays issued a "Overweight" rating on 12/10/2025
• Mizuho issued a "Outperform" rating on 12/10/2025
• Truist Securities issued a "Buy" rating on 12/10/2025
• Piper Sandler issued a "Overweight" rating on 12/10/2025
• Wells Fargo issued a "Overweight" rating on 11/13/2025
• TD Cowen issued a "Buy" rating on 11/03/2025

To track analyst ratings and price targets for CVS, check out Quiver Quantitative's $CVS forecast page.

CVS Price Targets

Multiple analysts have issued price targets for $CVS recently. We have seen 16 analysts offer price targets for $CVS in the last 6 months, with a median target of $95.0.

Here are some recent targets:

• Michael Ha from Baird set a target price of $94.0 on 04/15/2026
• Jessica Tassan from Piper Sandler set a target price of $99.0 on 03/31/2026
• Lance Wilkes from Bernstein set a target price of $94.0 on 03/12/2026
• Steve Silver from Argus Research set a target price of $90.0 on 01/28/2026
• Michael Cherny from B of A Securities set a target price of $95.0 on 01/27/2026
• Lisa Gill from JP Morgan set a target price of $101.0 on 12/17/2025
• Andrew Mok from Barclays set a target price of $93.0 on 12/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,290,000 of WALMART INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work Discussions regarding veteran and military spouse programs. Discussions in support of H.R.6400/S.4106, RX Access Act Discussions regarding U.S. manufacturing commitment and supply chain policy Discussions related to nutrition assistance programs Discussions related to groceries, consumer pricing, food processing and manufacturing, organics, and food ingredients as well as efforts to reduce food waste Discussions related to farm bill priorities Discussions related to corporate tax rate, tax credits and revenue measures Discussions regarding international taxation: OECD Pillar II Model rules Discussions on payment acceptance Discussions in support of the Credit Card Competition Act Discussions related to the Common Cents Act, H.R.3074, regarding federal guidance on rounding payments in cash transactions Discussions in support of the Combating Organized Retail Crime Act Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to drug prices Discussions related to Artificial Intelligence(AI) Discussions related to supply chain and inventory management technology Discussions regarding pricing and digital shelf labels Discussions regarding S3892/H.R.4966, the Stop Price Gouging in Grocery Stores Act Discussions regarding surface transportation issues including Surface Transportation Reauthorization, commercial trucking, driver compliance, supply chain automation, roadway infrastructure and highway trust funding. Matters related to Part 108 BVLOS Rule Discussions regarding drone commercial package delivery including related to rulemaking on operation of unmanned aircraft BVLOS Discussions regarding air quality related to refrigeration and coolant Discussions on development and foreign assistance Discussions regarding responsible sourcing intiatives Discussions related to annual appropriations Discussions related to GSA's Commercial Platforms Program Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation of USMCA Discussions regarding S.3841, Last Sale Valuation Act of 2026 Discussions regarding Securing Accountability in Foreign Entries (SAFE) Act Discussions regarding trade preference programs Discussions regarding the African Growth and Opportunity Act (AGOA) Discussions related to market operations and opportunities in ongoing trade negotiations"

You can find more data on corporate lobbying on Quiver Quantitative.

WMT Congressional Stock Trading

Members of Congress have traded $WMT stock 9 times in the past 6 months. Of those trades, 4 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $WMT stock by members of Congress over the last 6 months:

• REPRESENTATIVE JOHN MCGUIRE sold up to $15,000 on 01/20.
• REPRESENTATIVE JONATHAN L. JACKSON purchased up to $100,000 on 01/13.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
• REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

WMT Insider Trading Activity

WMT insiders have traded $WMT stock on the open market 71 times in the past 6 months. Of those trades, 0 have been purchases and 71 have been sales.

Here’s a breakdown of recent trading of $WMT stock by insiders over the last 6 months:

• FAMILY HOLDINGS TRUST WALTON has made 0 purchases and 26 sales selling 15,394,744 shares for an estimated $1,833,170,299.
• C DOUGLAS MCMILLON has made 0 purchases and 6 sales selling 116,496 shares for an estimated $13,544,770.
• DONNA MORRIS (Executive Vice President) has made 0 purchases and 2 sales selling 85,565 shares for an estimated $10,558,308.
• JOHN R. FURNER (President & CEO) has made 0 purchases and 11 sales selling 78,750 shares for an estimated $9,391,703.
• JOHN D RAINEY (Executive Vice President) has made 0 purchases and 11 sales selling 44,400 shares for an estimated $5,468,374.
• CHRISTOPHER JAMES NICHOLAS (Executive Vice President) has made 0 purchases and 3 sales selling 36,982 shares for an estimated $4,519,699.
• KATHRYN J. MCLAY (Executive Vice President) has made 0 purchases and 3 sales selling 12,000 shares for an estimated $1,298,360.
• LATRIECE WATKINS (Executive Vice President) sold 10,000 shares for an estimated $1,214,630
• DANIEL J BARTLETT (Executive Vice President) has made 0 purchases and 6 sales selling 8,358 shares for an estimated $1,001,377.
• DAVID CHOJNOWSKI (Senior Vice President) sold 7,000 shares for an estimated $746,550
• DANIEL DANKER (Executive Vice President) sold 4,365 shares for an estimated $524,629

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

WMT Hedge Fund Activity

We have seen 1,874 institutional investors add shares of WMT stock to their portfolio, and 1,815 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 87,294,683 shares (-76.9%) from their portfolio in Q4 2025, for an estimated $9,725,500,633
• MILLENNIUM MANAGEMENT LLC added 37,075,626 shares (+1001.5%) to their portfolio in Q4 2025, for an estimated $4,130,595,492
• PRICE T ROWE ASSOCIATES INC /MD/ removed 10,936,077 shares (-30.1%) from their portfolio in Q4 2025, for an estimated $1,218,388,338
• JANE STREET GROUP, LLC added 8,030,209 shares (+286.2%) to their portfolio in Q4 2025, for an estimated $894,645,584
• QUBE RESEARCH & TECHNOLOGIES LTD added 7,595,502 shares (+222.5%) to their portfolio in Q4 2025, for an estimated $846,214,877
• AMUNDI removed 7,557,068 shares (-32.2%) from their portfolio in Q4 2025, for an estimated $841,932,945
• GEODE CAPITAL MANAGEMENT, LLC added 6,517,394 shares (+6.8%) to their portfolio in Q4 2025, for an estimated $726,102,865

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

WMT Analyst Ratings

Wall Street analysts have issued reports on $WMT in the last several months. We have seen 17 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 02/20/2026
• Telsey Advisory Group issued a "Outperform" rating on 01/16/2026
• Morgan Stanley issued a "Overweight" rating on 01/15/2026
• Barclays issued a "Overweight" rating on 01/08/2026
• Oppenheimer issued a "Outperform" rating on 01/08/2026
• Evercore ISI Group issued a "Outperform" rating on 12/16/2025
• RBC Capital issued a "Outperform" rating on 11/21/2025

To track analyst ratings and price targets for WMT, check out Quiver Quantitative's $WMT forecast page.

WMT Price Targets

Multiple analysts have issued price targets for $WMT recently. We have seen 25 analysts offer price targets for $WMT in the last 6 months, with a median target of $137.0.

Here are some recent targets:

• John Heinbockel from Guggenheim set a target price of $137.0 on 04/13/2026
• Ivan Feinseth from Tigress Financial set a target price of $150.0 on 02/25/2026
• Greg Melich from Evercore ISI Group set a target price of $135.0 on 02/23/2026
• Oliver Chen from TD Cowen set a target price of $145.0 on 02/20/2026
• Zhihan Ma from Bernstein set a target price of $134.0 on 02/20/2026
• Michael Baker from DA Davidson set a target price of $150.0 on 02/20/2026
• Scot Ciccarelli from Truist Securities set a target price of $139.0 on 02/20/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,400,000 of EXXON MOBIL CORP lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Discussions related to global energy markets and regulation Discussions related to International Organization for Standardization and Greenhouse Gas Protocol Merger (ISO-GHG Protocol Merger) Discussions related to pipeline safety and permitting Discussions related to hydrogen Discussions related to fuels, sustainable aviation fuels, and biofuels Public Law No: 119-21 (H.R. 1 - 119th Congress): One Big Beautiful Bill Act; provisions related to energy tax credits, international tax, CSALT deduction, corporate tax rate, and the Tax Cuts Jobs Act tax extensions S. Con. Res. 7: An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.; provisions related to energy tax credits, international tax, CSALT deduction, corporate tax rate, and the Tax cuts and Jobs Act tax extensions Public Law No: 115-97 (H.R. 1- 115th Congress): Tax Cuts and Jobs Act; provisions related to the expiration of tax credits and international provisions Public Law No: 117-169 (H.R. 5376-117th Congress): Inflation Reduction Act of 2022; energy tax credit provisions, hydrogen, carbon capture and storage, biofuels, and critical minerals Discussions related to global corporate tax and competitiveness of U.S. companies Discussions related to United States tax rules coordination with global minimum tax rules, and other international provisions Discussions related to domestic and international tax provisions Discussions related to reporting transparency for tax incentives S. 985: PROTECT USA Act of 2025; provisions related to European Union directives Discussions related to international trade Discussions related to global energy markets and regulation Discussions related to impact of tariffs Discussions related to EU regulatory directives H.R. 7502: To prohibit a person from making a misleading recycled content claim in advertising, marketing, selling, or offering for sale a product to a consumer, and for other purposes; all provisions Discussions related to plastics, recycling, chemical regulations, and Toxic Substance Control Act implementation H.R. 4776: Standardizing Permitting and Expediting Economic Development (SPEED) Act; all provisions S. 4753 (118th Congress): Energy Permitting Reform Act of 2024; provisions related to permitting reform Public Law No: 117-58 (H.R. 3684 - 117th Congress): Infrastructure Investment and Jobs Act; provisions related to Outer Continental Shelf permitting, carbon storage Public Law No: 117-169 (H.R. 5376 - 117th Congress): Inflation Reduction Act of 2022; provisions related to implementation of energy tax credits, Outer Continental Shelf permitting, direct air capture, and methane Discussions related to hydrogen Discussions related to global energy markets and regulation Discussions related to plastics and recycling Discussions related to permitting, Upstream permitting, and improving the Federal drilling permit application process Discussions related to carbon capture and storage Discussion related to lithium extraction Discussions related to energy tax credits Discussions related to critical minerals Discussions related to Class VI well permitting and state primacy Discussions related to synthetic graphite Discussions related to carbon accounting, and carbon capture and storage Discussions related to permitting reform Discussions related to emissions and energy Discussions related to chemicals Discussions related to plastics and recycling Discussions related to the Toxic Substances Control Act Discussions related to global energy markets and regulation Discussions related to Class VI well permitting and state primacy Discussions related to Environmental Protection Agency proposal to end Greenhouse Gas Reporting Program (GHGRP) Discussions related to Environmental Agency reconsideration of methane regulations Discussions related to corporate issues"

You can find more data on corporate lobbying on Quiver Quantitative.

XOM Congressional Stock Trading

Members of Congress have traded $XOM stock 8 times in the past 6 months. Of those trades, 5 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $XOM stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $100,000 on 02/10 and 1 sale worth up to $100,000 on 01/09.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/04, 02/02 and 0 sales.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/08.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

XOM Insider Trading Activity

XOM insiders have traded $XOM stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $XOM stock by insiders over the last 6 months:

• DARRIN L TALLEY (VP - Corp Strategic Planning) has made 0 purchases and 7 sales selling 17,460 shares for an estimated $2,395,656.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

XOM Hedge Fund Activity

We have seen 2,108 institutional investors add shares of XOM stock to their portfolio, and 1,839 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,130,356 shares (-70.4%) from their portfolio in Q4 2025, for an estimated $4,588,607,041
• NORGES BANK added 6,185,309 shares (+10.8%) to their portfolio in Q4 2025, for an estimated $744,340,085
• JPMORGAN CHASE & CO removed 4,661,338 shares (-6.2%) from their portfolio in Q4 2025, for an estimated $560,945,414
• FMR LLC added 4,365,511 shares (+3.4%) to their portfolio in Q4 2025, for an estimated $525,345,593
• PACER ADVISORS, INC. removed 4,344,733 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $522,845,169
• BARCLAYS PLC removed 4,037,620 shares (-37.7%) from their portfolio in Q4 2025, for an estimated $485,887,190
• LAZARD ASSET MANAGEMENT LLC removed 3,677,926 shares (-63.3%) from their portfolio in Q4 2025, for an estimated $442,601,614

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

XOM Analyst Ratings

Wall Street analysts have issued reports on $XOM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 02/02/2026
• Barclays issued a "Overweight" rating on 01/21/2026
• Freedom Capital Markets issued a "Sell" rating on 01/06/2026
• Jefferies issued a "Buy" rating on 12/10/2025
• UBS issued a "Buy" rating on 12/01/2025
• Piper Sandler issued a "Overweight" rating on 11/10/2025
• Scotiabank issued a "Sector Outperform" rating on 11/03/2025

To track analyst ratings and price targets for XOM, check out Quiver Quantitative's $XOM forecast page.

XOM Price Targets

Multiple analysts have issued price targets for $XOM recently. We have seen 18 analysts offer price targets for $XOM in the last 6 months, with a median target of $164.0.

Here are some recent targets:

• Devin McDermott from Morgan Stanley set a target price of $171.0 on 04/17/2026
• Lucas Herrmann from BNP Paribas set a target price of $165.0 on 04/17/2026
• Jason Gabelman from TD Cowen set a target price of $172.0 on 04/10/2026
• Sam Margolin from Wells Fargo set a target price of $185.0 on 04/09/2026
• Biraj Borkhataria from RBC Capital set a target price of $180.0 on 04/09/2026
• Lloyd Byrne from Jefferies set a target price of $184.0 on 04/09/2026
• Ryan Todd from Piper Sandler set a target price of $182.0 on 04/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,580,000 of SANOFI US SERVICES INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"340B: Biologic/Small molecule drug negotiation eligibility within HR 7174/S.832 EPIC Act; CDC Type 1 Diabetes Awareness and Education within LHHS appropriations; Clinical Trial Diversity; Copay Accumulators; COPD Education and Awareness within LHHS appropriations; COPD Research Funding within LHHS appropriations; Delinking; Drug Pricing - General; Drug Price Negotiations within Inflation Reduction Act; Drug Pricing- General Issues; FDA Drug Development; FDA Issues - General; Issues related to HR 1 One Big Beautiful Bill; HR 6423/S864 HELP Copays Act; HR 2880: Protecting Patients Against PBM Abuses Act; HR 5376:Inflation Reduction Act; HRSA - Type 1 Diabetes Screening within LHHS appropriations; Influenza Vaccines; Insurance Design/Utilization Management; Intellectual Property; International Reference Pricing; Most Favored Nation; Orphan Drug Negotiation within HR 5539/S 3131 Orphan Cures Act; Out of Pocket Cap; Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization; Patient Experience/Patient Focused Drug Development within the FDA/AG Appropriations; Pharmacy Benefit Managers (PBM) Reform; Rare Pediatric Priority Review Voucher Program Reauthorization within HR 7834; Rebate Pass Through; Respiratory Syncytial Virus (RSV) Access; Routine Immunization Rates; S. 864 HELP Copays Act: S. 1339 (118th): PBM Reform Act; S. 1375: HELP Copays Act; S. 1542 (118th) DRUG Act; S. 2027: Prescription Information Modernization Act; S.4504 / HR 8698 (118th): SCREEN for Type 1 Diabetes Act; Supply Chain; Tax Credits; Transplant; Vaccine Injury Compensation Program; Vaccines-General Issues. 340B; Medicare Negotiation, and Most Favored Nation. Supply Chain Issues; and Importation issues. Supply Chain issues; TRIP Waivers; and Vaccine Injury Compensation Program. S. 43: Skinny Labels, Big Savings Act; S. 2276 ETHIC Act; and Intellectual Property. Insulin; Pharmacy Benefits Managers (PBMs); Taxes- General Issues; Type 1 Diabetes Screening; and Vaccines - General Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

SNY Hedge Fund Activity

We have seen 333 institutional investors add shares of SNY stock to their portfolio, and 336 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• DODGE & COX removed 12,439,148 shares (-18.0%) from their portfolio in Q4 2025, for an estimated $602,801,112
• PRICE T ROWE ASSOCIATES INC /MD/ removed 2,999,880 shares (-51.1%) from their portfolio in Q4 2025, for an estimated $145,374,184
• CAPITAL RESEARCH GLOBAL INVESTORS added 1,650,018 shares (+inf%) to their portfolio in Q4 2025, for an estimated $79,959,872
• MORGAN STANLEY added 1,540,271 shares (+20.4%) to their portfolio in Q4 2025, for an estimated $74,641,532
• NUVEEN, LLC removed 1,539,745 shares (-50.0%) from their portfolio in Q4 2025, for an estimated $74,616,042
• BANK OF AMERICA CORP /DE/ removed 1,328,467 shares (-13.5%) from their portfolio in Q4 2025, for an estimated $64,377,510
• MILLENNIUM MANAGEMENT LLC removed 1,296,873 shares (-90.4%) from their portfolio in Q4 2025, for an estimated $62,846,465

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SNY Analyst Ratings

Wall Street analysts have issued reports on $SNY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 10/27/2025

To track analyst ratings and price targets for SNY, check out Quiver Quantitative's $SNY forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,060,000 of FEDEX CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.2424 - Modern, Clean, and Safe Trucks Act of 2025 H.R.2391 - Strengthening the Supply Chain Through Truck Drivers Incentives Act of 2025 H.R.1659 - Truck Parking Safety Improvement Act H.R.2514 - Trucker Bathroom Access Act H.R.2954/S.1537 - Veterans Transition to Trucking Act of 2025 H.R.5268 - Forum Accountability and Integrity in Roadway Trucking Act (FAIR Act) H.R.1109 - Litigation Transparency Act of 2025 H.R.3512/S.1821 - Tackling Predatory Litigation Funding Act H.R.2662 - Staged Accident Fraud Prevention Act of 2025 S.711 - Transportation Freedom Act H.R.5688 - Non-Domiciled CDL Integrity Act S.191/H.R.623 - LICENSE Act of 2025 S.3007/H.R.8079 - Diesel Truck Liberation Act of 2025 S.3013/H.R.5767 - Secure Commercial Driver Licensing Act S.3950 - SAFER Transport Act H.R.7539 - The SAFE Act General monitoring of the DOT English Language Proficiency Rule Legislative monitoring of AV bills, including vehicle data ownership and zero occupant vehicles General monitoring of administration policy and Executive Orders Surface Transportation Reauthorization Draft H.R.3373 - GHOST Act H.R.631 - PARTS Act S.345/H.R.850 - Silencers Help Us Save Hearing (SHUSH) Act General monitoring of legislation related to shipping restricted commodities H.R.2853/S.1404 - Combatting Organized Retail Crime Act H.R.574/S.187 - ALIGN Act Legislative monitoring for tax credits involving EVs, SAFs, and zero emission charging infrastructure Corporate and international tax issues related to the Tax Cuts and Jobs Act H.R.1062 - Growing and Preserving Innovation in America Act of 2025 General monitoring of administration policy and Executive Orders The One Big Beautiful Bill Act H.R.1177/S.492 - Improve and Enhance the Work Opportunity Tax Credit Act H.R.6231/S.3265 - Improve and Enhance the Work Opportunity Tax Credit Act Legislative monitoring of U.S. Postal Service-related issues General monitoring of administration policy and Executive Orders S.1604 - No RTO Act H.R.3004 - USPS SERVES US Act H.R.3011 - USPS Shipping Equity Act H.Res.70/S.Res.147 - Expressing the sense of the House of Representatives that Congress should take all appropriate measures to ensure that the United States Postal Service remains an independent establishment of the Federal Government and is not subject to privatization Legislative monitoring of Open Skies Agreements Legislative monitoring of general trade issues including customs modernization, GSP, MTB, IPEF, CBAM, and de minimis Legislative monitoring around China PNTR Foreign Pollution Fee Act of 2025 S.1259/H.R.2653 - Manifest Modernization Act of 2025 H.R.1840 - Closing the De Minimis Loophole Act H.R.805 - End Chinas De Minimis Abuse Act H.R.322 - Import Security and Fairness Act H.R.1504 - China Trade Relations Act of 2025 H.R.694 - Restoring Trade Fairness Act S.206 - Restoring Trade Fairness Act H.R.407 - Prevent Tariff Abuse Act S.956 - Customs Facilitation Act of 2025 H.R.6500 - The AGOA Extension Act H.R.6504 - The Haiti Economic Lift Program Extension Act H.R.4930 - Information Sharing The One Big Beautiful Bill Act General monitoring of administration policy and Executive Orders FY 2026 Transportation, Housing, and Urban Development, and Related Agencies Appropriations bills H.R.7168 - Consolidated Appropriations Act, 2026 H.R.7744 - Department of Homeland Security Appropriations Act, 2026 H.R.7147 - Homeland Security and Further Additional Continuing Appropriations Act, 2026 General monitoring of administration policy and Executive Orders Legislative monitoring on aviation security and aviation safety issues including all-cargo flight time and duty rules; ATC modernization; and Open Skies agreements General monitoring of administration policy and Executive Orders S.1985 - Safe Operations of Shared Airspace Act of 2025 S.1706 - A bill to require aircraft operating in Class B airspace in the national airspace system to install and operate ADS-B In and ADS-B Out equipment, and for other purposes S.2503 - Rotorcraft Operations Transparency and Oversight Reform Act Transportation Security Reauthorization Act H.R.6086 - Aviation Funding Solvency Act S.1045/H.R.5451/H.R.5455 - Aviation Funding Stability Act of 2025 H.R.7191 - Fatigued Pilot Protection Act H.R.7526 - Safe Skies Act of 2026 H.R.7613 - Airspace Location and Enhanced Risk Transparency Act of 2026 H.R.20/S.852 - Richard L. Trumka Protecting the Right to Organize Act of 2025 H.R.1962/S.893 - Guaranteeing Overtime For Truckers Act H.R.4366 - Save Local Business Act H.R.5267 - American Franchise Act S.844 - Faster Labor Contracts Act S.2163 - Warehouse Worker Protection Act DOL Independent Contractor Rule NLRB Joint Employer Rule Package Delivery Parity Act Discussion Draft Legislative monitoring of activity related to the Railway Labor Act (RLA) General monitoring of the OSHA Walkaround Rule General monitoring of the OSHA Heat Illness Rule General monitoring of administration policy and Executive Orders Legislative monitoring of H1b visas and critical worker immigration General monitoring of administration policy and Executive Orders Legislative monitoring of consumer privacy issues, vehicle data issues, and AI H.R.1566 - REPAIR Act H.R.1664/S.1492 - Deploying American Blockchains Act of 2025 General monitoring of administration policy and Executive Orders Legislative monitoring of federal contracting issues General monitoring of administration policy and Executive Orders S.382/H.R.925 - Dismantle DEI Act H.R.5079 - Widespread Information Management for the Welfare of Infrastructure and Government Act S.1337 - Cybersecurity Information Sharing Extension Act S.2296 - The National Defense Authorization Act for FY 2026"

You can find more data on corporate lobbying on Quiver Quantitative.

FDX Congressional Stock Trading

Members of Congress have traded $FDX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $FDX stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

FDX Insider Trading Activity

FDX insiders have traded $FDX stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $FDX stock by insiders over the last 6 months:

• GINA F. ADAMS (EVP GENL COUNSEL/SECTY) has made 0 purchases and 2 sales selling 20,450 shares for an estimated $7,493,856.
• TRACY B BRIGHTMAN (EVP - Chief People Officer) has made 0 purchases and 3 sales selling 16,959 shares for an estimated $6,164,156.
• SUSAN C SCHWAB sold 5,795 shares for an estimated $2,138,355
• KAWAL PREET (EVP - Plng, Eng, & Transfmtn) sold 4,900 shares for an estimated $1,802,661
• BRIE CARERE (EVP/Chief Customer Officer) sold 2,700 shares for an estimated $999,067

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FDX Hedge Fund Activity

We have seen 829 institutional investors add shares of FDX stock to their portfolio, and 751 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,071,468 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $1,176,084,246
• FMR LLC added 2,053,626 shares (+69.5%) to their portfolio in Q4 2025, for an estimated $593,210,406
• PRIMECAP MANAGEMENT CO/CA/ removed 929,579 shares (-9.8%) from their portfolio in Q4 2025, for an estimated $268,518,189
• BALYASNY ASSET MANAGEMENT L.P. added 745,703 shares (+27008.4%) to their portfolio in Q4 2025, for an estimated $215,403,768
• WADDELL & ASSOCIATES, LLC added 738,122 shares (+164.0%) to their portfolio in Q4 2025, for an estimated $213,213,920
• CAPITAL INTERNATIONAL INVESTORS removed 685,766 shares (-15.9%) from their portfolio in Q4 2025, for an estimated $198,090,366
• DODGE & COX removed 642,992 shares (-4.0%) from their portfolio in Q4 2025, for an estimated $185,734,669

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FDX Analyst Ratings

Wall Street analysts have issued reports on $FDX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 12/19/2025
• Stifel issued a "Buy" rating on 12/19/2025
• Stephens & Co. issued a "Overweight" rating on 12/19/2025
• Truist Securities issued a "Buy" rating on 12/19/2025
• Morgan Stanley issued a "Underweight" rating on 12/19/2025
• Citigroup issued a "Buy" rating on 12/19/2025

To track analyst ratings and price targets for FDX, check out Quiver Quantitative's $FDX forecast page.

FDX Price Targets

Multiple analysts have issued price targets for $FDX recently. We have seen 18 analysts offer price targets for $FDX in the last 6 months, with a median target of $417.5.

Here are some recent targets:

• Reed Seay from Stephens & Co. set a target price of $435.0 on 04/14/2026
• John Eade from Argus Research set a target price of $400.0 on 04/06/2026
• Lucas Servera from Truist Securities set a target price of $425.0 on 03/20/2026
• Christian Wetherbee from Wells Fargo set a target price of $450.0 on 03/20/2026
• Ken Hoexter from B of A Securities set a target price of $440.0 on 03/20/2026
• J. Bruce Chan from Stifel set a target price of $425.0 on 03/20/2026
• Ravi Shanker from Morgan Stanley set a target price of $230.0 on 03/20/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Ryan Anthony Jankowski, the Chief Accounting Officer of $ARXS, bought 4,464 shares of the company on 04-17-2026 for an estimated $124,992. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 9.5%. Following this trade, they now own 51,331 shares of this class of $ARXS stock.

$ARXS Insider Trading Activity

$ARXS insiders have traded $ARXS stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ARXS stock by insiders over the last 6 months:

• JASON AARON ROTH (See Remarks) purchased 60,000 shares for an estimated $1,680,000
• KEVIN SCOTT PERHAMUS (See Remarks) purchased 53,600 shares for an estimated $1,500,800
• AZAD SID BADAKHSH (See Remarks) purchased 36,000 shares for an estimated $1,008,000
• STEPHEN DUANE OETGEN purchased 25,000 shares for an estimated $700,000
• ROSS BRADLEY SEALFON (See Remarks) purchased 12,500 shares for an estimated $350,000
• PATRICK E ALLEN purchased 10,000 shares for an estimated $280,000
• RYAN ANTHONY JANKOWSKI (Chief Accounting Officer) purchased 4,464 shares for an estimated $124,992

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Senator Jim Banks just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Senator Jim Banks and other politicians.

The trades in the new disclosure included a:

• Sale of $SBUX stock (Starbucks Corporation - Common Stock)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Senator Jim Banks

Representative Laura Friedman just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Laura Friedman and other politicians.

The trades in the new disclosure included a:

• Sale of $ABT stock (ABBOTT LABORATORIES COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Laura Friedman

$4,150,000 of MERCK & CO INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"S. 1339, Pharmacy Benefit Manager Reform Act S. 2076, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2021 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Cost and value of medicines; Vaccine issues; Package inserts and e-labeling; Package inserts, labeling issues, and e-labeling authorization legislation; Pharmaceutical supply channel issues; Drug shortages issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; One Big Beautiful Bill Act (P.L. 119-21), issues related to health care; FY-2027 Budget and Appropriations Legislation; Budget reconciliation drug pricing provisions; Commerce Justice, Science, and related agencies appropriations legislation for 2026; Interior, Environment, and related agencies appropriations legislation for 2026; Intellectual property protection and trade issues; Animal Health Policy Issues; Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Vaccine Policy; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues; Most Favored Nation (MFN) drug pricing; Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients; International competition in biopharmaceuticals. Issues relating to, One Big Beautiful Bill Act (P.L. 119-21), issues related to health care; Medicare; Medicare Part B and D drug pricing issues; 340B program integrity; 340B of the Public Health Services Act; 340B drug pricing program; Drug pricing; Cost and value of medicines: Drug pricing and reimbursement issues; FY-2027 Budget and Appropriations Legislation; Medicaid drug rebate program (MDRP). Issues relating to, Tax reform and tax policy, generally; Inflation Reduction Act (P.L. 117-169), provisions relating to budget reconciliation and taxes; Tax Cuts and Jobs Act (P.L. 115-97), provisions relating to tax reform. Issues relating to, Animal Health Policy Issues; Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Bill, 2026; Commerce, Justice, Science, and Related Agencies Appropriations Bill, 2026; Interior, Environment, and Related Agencies Appropriations Bill 2026."

You can find more data on corporate lobbying on Quiver Quantitative.

MRK Congressional Stock Trading

Members of Congress have traded $MRK stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $MRK stock by members of Congress over the last 6 months:

• REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/04.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 12/19, 11/18 and 0 sales.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MRK Insider Trading Activity

MRK insiders have traded $MRK stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $MRK stock by insiders over the last 6 months:

• JENNIFER ZACHARY (EVP, General Counsel) has made 0 purchases and 3 sales selling 121,573 shares for an estimated $14,485,690.
• ROBERT M DAVIS (Chairman, CEO & President) has made 0 purchases and 2 sales selling 47,434 shares for an estimated $5,599,327.
• CAROLINE LITCHFIELD (EVP & CFO) sold 41,997 shares for an estimated $5,023,311
• CHIRFI GUINDO (Chief Marketing Officer) has made 0 purchases and 3 sales selling 40,000 shares for an estimated $4,836,339.
• RICHARD R. DELUCA (EVP&Pres, Merck Animal Heallth) sold 37,685 shares for an estimated $4,557,024
• JOHANNES JACOBUS OOSTHUIZEN (President, U.S. Market) sold 15,000 shares for an estimated $1,827,991
• DEAN Y LI (Executive VP & President, MRL) sold 15,087 shares for an estimated $1,791,824
• DAVID MICHAEL WILLIAMS (EVP,Chief Info&Digital Officer) has made 0 purchases and 2 sales selling 13,614 shares for an estimated $1,329,564.
• DALTON E. III SMART (SVP Fin. - Global Controller) has made 0 purchases and 2 sales selling 6,400 shares for an estimated $765,920.
• CRISTAL N DOWNING (Chief Comm. & Public Afrs Ofcr) sold 7,085 shares for an estimated $616,395

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MRK Hedge Fund Activity

We have seen 1,639 institutional investors add shares of MRK stock to their portfolio, and 1,585 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 59,566,057 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $6,269,923,159
• WELLINGTON MANAGEMENT GROUP LLP added 11,156,354 shares (+14.8%) to their portfolio in Q4 2025, for an estimated $1,174,317,822
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 8,764,580 shares (-46.8%) from their portfolio in Q4 2025, for an estimated $922,559,690
• CARDANO RISK MANAGEMENT B.V. removed 8,639,639 shares (-89.8%) from their portfolio in Q1 2026, for an estimated $1,037,836,634
• FMR LLC added 7,409,816 shares (+22.2%) to their portfolio in Q4 2025, for an estimated $779,957,232
• MILLENNIUM MANAGEMENT LLC added 6,036,983 shares (+790.8%) to their portfolio in Q4 2025, for an estimated $635,452,830
• JPMORGAN CHASE & CO removed 6,001,669 shares (-17.0%) from their portfolio in Q4 2025, for an estimated $631,735,678

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MRK Analyst Ratings

Wall Street analysts have issued reports on $MRK in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 12/15/2025
• Wells Fargo issued a "Overweight" rating on 11/24/2025

To track analyst ratings and price targets for MRK, check out Quiver Quantitative's $MRK forecast page.

MRK Price Targets

Multiple analysts have issued price targets for $MRK recently. We have seen 18 analysts offer price targets for $MRK in the last 6 months, with a median target of $130.0.

Here are some recent targets:

• Michael Yee from UBS set a target price of $145.0 on 04/13/2026
• Chris Schott from JP Morgan set a target price of $135.0 on 04/06/2026
• Trung Huynh from RBC Capital set a target price of $142.0 on 03/30/2026
• Geoff Meacham from Citigroup set a target price of $125.0 on 03/20/2026
• Mohit Bansal from Wells Fargo set a target price of $150.0 on 03/12/2026
• Emily Field from Barclays set a target price of $140.0 on 02/20/2026
• Vamil Divan from Guggenheim set a target price of $140.0 on 02/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,500,000 of CHARTER COMMUNICATIONS INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to digital goods. P.L. 119-21 - One Big Beautiful Bill Act - implementation of provisions related to corporate tax. S. 559 - American Investment in Manufacturing and Main Street Act, all provisions. H.R. 1347 - American Investment in Manufacturing and Main Street Act, all provisions. H.R. 651 - Spectrum Pipeline Act of 2025 - all provisions. H.R. 791 - Foreign Anti-Digital Piracy Act - all provisions. S. 244 - ROUTERS Act - all provisions. H.R. 866 - ROUTERS Act - all provisions. S. 328 - Stop Sports Blackouts Act - all provisions. H.R. 888 - Stop Sports Blackouts Act of 2025 - all provisions. S. 792 - Government Spectrum Valuation Act - all provisions. S. 794 - A bill to require the Assistant Secretary of Commerce for Communications and Information to audit Federal spectrum - all provisions. S. 725 - Enhancing First Response Act - all provisions. Issues related to Federal Communications Commission pole dispute bills. P.L. 119-21 - One Big Beautiful Bill Act - implementation of provisions related to spectrum. H.R. 2784 - Stopping the Theft and Destruction of Broadband Act of 2025 - all provisions. S.J.Res. 7 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Communications Commission relating to "Addressing the Homework Gap Through the E-Rate Program" - all provisions. H.R. 278 - BROADBAND Leadership Act - all provisions. H.R.339 - Broadband Resiliency and Flexible Investment Act, all provisions. H.R.1343 - Federal Broadband Deployment Tracking Act, all provisions. H.R.1541 - Wireless Broadband Competition and Efficient Deployment Act, all provisions. H.R.1588 - Facilitating DIGITAL Applications Act, all provisions. H.R.1617 - Wireless Resiliency and Flexible Investment Act of 2025, all provisions. H.R. 1681 - Expediting Federal Broadband Deployment Reviews Act, all provisions. H.R.1731 - Standard FEES Act, provisions related to broadband. H.R.1836 - GRANTED Act of 2025, provisions related to broadband. H.R.1975 - BEAD FEE Act of 2025, all provisions. H.R.2289 - American Broadband Deployment Act of 2025, all provisions. H.R.2298 - Reducing Barriers for Broadband on Federal Lands Act of 2025, all provisions. H.R.2817 - Coastal Broadband Deployment Act, all provisions. H.R.2975 - Broadband Incentives for Communities Act, all provisions. H.R.3960 - Connecting Communities Post Disasters Act of 2025, provisions related to broadband. H.R.4211 - Brownfields Broadband Deployment Act, all provisions. H.R.4927 - CABLE Competition Act, all provisions. H.R.5147 - Winning the International Race for Economic Leadership and Expanding Service to Support Leadership Act or the WIRELESS Leadership Act, all provisions. H.R.5170 - Cable Access for Broadband and Local Economic Leadership Act or the CABLE Leadership Act, all provisions. H.R.5264 - Streamlining Permitting to Enable Efficient Deployment for Broadband Infrastructure Act of 2025 or the SPEED for Broadband Infrastructure Act of 2025, all provisions. H.R.5266 - 5G Using Previously Granted Rulings that Accelerate Deployment Everywhere Act of 2025 or the 5G UPGRADE Act of 2025, all provisions. H.R.5273 - Broadband Competition and Efficient Deployment Act, all provisions. H.R.5290 - Cable Transparency Act, all provisions. H.R.5311 - Connecting and Building Lines for Expedited Expansion Act or the CABLE Expansion Act, all provisions. H.R.5318 - Reducing Antiquated Permitting for Infrastructure Deployment Act, provisions related to broadband. H.R. 5358 - TRUSTED Broadband Networks Act, all provisions. Discussions regarding the proposed Broadband and Telecommunications RAIL Act, all provisions. S. 2254 - Click to Cancel Consumer Protection Act of 2025, provisions related to broadband. S. 2253 - Unsubscribe Act of 2025, provisions related to broadband. HR 6292 - Dont Sell Kids Data Act of 2025, all provisions. HR 6291 - Children and Teens Online Privacy Protection Act, all provisions. HR 6920 - Success for BEAD Act, all provisions. S. 2983 - Extending Expired Cybersecurity Authorities Act, all provisions. S.1071 - National Defense Authorization Act for Fiscal Year 2026, provisions related to spectrum. H.R. 6046 - Broadband and Telecommunications RAIL Act, all provisions. S.3565 - SUCCESS for BEAD Act, all provisions. Draft of Outage Refund Protection Act, provisions related to broadband. Draft of Communications, Video, and Technology Accessibility (CVTA) Act, all provisions."

You can find more data on corporate lobbying on Quiver Quantitative.

CHTR Congressional Stock Trading

Members of Congress have traded $CHTR stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CHTR stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 03/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CHTR Insider Trading Activity

CHTR insiders have traded $CHTR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CHTR stock by insiders over the last 6 months:

• DAVID C MERRITT sold 1,200 shares for an estimated $271,416

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CHTR Hedge Fund Activity

We have seen 343 institutional investors add shares of CHTR stock to their portfolio, and 424 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL INTERNATIONAL INVESTORS removed 6,511,392 shares (-71.3%) from their portfolio in Q4 2025, for an estimated $1,359,253,080
• CAPITAL RESEARCH GLOBAL INVESTORS added 3,626,135 shares (+304.9%) to their portfolio in Q4 2025, for an estimated $756,955,681
• DODGE & COX added 2,801,671 shares (+23.7%) to their portfolio in Q4 2025, for an estimated $584,848,821
• VOYAGER GLOBAL MANAGEMENT LP added 1,725,000 shares (+1380.0%) to their portfolio in Q4 2025, for an estimated $360,093,750
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,709,783 shares (-72.0%) from their portfolio in Q4 2025, for an estimated $356,917,201
• FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 1,617,148 shares (+119.6%) to their portfolio in Q4 2025, for an estimated $337,579,645
• STATE STREET CORP removed 1,384,824 shares (-17.4%) from their portfolio in Q4 2025, for an estimated $289,082,010

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CHTR Analyst Ratings

Wall Street analysts have issued reports on $CHTR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Underweight" rating on 02/02/2026
• Benchmark issued a "Buy" rating on 02/02/2026
• Citigroup issued a "Buy" rating on 11/03/2025

To track analyst ratings and price targets for CHTR, check out Quiver Quantitative's $CHTR forecast page.

CHTR Price Targets

Multiple analysts have issued price targets for $CHTR recently. We have seen 9 analysts offer price targets for $CHTR in the last 6 months, with a median target of $235.0.

Here are some recent targets:

• Bryan Kraft from Deutsche Bank set a target price of $235.0 on 02/03/2026
• Steven Cahall from Wells Fargo set a target price of $200.0 on 02/02/2026
• Matthew Harrigan from Benchmark set a target price of $455.0 on 02/02/2026
• Michael Ng from Goldman Sachs set a target price of $185.0 on 02/02/2026
• Laurent Yoon from Bernstein set a target price of $240.0 on 01/16/2026
• John Hodulik from UBS set a target price of $233.0 on 12/22/2025
• Jonathan Atkin from RBC Capital set a target price of $265.0 on 11/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,390,000 of MICROSOFT CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Licensing, competition, trade, and government procurement. Health IT procurement; health reform and related IT issues. Private sector preparedness; cyber research and development. Standards and interoperability. Competitiveness and high-tech sector. Policy issues in cloud computing. Open government, government IT modernization, open data, and technology choice. Supply chain security efforts within US government. Cybersecurity policies, legislation, protecting critical infrastructure, and International Cybersecurity norms. Legislative proposals related to government surveillance and data collection, including issues of transparency, FISA Section 702 reforms and ECPA reform. Non-disclosure order reform issues. Appropriations. Trade and trade agreements. Issues related to the EU US Privacy Shield agreement. Expanding access to K-12 computer science education. Issues related to the Privacy and Civil Liberty Review Board. Issues related to proposed changes to electronic communications transactional records (ECTRs). Issues related to Artificial Intelligence (AI), including Facial Recognition. Data breach legislation. Smart Spaces/Smart Infrastructure. Issues related to privacy; Federal privacy legislation. Issues related to children's privacy and safety. American Data Privacy and Protection Act (no bill number). Issues related to IT procurement, digital transformation, and modernization. Actions and guidance related to securing the information and communications technology and services supply chain. Open-Source Software Security. S. 2253, Unsubscribe Act. AI Legislation. Issues related to non-consensual intimate imagery. Issues related to Cloud Act and implementing agreements. Digital replicas. S. 1367, NO FAKES Act. AI Fraud and Open Data. Software copyright and related policy issues. Software patents and related policy issues. S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S. 1546, Patent Eligibility Restoration Act. S. 1367, NO FAKES Act. Online Child Safety and video gaming issues. Intermediary liability. S. 1748, Kids Online Safety Act. S. 836, Children and Teens Online Privacy Protection 2.0 Reform Act. Deceptive Experiences To Online Users Reduction Act (no bill number). S. 278, Kids Off Social Media Act. S. 3062, GUARD Act. H.R. 3149, App Store Accountability Act. S. 3982, AI Fraud Accountability Act. Promoting excellence in technology, education, standards, and science. Promoting excellence in education through K-12 reforms. STEM for youth. Expanding access to K-12 computer science education. Cybersecurity skill and talent pipelines. High-skilled immigration reforms. Legislation on Dreamers. Innovation and competitiveness; science development; technical computing; basic research priorities. Science, Technology, Engineering, and Mathematics education (STEM) issues. H.R.33 and S. 199 - To amend the Internal Revenue Code of 1986 to provide special rules for the taxation of certain residents of Taiwan with income from sources within the United States. H.R. 1, One Big Beautiful Bill Act tax provisions. Corporate tax, transfer pricing, treaty, foreign tax credit, tax administration, mobile worker, international tax, and foreign tax issues. Robocalling. Robotexting. H.R 1027, QUIET Act. Telecom Network Security. H.R. 866, S. 244, ROUTERS Act. Subsea Cables. H.R. 261 Undersea Cable Protection Act of 2025. Digital Trade Policies in Trade Agreements. U.S.-China Trade Relations. Sanctions. Climate change policies. Renewable, energy storage, and advanced clean energy policies. Grid reliability, resilience and digitization. Carbon pricing. Clean energy, carbon reduction & carbon removal R&D. Nature based carbon removal solutions & standards. Direct air capture & other net negative engineered carbon removal policies. U.S. Reentry in Paris Climate Agreement. U.S. Nationally Determined Contribution. S. 2153, Open App Markets Act. Competition Policy and antitrust enforcement. National Defense Authorization Act (No Bill Number). Intelligence Authorization Act (No Bill Number). Defense Appropriations. Quantum Computing. Cybersecurity: Focused on procurement and adoption of zero trust at DoD. Artificial Intelligence: Focused on DoD policy and adoption of AI. Mixed Reality: Focused on DoD procurement of the Integrated Visual Augmentation System. Cascadia High Speed Rail Funding opportunities."

You can find more data on corporate lobbying on Quiver Quantitative.

MSFT Congressional Stock Trading

Members of Congress have traded $MSFT stock 42 times in the past 6 months. Of those trades, 26 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $MSFT stock by members of Congress over the last 6 months:

• SENATOR JOHN FETTERMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/30, 03/27 and 0 sales.
• REPRESENTATIVE RICHARD MCCORMICK has traded it 3 times. They made 3 purchases worth up to $45,000 on 03/19, 11/05 and 0 sales.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $165,000 on 03/13, 11/18, 11/12 and 2 sales worth up to $100,000 on 02/10, 12/19.
• REPRESENTATIVE CLEO FIELDS has traded it 4 times. They made 4 purchases worth up to $60,000 on 03/12, 12/11 and 0 sales.
• SENATOR JOHN BOOZMAN has traded it 3 times. They made 3 purchases worth up to $45,000 on 03/05, 02/13, 12/17 and 0 sales.
• REPRESENTATIVE DAVID TAYLOR has traded it 6 times. They made 6 purchases worth up to $90,000 on 02/26, 02/09, 01/29, 01/16, 01/08 and 0 sales.
• SENATOR ANGUS S. KING JR. sold up to $15,000 on 02/13.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 02/02.
• REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 02/02.
• REPRESENTATIVE JOHN MCGUIRE has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/21 and 1 sale worth up to $15,000 on 01/30.
• REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $15,000 on 01/23.
• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 2 purchases worth up to $750,000 on 12/29, 11/03 and 0 sales.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
• SENATOR SHELLEY MOORE CAPITO has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 12/16, 10/29, 10/22.
• REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 11/21.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $50,000 on 10/30 and 2 sales worth up to $100,000 on 10/31, 10/30.
• REPRESENTATIVE KEVIN HERN sold up to $50,000 on 10/28.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MSFT Insider Trading Activity

MSFT insiders have traded $MSFT stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $MSFT stock by insiders over the last 6 months:

• BRADFORD L SMITH (Vice Chair and President) has made 0 purchases and 2 sales selling 38,500 shares for an estimated $19,967,707.
• JUDSON ALTHOFF (CEO Microsoft Commercial) sold 12,750 shares for an estimated $6,266,829
• KATHLEEN T HOGAN (EVP, Strategy) sold 12,320 shares for an estimated $5,045,642
• JOHN W STANTON purchased 5,000 shares for an estimated $1,986,750
• TAKESHI NUMOTO (EVP, Chief Marketing Officer) sold 2,850 shares for an estimated $1,364,352

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MSFT Hedge Fund Activity

We have seen 2,847 institutional investors add shares of MSFT stock to their portfolio, and 2,638 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 178,000,181 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $86,084,447,535
• AUTO-OWNERS INSURANCE CO removed 59,992,081 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $21,886,910,911
• CARDANO RISK MANAGEMENT B.V. removed 21,143,944 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $7,713,945,089
• VANGUARD GROUP INC added 15,955,898 shares (+2.3%) to their portfolio in Q4 2025, for an estimated $7,716,591,390
• CORIENT PRIVATE WEALTH LLC added 12,492,886 shares (+234.4%) to their portfolio in Q4 2025, for an estimated $6,041,809,527
• JPMORGAN CHASE & CO removed 11,048,048 shares (-7.0%) from their portfolio in Q4 2025, for an estimated $5,343,056,973
• BLACKROCK, INC. added 10,037,437 shares (+1.7%) to their portfolio in Q4 2025, for an estimated $4,854,305,281

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MSFT Analyst Ratings

Wall Street analysts have issued reports on $MSFT in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Piper Sandler issued a "Overweight" rating on 01/29/2026
• DA Davidson issued a "Buy" rating on 01/29/2026
• Mizuho issued a "Outperform" rating on 01/21/2026
• Citigroup issued a "Buy" rating on 01/21/2026
• TD Cowen issued a "Buy" rating on 01/20/2026
• Wedbush issued a "Outperform" rating on 12/22/2025
• Wells Fargo issued a "Overweight" rating on 10/30/2025

To track analyst ratings and price targets for MSFT, check out Quiver Quantitative's $MSFT forecast page.

MSFT Price Targets

Multiple analysts have issued price targets for $MSFT recently. We have seen 27 analysts offer price targets for $MSFT in the last 6 months, with a median target of $586.0.

Here are some recent targets:

• Derrick Wood from TD Cowen set a target price of $540.0 on 04/16/2026
• William Power from Baird set a target price of $500.0 on 04/15/2026
• Gregg Moskowitz from Mizuho set a target price of $515.0 on 04/14/2026
• Billy Fitzsimmons from Piper Sandler set a target price of $500.0 on 04/14/2026
• Stefan Slowinski from BNP Paribas set a target price of $556.0 on 04/10/2026
• Karl Keirstead from UBS set a target price of $510.0 on 03/25/2026
• Tal Liani from B of A Securities set a target price of $500.0 on 03/24/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,580,000 of AMGEN INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act H.R.5526 Biosimilar Red Tape Elimination Act HR 7391 Community Health Center Drug Pricing Protection Act Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S.3345, PBM Price Transparency and Accountability Act HR 6166, Lowering Drug Costs for American Families Act S 3019 - No Big Blockbuster Bailouts Act S 3349 PBM Disclosure Act HR 4317 PBM Reform Act Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act (EPIC) HR 1672 Maintaining Investments in New Innovation Act (MINI) HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 PL 119-75 Consolidated Appropriations Act of 2026 Issues related to corporate and international tax Public Law 115-97, Tax Cuts and Jobs Act Public Law 119-21, One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) Issues related to Puerto Rico Issues related to OECD negotiations on the taxation of global income Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025 Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025"

You can find more data on corporate lobbying on Quiver Quantitative.

AMGN Congressional Stock Trading

Members of Congress have traded $AMGN stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $AMGN stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 5 times. They made 1 purchase worth up to $15,000 on 01/16 and 4 sales worth up to $60,000 on 02/26, 01/29, 12/03.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AMGN Insider Trading Activity

AMGN insiders have traded $AMGN stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $AMGN stock by insiders over the last 6 months:

• ESTEBAN SANTOS (EVP, Operations) has made 0 purchases and 2 sales selling 54,792 shares for an estimated $20,772,595.
• MURDO GORDON (EVP, Global Commercial Ops) sold 6,879 shares for an estimated $2,317,071
• NANCY A. GRYGIEL (SVP & CCO) has made 0 purchases and 2 sales selling 3,139 shares for an estimated $1,058,666.
• MATTHEW C. BUSCH (VP, Finance & CAO) sold 1,000 shares for an estimated $375,790
• RACHNA KHOSLA (SVP, Business Development) sold 890 shares for an estimated $299,255

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AMGN Hedge Fund Activity

We have seen 1,388 institutional investors add shares of AMGN stock to their portfolio, and 1,256 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,593,173 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $4,449,181,454
• CAPITAL WORLD INVESTORS added 4,302,237 shares (+22.9%) to their portfolio in Q4 2025, for an estimated $1,408,165,192
• JPMORGAN CHASE & CO removed 1,936,240 shares (-45.8%) from their portfolio in Q4 2025, for an estimated $633,750,714
• ROCKEFELLER CAPITAL MANAGEMENT L.P. added 1,785,595 shares (+354.6%) to their portfolio in Q4 2025, for an estimated $584,443,099
• CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 1,739,567 shares (-12.8%) from their portfolio in Q4 2025, for an estimated $569,377,674
• PACER ADVISORS, INC. removed 1,613,121 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $527,990,634
• BLACKROCK, INC. added 1,361,706 shares (+3.0%) to their portfolio in Q4 2025, for an estimated $445,699,990

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMGN Analyst Ratings

Wall Street analysts have issued reports on $AMGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 12/03/2025
• Piper Sandler issued a "Overweight" rating on 11/14/2025

To track analyst ratings and price targets for AMGN, check out Quiver Quantitative's $AMGN forecast page.

AMGN Price Targets

Multiple analysts have issued price targets for $AMGN recently. We have seen 14 analysts offer price targets for $AMGN in the last 6 months, with a median target of $350.5.

Here are some recent targets:

• Michael Yee from UBS set a target price of $400.0 on 04/13/2026
• Terence Flynn from Morgan Stanley set a target price of $326.0 on 04/10/2026
• Vamil Divan from Guggenheim set a target price of $351.0 on 04/09/2026
• Carter Gould from Cantor Fitzgerald set a target price of $350.0 on 04/08/2026
• Akash Tewari from Jefferies set a target price of $350.0 on 03/10/2026
• Emily Field from Barclays set a target price of $350.0 on 02/20/2026
• Mohit Bansal from Wells Fargo set a target price of $375.0 on 02/19/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,570,000 of VISA INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues relating to digital payments including the cost of acceptance, interchange fees, payment card security, data security, and cybersecurity. Issues relating to financial literacy. Issues relating to fraud & ID theft. Issues relating to digital transformation and payments innovations. Issues relating to artificial intelligence (AI) in payments innovations. Issues relating to the Credit Card Competition Act (S.3623, H.R. 7035) - Including S.Amd. 4305 to H.R. 6644 - 21st Century Road to Housing Act Issues relating to merchant category codes. Issues relating to privacy and data use. Issues relating to stablecoin regulation. Issues relating to S. 1582/PL-119-27, the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act and the Credit Card Competition Act. Issues relating to H.R. 3633, the Digital Asset Market Clarity (CLARITY) Act of 2025. Issues relating to cybersecurity. Issues relating to information sharing and cyber threats. Issues relating to S.1337, the Cybersecurity Information Sharing Extension Act. Issues relating to H.R. 5079, the Widespread Information Management for the Welfare of Infrastructure and Government Act. Issues relating to payment network brand risk. Issues relating to domestic and international tax rules in H.R. 1/PL-119-21, the One Big Beautiful Bill Act. Issues relating to general international trade & sanctions issues. Issues relating to electronic payment services with China, Costa Rica, Brazil, Mexico, Central Asia and India. Issues relating to USMCA enforcement. Issues relating to U.S. tariffs. Issues relating to small business access to resources. Issues relating to immigration. Issues relating to artificial intelligence (AI)."

You can find more data on corporate lobbying on Quiver Quantitative.

V Congressional Stock Trading

Members of Congress have traded $V stock 13 times in the past 6 months. Of those trades, 10 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $V stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 5 times. They made 5 purchases worth up to $75,000 on 02/26, 02/09, 01/16, 12/03, 11/12 and 0 sales.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 02/18.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/15.
• SENATOR KATIE BOYD BRITT purchased up to $15,000 on 11/07.
• REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
• REPRESENTATIVE BYRON DONALDS purchased up to $15,000 on 10/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

V Insider Trading Activity

V insiders have traded $V stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $V stock by insiders over the last 6 months:

• RYAN MCINERNEY (Chief Executive Officer) has made 0 purchases and 3 sales selling 31,455 shares for an estimated $10,802,173.
• RAJAT TANEJA (PRESIDENT, TECHNOLOGY) has made 0 purchases and 2 sales selling 30,048 shares for an estimated $9,919,275.
• PAUL D FABARA (CHIEF RISK & CLIENT SVCS OFC) has made 0 purchases and 2 sales selling 9,728 shares for an estimated $3,212,353.
• JULIE B ROTTENBERG (GENERAL COUNSEL) sold 2,027 shares for an estimated $699,315
• LLOYD CARNEY has made 0 purchases and 2 sales selling 1,550 shares for an estimated $504,084.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

V Hedge Fund Activity

We have seen 1,926 institutional investors add shares of V stock to their portfolio, and 2,020 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,373,099 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $13,457,829,550
• CARDANO RISK MANAGEMENT B.V. removed 7,414,063 shares (-90.3%) from their portfolio in Q1 2026, for an estimated $2,202,050,851
• ROCKEFELLER CAPITAL MANAGEMENT L.P. added 3,702,323 shares (+278.6%) to their portfolio in Q4 2025, for an estimated $1,298,441,699
• J. STERN & CO. LLP added 3,351,223 shares (+12497.1%) to their portfolio in Q4 2025, for an estimated $1,175,307,418
• NORGES BANK removed 3,054,401 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $1,071,208,974
• GQG PARTNERS LLC removed 2,611,473 shares (-99.7%) from their portfolio in Q4 2025, for an estimated $915,869,695
• VICTORY CAPITAL MANAGEMENT INC added 2,116,463 shares (+48.2%) to their portfolio in Q4 2025, for an estimated $742,264,738

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

V Analyst Ratings

Wall Street analysts have issued reports on $V in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Cantor Fitzgerald issued a "Overweight" rating on 01/30/2026
• HSBC issued a "Buy" rating on 12/08/2025
• UBS issued a "Buy" rating on 10/29/2025
• Macquarie issued a "Outperform" rating on 10/29/2025

To track analyst ratings and price targets for V, check out Quiver Quantitative's $V forecast page.

V Price Targets

Multiple analysts have issued price targets for $V recently. We have seen 12 analysts offer price targets for $V in the last 6 months, with a median target of $392.5.

Here are some recent targets:

• Bryan Keane from Citigroup set a target price of $400.0 on 04/14/2026
• Adam Frisch from Evercore ISI Group set a target price of $340.0 on 04/01/2026
• Timothy Chiodo from UBS set a target price of $390.0 on 03/31/2026
• Dominick Gabriele from Loop Capital set a target price of $387.0 on 03/31/2026
• Mikhail Paramonov from Freedom Capital Markets set a target price of $375.0 on 02/17/2026
• Ramsey El-Assal from Cantor Fitzgerald set a target price of $400.0 on 01/30/2026
• Daniel R. Perlin from RBC Capital set a target price of $395.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,550,000 of HUMANA INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Medicare Advantage (MA) Policy and Reimbursement Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R. 3514/S.1816, Improving Seniors' Timely Access to Care Act of 2025 (119th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F) Implementation of CMS Interoperability and Prior Authorization final rule (CMS-0057-F) Calendar Year (CY) 2025 Home Health Prospective Payment System Final Rule (CMS-1803-F) Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F) Announcement of Calendar Year (CY) 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Final Calendar Year (CY) 2025 Part D Redesign Program Instructions Fiscal Year (FY) 2025 Hospice Payment Rate Update Final Rule (CMS-1810-F) PL 119-21, One Big Beautiful Bill Act S.1105, No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act H.R. 3467, Medicare Advantage Reform Act Policy issues related to VA-eligible Medicare beneficiaries Final Calendar Year (CY) 2026 Part D Redesign Program Instructions Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-F) Fiscal Year (FY) 2026 Skilled Nursing Facility (SNF) Prospective Payment System Final Rule (CMS-1827-F) Final Guidance for Medicare Drug Price Negotiation Program guidance for initial price applicability year 2028 CMS Health Tech Ecosystem initiative H.R. 1732, GUARD VA Benefits Act H.R. 5454/S. 2789, Medicare Advantage Prompt Pay Act Calendar Year (CY) 2026 Home Health Prospective Payment System Final Rule (CMS-1828-F) Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) Calendar Year (CY) 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (the CY 2027 Advance Notice) TRICARE Policy Issues including Telehealth, Value-Based Care, and T-5 Transition NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues PL 118-159, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 Tax Reform Implementation Issues PL 119-21, One Big Beautiful Bill Act Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

HUM Congressional Stock Trading

Members of Congress have traded $HUM stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $HUM stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 02/10.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 11/12.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HUM Insider Trading Activity

HUM insiders have traded $HUM stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $HUM stock by insiders over the last 6 months:

• SANJAY K SHETTY (President, CenterWell) purchased 810 shares for an estimated $150,016

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HUM Hedge Fund Activity

We have seen 329 institutional investors add shares of HUM stock to their portfolio, and 504 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,514,521 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $900,174,263
• CAPITAL INTERNATIONAL INVESTORS added 3,097,571 shares (+113.9%) to their portfolio in Q4 2025, for an estimated $793,380,860
• WELLINGTON MANAGEMENT GROUP LLP added 1,170,387 shares (+4481.7%) to their portfolio in Q4 2025, for an estimated $299,771,222
• FRANKLIN RESOURCES INC added 1,131,893 shares (+914.5%) to their portfolio in Q4 2025, for an estimated $289,911,754
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,008,514 shares (+28.9%) to their portfolio in Q4 2025, for an estimated $258,310,690
• SLATE PATH CAPITAL LP added 953,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $244,091,890
• EAGLE CAPITAL MANAGEMENT LLC removed 711,094 shares (-17.9%) from their portfolio in Q4 2025, for an estimated $182,132,506

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HUM Analyst Ratings

Wall Street analysts have issued reports on $HUM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 12/05/2025

To track analyst ratings and price targets for HUM, check out Quiver Quantitative's $HUM forecast page.

HUM Price Targets

Multiple analysts have issued price targets for $HUM recently. We have seen 12 analysts offer price targets for $HUM in the last 6 months, with a median target of $195.0.

Here are some recent targets:

• David Macdonald from Truist Securities set a target price of $220.0 on 04/13/2026
• Elizabeth Suzuki from Evercore ISI Group set a target price of $195.0 on 04/08/2026
• Stephen Baxter from Wells Fargo set a target price of $227.0 on 04/07/2026
• Andrew Mok from Barclays set a target price of $176.0 on 02/25/2026
• Nathan Rich from Goldman Sachs set a target price of $158.0 on 02/17/2026
• Ryan Langston from TD Cowen set a target price of $173.0 on 02/13/2026
• David Windley from Jefferies set a target price of $235.0 on 02/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,860,000 of GOOGLE CLIENT SERVICES LLC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Regulation of online advertising Privacy and competition issues in online advertising S.1060 - AMERICA Act Intellectual property enforcement Intermediary liability for copyright infringing content generated by users Generative AI and copyright Generative AI and patents H.R. 2794 / S. 1367 - NO FAKES Act S. XXXX - Generative AI Copyright Disclosure Act of 2024 H.R. 791 -The Foreign Anti-Digital Piracy Act (FADPA) H.R.XXXX - Preventing Abuse of Digital Replicas Act (PADRA) H.R. XXXX - Customer Legal Ease and Relief Act H.R.1109 - Litigation Transparency Act of 2025 Privacy and data security issues Transparency related to the Foreign Intelligence Surveillance Act and national security orders General online consumer protection issues Online child safety protection issues; COPPA Mobile location privacy issues Cybersecurity Electronic communications privacy Data breach issues Policies on online controversial, inciting, and manipulative content Digital wellbeing Generative AI safety and privacy issues Age assurance H.R. 859 / S. 28 Informing Consumers About Smart Devices Act S. 1748 / H.R. 6484 - Kids Online Safety Act S. 836 / H.R. 6291 - Children and Teens' Online Privacy Protection Act S. 278 - Kids Off Social Media Act H.R. 3149 / S. 1586 - App Store Accountability Act H.R. 1941 - Preventing Deepfakes of Intimate Images Act H.R. XXX - Verifying Kids' Online Privacy Act S. 737 / H.R. 1623 - Shielding Children's Retinas from Egregious Exposure on the Net (SCREEN Act) H.R. 3209 - App Store Freedom Act S. 2153 - Open App Markets Act S. 2714 - Children Harmed by AI Technology Act (CHAT) Act H.R. 5173 - No Social Media at School Act H.R. 5272 - Protect Elections from Deceptive AI Act S. 2381 - Preventing Recurring Online Abuse of Children Through Intentional Vetting of Artificial Intelligence (PROACTIVE AI) Data Act S. 1792 - AI Whistleblower Protection Act H.R. 6290, Safe Social Media Act H.R. 6259, No Fentanyl on Social Media Act H.R. 6289, Promoting a Safe Internet for Minors Act H.R. 6437, Kids Internet Safety Partnership Act H.R. 6499, Assessing Safety Tools for Parents and Minors Act H.R. 5360, AI Warnings And Resources for Education (AWARE) Act H.R. 2657, Sammys Law H.R. 6265, Safer Guarding of Adolescents from Malicious Interactions on Network Games (GAMING) Act H.R. 6273, Stop Profiling Youth and (SPY) Kids Act H.R. 6253, Algorithmic Choice and Transparency Act H.R. 6489, Safeguarding Adolescents From Exploitative (SAFE) Bots Act H.R. 6257, Safe Messaging for Kids Act of 2025 H.R. 6333, Parents Over Platforms Act H.R. 6334, Deepfake Liability Act S. 3062, GUARD Act H.R. 6488, the Reducing Exploitative Social Media Exposure for Teens (RESET Act) H.R. 7757, Kids Internet and Digital Safety (KIDS) Act S. 2950, SCAM Act Connected education Rolling Study Halls Digital skilling/Workforce development AI tools for education Freedom of expression and free flow of information Global trade issues Ukraine Response Israel Response Global connectivity/subsea cables/foreign data centers S. 1705 / H.R. 3447 - Chip Security Act H.R 2683 / S. - Remote Access Security Act (RASA) HR 5885 / S. 3150 GAIN AI Act H.R. 2503 - Undersea Cable Control Act H.R. 6875 - AI Overwatch Act S. 3374 - SAFE Chips Act Health IT Health data policy Opioid and fentanyl crisis Public health information Mental health Health and fitness issues in the National Defense Authorization Act Health & AI Cybersecurity issues Online content moderation Cybersecurity workforce S. 438 / H.R. 1000 - Cyber PIVOTT Act H.R. 872 - Federal Contractor Cybersecurity Vulnerability Reduction Act H.R. 5079 - Widespread Information Management for the Welfare of Infrastructure and Government Act High-skilled immigration and job creation STEM and innovation DACA H-1B visa reform Openness and competition in online services and devices Workplace policies; diversity and inclusion Future of work Competition regulation and antitrust law, domestically and internationally Interoperability/messaging standard issues affecting mobile handsets S. 1073 - Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act (AMERICA) S. 4046 Economy of the Future Commission Act S. 3339 AI Workforce Prepare Act S. 1290 AI and Critical Workforce Framework Act H.R. 5583, LIFT AI Act H.R. 5351, NSF AI Education Act H.R. 5764, AI Mainstreet Act H.R. 5784, AI Wise Act H.R. 5673, AI Talent Act General issues related to Science, Technology, Engineering and Math (STEM) Open-source software Cloud computing Quantum computing AI principles R&D on artificial intelligence, machine learning, and quantum information science Semiconductor supply chain and domestic production Generative AI CHIPS and Science Act implementation Strengthening Agency Management and Oversight of Software Assets (SAMOSA) Act S. 1106 / H.R. 2321 - US Leadership in Immersive Technology S. 1235 / H.R. 2583 Expanding Partnerships for Innovation and Competitiveness Act (EPIC) Act S. XXX - AI Modernization of Veterans Benefits Act S. XXX, VET AI Act S. 1462 / H.R. 471, Fix Our Forests Act S. 1269, Promoting United States Leadership in Standards Act H.R. 2385, CREATE AI Act of 2025 S. 1633, TEST AI Act of 2025 S. 1699, Artificial Intelligence Public Awareness and Education Campaign Act H.R. 1534 - IMPACT Act H.R. XX - Quantum Leaders Education and Advancement Program Act or the Q-LEAP Act H.R. XX, AI Foundation Model and Transparency Act H.R. 7158 - Expanding AI Voices Act Benefits of online services for small businesses Grow with Google Small business advertising issues Small business competitive landscape Online video Competition in video programming Promoting broadband infrastructure deployment FCC regulation of privacy, broadband USF Reform MVPD Definition S. XXXX - Communications, Video, and Technology Accessibility Act Freedom of expression, intermediary liability, and intellectual property in international trade agreements Data localization New trade agreement negotiations (e.g., USMCA) China tariffs Technology transfer, export administration and licensing, and supply chain security On-shoring the semiconductor supply chain DMA/DSA USMCA Review H.R. 8025 - Protecting American Streaming and Innovation Act Anti-human trafficking efforts Internet intermediary liability Law enforcement access to data stored abroad Reporting of online terrorist activity Government access to electronic communications transactional records S. XXX - STOP CSAM Act H.R. 633 / S. 146 - Take It Down Act S. 962 - Protecting Children Over Profits Act H.R. 1623 / S. 737 - SCREEN Act S. XXXX, Invest in Child Safety Act S. 3398, Stop Sextortion Act S. 3397, Ending Coercion of Children and Harm Online (ECCHO) Act S. 3394, Sentencing Accountability for Exploitation (SAFE) Act International tax reform/OECD Digital services taxation On-shoring the semiconductor supply chain Tax Cuts and Jobs Act (TCJA)/foreign-derived intangible income (FDII) Permanency R&D Amortization H.R. 6335, Education Not Endless Scrolling Act Transmission development and deployment Sustainability efforts Energy Permitting Reform H.R. XXX / S. XXX - Advancing GETS Act H.R. 1077 / S. 456 STEAM Act H.R. 301 - GEO Act H.R. 3838 - SPEED Act H.R.6633, High Capacity Grid Act H.R. 2122 - IMPACT Act Continuing Appropriations for FY2025 Budget Reconciliation - H.R.1 - One Big Beautiful Bill Act Appropriations for FY2027 Commercial Cloud Enterprise (C2E) and procurement National Defense Authorization Act for Fiscal Year 2025 National Defense Authorization Act for Fiscal Year 2026 National Defense Authorization Act for Fiscal Year 2027 National Defense Authorization Act for Fiscal Year 2026 Encryption"

You can find more data on corporate lobbying on Quiver Quantitative.

GOOGL Congressional Stock Trading

Members of Congress have traded $GOOGL stock 23 times in the past 6 months. Of those trades, 12 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 1 purchase worth up to $15,000 on 02/26 and 3 sales worth up to $45,000 on 01/16, 11/03.
• REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $50,000 on 02/05.
• REPRESENTATIVE CLEO FIELDS has traded it 7 times. They made 7 purchases worth up to $1,100,000 on 02/03, 12/26, 12/15, 12/11, 12/09, 12/01, 10/23 and 0 sales.
• REPRESENTATIVE NANCY PELOSI has traded it 2 times. They made 1 purchase worth up to $1,000,000 on 01/16 and 1 sale worth up to $5,000,000 on 12/30.
• SENATOR MARKWAYNE MULLIN purchased up to $250,000 on 12/29.
• SENATOR TOMMY TUBERVILLE sold up to $15,000 on 12/17.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 12/16.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 12/11.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 11/18 and 1 sale worth up to $15,000 on 11/26.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GOOGL Insider Trading Activity

GOOGL insiders have traded $GOOGL stock on the open market 185 times in the past 6 months. Of those trades, 0 have been purchases and 185 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by insiders over the last 6 months:

• SUNDAR PICHAI (Chief Executive Officer) has made 0 purchases and 90 sales selling 325,000 shares for an estimated $100,694,346.
• JOHN KENT WALKER (President, Global Affairs, CLO) has made 0 purchases and 16 sales selling 74,396 shares for an estimated $22,436,626.
• AMIE THUENER O'TOOLE (VP, Chief Accounting Officer) has made 0 purchases and 13 sales selling 9,969 shares for an estimated $3,017,400.
• JOHN L. HENNESSY has made 0 purchases and 60 sales selling 4,500 shares for an estimated $1,406,310.
• FRANCES ARNOLD has made 0 purchases and 6 sales selling 632 shares for an estimated $193,739.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GOOGL Hedge Fund Activity

We have seen 2,243 institutional investors add shares of GOOGL stock to their portfolio, and 2,640 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 132,304,945 shares (-76.4%) from their portfolio in Q4 2025, for an estimated $41,411,447,785
• NORGES BANK removed 26,966,798 shares (-21.7%) from their portfolio in Q4 2025, for an estimated $8,440,607,774
• BLACKROCK, INC. added 13,547,648 shares (+3.2%) to their portfolio in Q4 2025, for an estimated $4,240,413,824
• CARDANO RISK MANAGEMENT B.V. removed 12,983,401 shares (-89.4%) from their portfolio in Q1 2026, for an estimated $3,659,241,737
• VANGUARD GROUP INC added 12,531,695 shares (+2.4%) to their portfolio in Q4 2025, for an estimated $3,922,420,535
• SG AMERICAS SECURITIES, LLC added 9,819,146 shares (+126.5%) to their portfolio in Q1 2026, for an estimated $2,767,428,108
• WELLINGTON MANAGEMENT GROUP LLP removed 8,322,648 shares (-12.7%) from their portfolio in Q4 2025, for an estimated $2,604,988,824

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GOOGL Analyst Ratings

Wall Street analysts have issued reports on $GOOGL in the last several months. We have seen 22 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 03/27/2026
• Pivotal Research issued a "Buy" rating on 02/05/2026
• Roth Capital issued a "Buy" rating on 02/05/2026
• Mizuho issued a "Outperform" rating on 01/09/2026
• Cantor Fitzgerald issued a "Overweight" rating on 01/08/2026
• Jefferies issued a "Buy" rating on 01/05/2026
• Citizens issued a "Market Outperform" rating on 12/31/2025

To track analyst ratings and price targets for GOOGL, check out Quiver Quantitative's $GOOGL forecast page.

GOOGL Price Targets

Multiple analysts have issued price targets for $GOOGL recently. We have seen 33 analysts offer price targets for $GOOGL in the last 6 months, with a median target of $375.0.

Here are some recent targets:

• Justin Patterson from Keybanc set a target price of $380.0 on 04/20/2026
• Ronald Josey from Citigroup set a target price of $405.0 on 04/14/2026
• Andrew Boone from Citizens set a target price of $385.0 on 04/13/2026
• Mark Kelley from Stifel set a target price of $387.0 on 04/13/2026
• Deepak Mathivanan from Cantor Fitzgerald set a target price of $370.0 on 04/08/2026
• Laura Martin from Needham set a target price of $400.0 on 04/08/2026
• Ken Gawrelski from Wells Fargo set a target price of $361.0 on 04/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,280,000 of ASTRAZENECA PHARMACEUTICALS LP lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"CMMI GENEROUS Demo Medicare Part B ASP compliance FDA modernization policy Implementation of the Inflation Reduction Act (IRA) -- with specific focus on drug negotiation (orphan drug exemption language) BIOSECURE Act implementation Issues related to the Medicare title in the One Big Beautiful Bill Act Issues related to the IRA definition of a drug for purposes of price negotiation selection Duplicate discounts as required by IRA Issues related to direct-to-consumer drug delivery policy options Issues related to expanding/amending the orphan drug exclusion in IRA Issues related to pharmacy benefit manager (PBM) reform Issues related to mitigation of 340B Issues related to 340B Rebate Model Pilot Program for IRA compliance Issues related to next generation propellant and PFAS Issues related to the US manufacturing of pharmaceuticals Issues related to the price and manufacture of inhaled medicines Issues related to environmental sustainability Issues related to the development of novel therapies including cell therapy and antibody drug conjugates (ADCs) Issues related to vaccine access and vaccine R&D Issues related to FDA Orange Book patent listings Issues related to the recruitment of patients for clinical trials Issues related to most-favored nations drug pricing proposals General issues related to rare disease and orphan drugs General issues related to health equity in rare disease and clinical trials General issues related to vaccine safety, efficacy, and access General issues related to ACIP recommendations Policies related to international reference pricing for pharmaceuticals Pediatric rare disease priority review voucher Reauthorization of the pediatric priority review voucher program HR 946/S 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures) Act HR 1262/ S 932, Give Kids A Chance Act HR 4132/S 2027, Prescription Information Modernization Act HR 6166, the Lowering Drug Costs for American Families Act Issues related to a Most Favored Nations policy in Medicare and Medicaid Most Favored Nation drug pricing proposals Policies related to the use of international reference pricing in Medicare/Medicaid 340B rebate model Part B and Part D drugs Medicare drug price negotiation Medicare Part D reform and inflation penalties Medicaid Drug Rebate Program proposed rule Definition of Qualified Single Source Drug (QSSD) for purposes of Medicare drug price negotiation Medicare patient access to cancer screening Medicare patient access to rare disease therapies Issues related to the digital communication of prescribing information for drugs Issues related to e-labeling and allowing FDA to finalize a rule to allow digital versions of prescriptions Centers for Medicare and Medicaid Innovation (CMMI) policy issues Value-based payment arrangements Efforts to improve coding, coverage, and access for rare disease therapies General issues related to diagnostic reimbursement E-labeling (allowing health care providers to receive prescribing information for drugs electronically rather than in paper form from manufacturers) Issues related to increasing production of US manufacturing HR 4132/S 2027, Prescription Information Modernization Act Potential for a second reconciliation bill and potential offsets (increase in corporate tax rate, Sec 899 taxation) Tax reform in budget reconciliation and Byrd rules Section 899 tax proposal IRS guidance on R&D tax credit Base Erosion and Anti-Abuse Tax (BEAT) tax Corporate alternative minimum tax (CAMT) interaction with R&D expensing Global Intangible Low-Taxed Income (GILTI), Foreign-Derived Intangible Income (FDII) deduction OECD Pillar Two side by side deal Workforce Tax Credits USMCA negotiations Pharmaceutical pricing negotiations Implementation of One Big Beautiful Bill Act law (corporate minimum tax, R&D expensing) Expiring provisions of the Tax Cut and Jobs Act law - deduction of research and development expenditures Interaction of state and federal R&D credits Issues related to international tax rules including HR 591 - Defending American Jobs and Investment Act HR 1414 - Camerons Law, to restore orphan drug research tax credit S.1605 - International Competition for American Jobs Act Issues related to patents and intellectual property Commerce Section 232 tariffs on pharmaceuticals Section 301 investigations Tariffs/trade policies related to tariffs on pharmaceuticals Trade and tariffs (general education, country-specific tariffs, sector-specific tariffs) Pharmaceutical manufacturing (general education) Most favored nation policies related to pharmaceuticals Most Favored Nation voluntary agreement implementation Issues related to critical supply chains reshoring investments Issues related to importation of drugs Issues related to direct-to-consumer advertising by pharmaceutical manufacturers Trade and tariffs (general education, country-specific tariffs, sector-specific tariffs) Pharmaceutical manufacturing (general education)"

You can find more data on corporate lobbying on Quiver Quantitative.

AZN Congressional Stock Trading

Members of Congress have traded $AZN stock 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $AZN stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 12/18, 11/19, 10/21 and 0 sales.
• REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 12/08.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AZN Hedge Fund Activity

We have seen 569 institutional investors add shares of AZN stock to their portfolio, and 728 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL INTERNATIONAL INVESTORS removed 10,531,442 shares (-42.0%) from their portfolio in Q4 2025, for an estimated $968,155,463
• WELLINGTON MANAGEMENT GROUP LLP removed 9,471,315 shares (-29.3%) from their portfolio in Q4 2025, for an estimated $870,697,987
• BANK OF AMERICA CORP /DE/ removed 6,276,788 shares (-19.2%) from their portfolio in Q4 2025, for an estimated $577,025,120
• AMERIPRISE FINANCIAL INC added 4,788,038 shares (+83.9%) to their portfolio in Q4 2025, for an estimated $440,164,333
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,697,895 shares (+552.9%) to their portfolio in Q4 2025, for an estimated $431,877,487
• HARRIS ASSOCIATES L P added 3,729,731 shares (+inf%) to their portfolio in Q4 2025, for an estimated $342,874,170
• PRIMECAP MANAGEMENT CO/CA/ removed 2,942,710 shares (-7.4%) from their portfolio in Q4 2025, for an estimated $270,523,330

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AZN Analyst Ratings

Wall Street analysts have issued reports on $AZN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 10/27/2025

To track analyst ratings and price targets for AZN, check out Quiver Quantitative's $AZN forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,670,000 of THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to prior authorization. S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues relating to implementation of the No Surprises Act. H.R. 3838/S. 2296 Pharmacy issues related to the National Defense Authorization Act, FY2026. "S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act." Issues related to the specialty drug market. Issues related to transparency. Issues related to competition in the health care marketplace."

You can find more data on corporate lobbying on Quiver Quantitative.

CI Congressional Stock Trading

Members of Congress have traded $CI stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CI stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 12/19 and 2 sales worth up to $30,000 on 03/13, 11/12.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CI Insider Trading Activity

CI insiders have traded $CI stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:

• DAVID CORDANI (Chairman & CEO) purchased 4,134 shares for an estimated $999,916
• NICOLE S JONES (See Remarks) sold 2,307 shares for an estimated $666,515
• EVERETT NEVILLE (See Remarks) sold 1,719 shares for an estimated $496,636

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CI Hedge Fund Activity

We have seen 697 institutional investors add shares of CI stock to their portfolio, and 742 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 6,882,711 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $1,894,328,548
• PRICE T ROWE ASSOCIATES INC /MD/ removed 5,032,153 shares (-44.5%) from their portfolio in Q4 2025, for an estimated $1,384,999,470
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,738,636 shares (-99.9%) from their portfolio in Q4 2025, for an estimated $1,028,984,786
• NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,141,844 shares (+13333.2%) to their portfolio in Q4 2025, for an estimated $864,729,724
• DODGE & COX added 1,833,389 shares (+19.7%) to their portfolio in Q4 2025, for an estimated $504,603,654
• CAPITAL RESEARCH GLOBAL INVESTORS removed 1,245,656 shares (-39.2%) from their portfolio in Q4 2025, for an estimated $342,841,900
• BOSTON PARTNERS added 1,243,056 shares (+314.6%) to their portfolio in Q4 2025, for an estimated $342,126,302

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CI Analyst Ratings

Wall Street analysts have issued reports on $CI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 02/02/2026
• Truist Securities issued a "Buy" rating on 01/05/2026
• Goldman Sachs issued a "Buy" rating on 11/04/2025
• TD Cowen issued a "Buy" rating on 11/04/2025

To track analyst ratings and price targets for CI, check out Quiver Quantitative's $CI forecast page.

CI Price Targets

Multiple analysts have issued price targets for $CI recently. We have seen 11 analysts offer price targets for $CI in the last 6 months, with a median target of $334.0.

Here are some recent targets:

• David Windley from Jefferies set a target price of $330.0 on 04/20/2026
• Lance Wilkes from Bernstein set a target price of $358.0 on 03/12/2026
• Jessica Tassan from Piper Sandler set a target price of $370.0 on 03/03/2026
• David Macdonald from Truist Securities set a target price of $350.0 on 02/17/2026
• Charles Rhyee from TD Cowen set a target price of $338.0 on 02/09/2026
• Andrew Mok from Barclays set a target price of $303.0 on 02/06/2026
• Jason Cassorla from Guggenheim set a target price of $334.0 on 02/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,360,000 of GENERAL DYNAMICS CORP lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues and funding related to Fiscal Year 2027 (FY27) Defense Appropriations (bill numbers not yet assigned); FY27 Homeland Security Appropriations (bill numbers not yet assigned); FY27 Energy and Water Development Appropriations (bill numbers not yet assigned); FY27 Commerce, Justice, Science Appropriations (bill numbers not yet assigned); FY27 Labor, Health and Human Services, and Education Appropriations (bill numbers not yet assigned); FY27 Intelligence Classified Annex; FY27 State-Foreign Operations Appropriations (bill numbers not yet assigned); FY27 Transportation, Housing, and Urban Development Appropriations (bill numbers not yet assigned); FY27 Financial Services and General Government Appropriations (bill numbers not yet assigned); FY27 Interior Appropriations (bill numbers not yet assigned); FY27 Military Construction and Veterans Affairs Appropriations (bill numbers not yet assigned). Issues and funding related to Fiscal Year 2026 (FY26) Defense Appropriations (HR 4016 / S 2572 / HR 7148); FY26 Homeland Security Appropriations (HR 4213 / Senate bill introduced, number not yet assigned / HR 7148); FY26 Energy and Water Development Appropriations (HR 4553 / HR 6938 includes conferenced text); FY26 Commerce, Justice, Science Appropriations (HR 5342 / S 2354 / HR 6938 includes conferenced text); FY26 Labor, Health and Human Services, and Education Appropriations (HR 7148); FY26 Intelligence Classified Annex; FY26 State-Foreign Operations Appropriations (HR 7006); FY26 Transportation, Housing, and Urban Development Appropriations (HR4552 / S 2465 / HR 7148); FY26 Financial Services and General Government Appropriations (HR 7006); FY26 Interior Appropriations (House bill number not yet assigned / S 2431 / HR 6938 includes conferenced text); FY26 Military Construction and Veterans Affairs Appropriations (HR 3944 / Senate bill number not yet assigned / became Public Law 119-37). Issues related to FY27 Defense Authorization (bill numbers not yet assigned). FY26 and FY27 Department of Defense Appropriations and Authorization issues and funding include but are not limited to shipbuilding; submarines; submarine workforce training and education; Navy ship repair; ground vehicles; air defense systems in regards to M-SHORAD; aircraft; communication systems; classified programs; ammunition and weapon systems; cloud computing; nontraditional defense contractors and acquisition policy; and acquisition reform. FY26 and FY27 Homeland Security Appropriations issues and funding include but are not limited to cyber programs; information systems; telecommunications; technology equipment; infrastructure; support and services; border security technologies; Department of Homeland Security Headquarters Consolidation at St. Elizabeths; Office of Biometric Identity Management. FY26 and FY27 Financial Services and General Government Appropriations issues are related to Department of Homeland Security Headquarters consolidation. FY26 and FY27 Transportation, Housing, and Urban Development issues related to FAA communications, funding for the FAA Aircraft Certification Service, all general aviation related issues, FAA air/ground communications, Maritime Administration's Ready Reserve sealift recapitalization, commercial shipping, and the shipbuilding industry regarding Maritime Guaranteed Loan Program and the Jones Act. FY26 and FY27 Labor, Health, and Human Services, and Education Appropriations Bill for submarine supplier development and community college partnerships; submarine workforce training and education; pension funding stabilization for single-employer plans. FY26 and FY27 Intelligence Community issues and funding related to classified programs. FY26 and FY27 Interior issues related to Indian Health Services. FY26 and FY27 Military Construction and Veterans Affairs issues related to Veterans Administration Technology Modernization. FY27 Department of Defense Appropriations and Authorization issues and funding included but are not limited to shipbuilding; submarines; submarine workforce training and education, Navy ship repair; ground vehicles; air defense systems in regards to M-SHORAD; aircraft; communication systems; classified programs; ammunition and weapon systems; cloud computing; US Battlefield Information Collection and Exploitation- eXtended (US BICES-X); nontraditional defense contractors and acquisition policy; and acquisition reform. FY27 State-Foreign Operations Appropriations (bill numbers not yet assigned); FY27 Department of State Authorization Bill (bill numbers not yet assigned). FY27 and Defense Authorization (bill numbers not yet assigned). The treatment of research & experimental expenditures incurred during the taxable year in connection with trade or business expenses. FY26 and FY27 Homeland Security Appropriations issues and funding include but are not limited to cyber programs; information systems; telecommunications; technology equipment; infrastructure; support and services; border security technologies; Consolidated Tower and Surveillance Equipment; Department of Homeland Security Headquarters Consolidation at St. Elizabeths; and Office of Biometric Identity Management. FY26 and FY27 Transportation, Housing, and Urban Development issues related to FAA communications, FY25 Transportation, Housing, and Urban Development issues related to FAA communications, funding for the FAA Aircraft Certification Service, all general aviation related issues, FAA air/ground communications, commercial shipping, and the shipbuilding industry regarding Maritime Guaranteed Loan Program and the Jones Act. Maritime Administration's Ready Reserve sealift recapitalization. Issues related to FAA communications, FAA Aircraft Certification Service, FAA air/ground communications, and all general aviation related issues in the FAA Reauthorization Act of 2024 (HR 3935 that became Public Law 118-63) to include the enacted legislation's implementation. FY26 and FY27 Transportation, Housing, and Urban Development issues are related to FAA Aircraft Certification Service, emissions standards, all general aviation related issues, FAA air/ground communications, and IT & cyber security issues. FY26 and FY27 Commerce, Justice and Science issues are related to the National Oceanic and Atmospheric Administration Hurricane Hunter aircraft fleet. FY26 and FY27 Labor, Health, and Human Services, and Education issues for submarine supplier development and community college partnerships; submarine workforce training and education; pension funding stabilization for single-employer plans. Issues related to Free Application for Federal Student Aid (FAFSA) technology modernization and award eligibility determination. FY26 and FY27 Intelligence Community issues and funding related to classified programs. FY26 and FY27 Labor, Health and Human Services, and Education issues regarding submarine supplier development and community college partnerships. FY26 and FY27 State and Foreign Operations & FY26 and FY27 Department of State issues and funding including but not limited to relevant cyber programs; information systems; telecommunications; technology equipment; infrastructure; support & services; foreign military sales & direct commercial sales to include those by non-United States based subsidiaries; the Australia - United Kingdom - United States (AUKUS) partnership and Virginia Class Submarines. Issues related to funding and user fees for USCIS (United States Citizenship & Immigration Services) within FY26 and FY27 appropriations bills. Issues related to the Office of Refugee Resettlement (ORR). FY26 and FY27 Department of Interior Appropriations and FY26 and FY27 Department of Health and Human Services Appropriations issues and funding related to Indian Health Services Electronic Health Records."

You can find more data on corporate lobbying on Quiver Quantitative.

GD Congressional Stock Trading

Members of Congress have traded $GD stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $GD stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GD Insider Trading Activity

GD insiders have traded $GD stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $GD stock by insiders over the last 6 months:

• PHEBE N NOVAKOVIC (Chairman and CEO) has made 0 purchases and 2 sales selling 32,918 shares for an estimated $11,656,060.
• DAVID PADDOCK (Vice President) has made 0 purchases and 2 sales selling 20,360 shares for an estimated $6,818,920.
• MARK LAGRAND BURNS (Executive Vice President) sold 10,153 shares for an estimated $3,603,827
• MARK RAYHA (Vice President) has made 0 purchases and 2 sales selling 4,470 shares for an estimated $1,558,184.
• MARGUERITE AMY GILLILAND (Executive Vice President) sold 3,819 shares for an estimated $1,350,020
• GREGORY S GALLOPOULOS (Senior VP, Gen. Counsel, Sec.) sold 3,729 shares for an estimated $1,321,359

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GD Hedge Fund Activity

We have seen 984 institutional investors add shares of GD stock to their portfolio, and 807 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,932,919 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $650,736,510
• HAMILTON WEALTH, LLC added 1,336,858 shares (+209538.9%) to their portfolio in Q4 2025, for an estimated $450,066,614
• CAPITAL RESEARCH GLOBAL INVESTORS removed 1,168,249 shares (-17.0%) from their portfolio in Q4 2025, for an estimated $393,302,708
• AMERIPRISE FINANCIAL INC added 1,048,661 shares (+28.9%) to their portfolio in Q4 2025, for an estimated $353,042,212
• BANK OF AMERICA CORP /DE/ removed 993,501 shares (-10.4%) from their portfolio in Q4 2025, for an estimated $334,472,046
• PACER ADVISORS, INC. removed 871,052 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $293,248,366
• BALYASNY ASSET MANAGEMENT L.P. removed 727,332 shares (-98.7%) from their portfolio in Q4 2025, for an estimated $244,863,591

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GD Analyst Ratings

Wall Street analysts have issued reports on $GD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 01/30/2026
• JP Morgan issued a "Overweight" rating on 12/19/2025
• Susquehanna issued a "Positive" rating on 10/27/2025

To track analyst ratings and price targets for GD, check out Quiver Quantitative's $GD forecast page.

GD Price Targets

Multiple analysts have issued price targets for $GD recently. We have seen 9 analysts offer price targets for $GD in the last 6 months, with a median target of $388.0.

Here are some recent targets:

• Sheila Kahyaoglu from Jefferies set a target price of $380.0 on 04/07/2026
• John Godyn from Citigroup set a target price of $380.0 on 04/02/2026
• David Strauss from Wells Fargo set a target price of $400.0 on 04/01/2026
• Ronald Epstein from B of A Securities set a target price of $400.0 on 01/30/2026
• Gavin Parsons from UBS set a target price of $388.0 on 01/15/2026
• Seth Seifman from JP Morgan set a target price of $385.0 on 12/19/2025
• Kristine Liwag from Morgan Stanley set a target price of $408.0 on 12/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,587,441 of TEXTRON INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Department of Defense Appropriations Act National Defense Authorization Act (NDAA) Defense Industrial Base Department of Homeland Security Appropriations Act U.S. Security Assistance and Cooperation Arms Sales Transportation, Housing and Urban Development Appropriations FAA Reauthorization General Aviation issues"

You can find more data on corporate lobbying on Quiver Quantitative.

TXT Congressional Stock Trading

Members of Congress have traded $TXT stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $TXT stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/11.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TXT Insider Trading Activity

TXT insiders have traded $TXT stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $TXT stock by insiders over the last 6 months:

• SCOTT C DONNELLY (Executive Chairman) has made 0 purchases and 3 sales selling 219,619 shares for an estimated $21,612,724.
• MARK S BAMFORD (VP & Corporate Controller) has made 0 purchases and 2 sales selling 29,341 shares for an estimated $2,881,103.
• E ROBERT LUPONE (EVP, General Counsel & Secy) sold 28,056 shares for an estimated $2,773,156
• JULIE G DUFFY (EVP and CHRO) sold 19,857 shares for an estimated $1,959,842
• LISA M ATHERTON (President and CEO) sold 7,600 shares for an estimated $749,968

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TXT Hedge Fund Activity

We have seen 358 institutional investors add shares of TXT stock to their portfolio, and 287 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,573,256 shares (-43.5%) from their portfolio in Q4 2025, for an estimated $311,480,725
• FMR LLC added 2,935,272 shares (+51.1%) to their portfolio in Q4 2025, for an estimated $255,867,660
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,138,012 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $186,370,506
• AQR CAPITAL MANAGEMENT LLC added 1,811,787 shares (+51.1%) to their portfolio in Q4 2025, for an estimated $157,933,472
• PRIMECAP MANAGEMENT CO/CA/ removed 1,778,280 shares (-58.4%) from their portfolio in Q4 2025, for an estimated $155,012,667
• JPMORGAN CHASE & CO removed 1,177,058 shares (-40.9%) from their portfolio in Q4 2025, for an estimated $102,604,145
• BALYASNY ASSET MANAGEMENT L.P. removed 645,938 shares (-97.0%) from their portfolio in Q4 2025, for an estimated $56,306,415

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TXT Price Targets

Multiple analysts have issued price targets for $TXT recently. We have seen 7 analysts offer price targets for $TXT in the last 6 months, with a median target of $99.0.

Here are some recent targets:

• Sheila Kahyaoglu from Jefferies set a target price of $110.0 on 04/07/2026
• John Godyn from Citigroup set a target price of $99.0 on 04/02/2026
• David Strauss from Wells Fargo set a target price of $92.0 on 04/01/2026
• Douglas Harned from Bernstein set a target price of $108.0 on 02/19/2026
• Seth Seifman from JP Morgan set a target price of $90.0 on 01/29/2026
• Gavin Parsons from UBS set a target price of $99.0 on 01/15/2026
• Gautam Khanna from TD Cowen set a target price of $90.0 on 10/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,080,000 of COMCAST CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"One Big Beautiful Bill Act (H.R.1). Foreign distribution of U.S. films. Implementation of section 224 of the Communications Act, as amended, regarding pole attachments. Privacy and data security. Rural Broadband Deployment and Mapping. Broadband Adoption and Network. BEAD Implementation. Network Resiliency and Security. Online Video/Over the Top Video. Media reform, retrans, program carriage and diversity. Implementation of Section 621 of the Communications Act. Sports Programming. Media Diversity. 2026 National Defense Authorization Act. Issues related to artificial intelligence. Universal Service Fund. Media Consolidation. Keep It Moving Act. Media Regulation. Intellectual Property Issues. Consumer data privacy. Childrens privacy (Children's Online Privacy Protection Act). Childrens privacy (Kids Online Safety Act). Workforce Issues. Corporate tax rate. One Big Beautiful Bill Act (H.R.1). Judicial site blocking. Legislation and regulation regarding a framework for cybersecurity, and mitigation and prevention of cyber threats. Spectrum, including shared and unlicensed spectrum. Commerce, Justice, Science, and Related Agencies Appropriations Act, FY 2026. Legislative Branch Appropriations, FY 2026. Financial Services Appropriations, FY 2026. Agriculture Appropriations, FY 2026. Judiciary Committee Issues. Commerce Committee Issues. Advertising issues. 2026 National Defense Authorization Act. Permitting Reform. Implementation of FAA Drone Rule. Stopping the Theft and Destruction of Broadband Act of 2025 (H.R.2784) Internet of Things."

You can find more data on corporate lobbying on Quiver Quantitative.

CMCSA Congressional Stock Trading

Members of Congress have traded $CMCSA stock 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $CMCSA stock by members of Congress over the last 6 months:

• REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 01/09 and 2 sales worth up to $30,000 on 11/18, 11/12.
• SENATOR ANGUS S. KING JR. sold up to $15,000 on 12/29.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CMCSA Insider Trading Activity

CMCSA insiders have traded $CMCSA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CMCSA stock by insiders over the last 6 months:

• MICHAEL J CAVANAGH (Co-CEO) sold 57,947 shares for an estimated $1,892,549
• ASUKA NAKAHARA sold 8,275 shares for an estimated $245,767

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CMCSA Hedge Fund Activity

We have seen 811 institutional investors add shares of CMCSA stock to their portfolio, and 1,228 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 80,973,101 shares (-74.2%) from their portfolio in Q4 2025, for an estimated $2,420,285,988
• FMR LLC removed 29,289,351 shares (-30.4%) from their portfolio in Q4 2025, for an estimated $875,458,701
• CAPITAL WORLD INVESTORS added 24,166,881 shares (+20.8%) to their portfolio in Q4 2025, for an estimated $722,348,073
• CAPITAL RESEARCH GLOBAL INVESTORS added 21,958,603 shares (+65.1%) to their portfolio in Q4 2025, for an estimated $656,342,643
• JPMORGAN CHASE & CO removed 20,965,471 shares (-24.9%) from their portfolio in Q4 2025, for an estimated $626,657,928
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 16,957,412 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $506,857,044
• NORGES BANK removed 15,267,310 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $456,339,895

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CMCSA Analyst Ratings

Wall Street analysts have issued reports on $CMCSA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 01/12/2026
• Benchmark issued a "Buy" rating on 01/06/2026
• Citigroup issued a "Buy" rating on 11/03/2025
• TD Cowen issued a "Buy" rating on 10/31/2025

To track analyst ratings and price targets for CMCSA, check out Quiver Quantitative's $CMCSA forecast page.

CMCSA Price Targets

Multiple analysts have issued price targets for $CMCSA recently. We have seen 12 analysts offer price targets for $CMCSA in the last 6 months, with a median target of $33.0.

Here are some recent targets:

• Maher Yaghi from Scotiabank set a target price of $34.0 on 04/01/2026
• Barton Crockett from Rosenblatt set a target price of $30.0 on 01/30/2026
• Gregory Williams from TD Cowen set a target price of $39.0 on 01/30/2026
• Michael Rollins from Citigroup set a target price of $33.0 on 01/30/2026
• Laurent Yoon from Bernstein set a target price of $32.0 on 01/16/2026
• Kannan Venkateshwar from Barclays set a target price of $28.0 on 01/13/2026
• Jessica Reif Cohen from B of A Securities set a target price of $37.0 on 01/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,190,000 of GILEAD SCIENCES INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate on domestic and global drug pricing proposals, international trade and protection of intellectual property; global supply chain issues, including the Medical Supply Chain Resiliency Act and tariffs; compulsory licensing and other IP issues in multiple countries. Advocate on drug pricing proposals. Proposals to expand access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Issues related to triple negative breast cancer (TNBC) and early detection and screenings for breast cancer. Advocate in favor of 340B program reforms and changes. Issues related to developing treatments and therapies, including: manufacturing, clinical trials, reimbursement and coverage. Advocate for provisions modifying the Inflation Reduction Act and other drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, oncology products, and COVID-19 therapies and prevention including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules, including those related to payments in Medicare, Medicaid drug rebates, and proposed CMMI demonstrations. Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals. Legislative and regulatory proposals to change international and domestic corporate tax law and policy."

You can find more data on corporate lobbying on Quiver Quantitative.

GILD Congressional Stock Trading

Members of Congress have traded $GILD stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $GILD stock by members of Congress over the last 6 months:

• REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 01/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GILD Insider Trading Activity

GILD insiders have traded $GILD stock on the open market 35 times in the past 6 months. Of those trades, 0 have been purchases and 35 have been sales.

Here’s a breakdown of recent trading of $GILD stock by insiders over the last 6 months:

• DANIEL PATRICK O'DAY (Chairman & CEO) has made 0 purchases and 13 sales selling 291,280 shares for an estimated $40,879,973.
• JOHANNA MERCIER (Chief Comm & Corp Aff Officer) has made 0 purchases and 9 sales selling 68,000 shares for an estimated $9,442,901.
• DEBORAH H TELMAN (EVP, Corporate Affairs & GC) has made 0 purchases and 3 sales selling 53,646 shares for an estimated $6,590,487.
• ANDREW D DICKINSON (Chief Financial Officer) has made 0 purchases and 6 sales selling 17,500 shares for an estimated $2,370,865.
• JEFFREY BLUESTONE has made 0 purchases and 2 sales selling 10,000 shares for an estimated $1,242,900.
• KELLY A. KRAMER has made 0 purchases and 2 sales selling 5,611 shares for an estimated $713,186.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GILD Hedge Fund Activity

We have seen 1,083 institutional investors add shares of GILD stock to their portfolio, and 879 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,953,246 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $4,781,121,414
• WELLINGTON MANAGEMENT GROUP LLP removed 9,711,230 shares (-37.9%) from their portfolio in Q4 2025, for an estimated $1,191,956,370
• BLACKROCK, INC. added 6,914,187 shares (+5.9%) to their portfolio in Q4 2025, for an estimated $848,647,312
• FMR LLC added 5,263,211 shares (+8.7%) to their portfolio in Q4 2025, for an estimated $646,006,518
• CAPITAL RESEARCH GLOBAL INVESTORS removed 4,706,975 shares (-15.7%) from their portfolio in Q4 2025, for an estimated $577,734,111
• BOSTON PARTNERS added 4,220,501 shares (+inf%) to their portfolio in Q4 2025, for an estimated $518,024,292
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 4,113,999 shares (+3763.8%) to their portfolio in Q4 2025, for an estimated $504,952,237

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GILD Analyst Ratings

Wall Street analysts have issued reports on $GILD in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 02/11/2026
• Wells Fargo issued a "Overweight" rating on 12/10/2025
• Truist Securities issued a "Buy" rating on 11/24/2025
• Scotiabank issued a "Sector Outperform" rating on 11/13/2025
• JP Morgan issued a "Overweight" rating on 10/31/2025
• TD Cowen issued a "Buy" rating on 10/23/2025

To track analyst ratings and price targets for GILD, check out Quiver Quantitative's $GILD forecast page.

GILD Price Targets

Multiple analysts have issued price targets for $GILD recently. We have seen 14 analysts offer price targets for $GILD in the last 6 months, with a median target of $155.0.

Here are some recent targets:

• Geoff Meacham from Citigroup set a target price of $165.0 on 04/13/2026
• Matthew Harrison from Morgan Stanley set a target price of $175.0 on 04/10/2026
• Akash Tewari from Jefferies set a target price of $180.0 on 03/10/2026
• Joseph Stringer from Needham set a target price of $170.0 on 02/23/2026
• Emily Field from Barclays set a target price of $155.0 on 02/20/2026
• Carter Gould from Cantor Fitzgerald set a target price of $155.0 on 02/11/2026
• Louis Chen from Scotiabank set a target price of $177.0 on 02/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,450,000 of BOEING COMPANY lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.4552 & S.2465 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026. FY27 Transportation, Housing and Urban Development, and Related Agencies appropriations. FY27 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations. Toxic Substances Control Act authorizations. Agriculture legislation with a nexus to aerospace issues. Clean air/CO2 emissions standards and related issues. Clean Water Act. Chemical manufacturing and use. Superfund and site remediation. Solid waste and recycling. Renewable energy, energy policy, and sustainable aviation fuel related issues. H.R.6084 - ERISA Litigation Reform Act. Implementation of P.L. 119-21 - One Big Beautiful Bill Act. Implementation of P.L. 116-94 - Setting Every Community Up for Retirement Enhancement (Secure 1.0). Implementation of P.L. 117-328, Division T - Secure 2.0 Act of 2022. Single-employer pension premiums. Tariffs and import duties imposed under authority of: International Emergency Economic Powers Act. Trade Expansion Act of 1962, Section 232. Trade Act of 1974, Section 301. H.R.4016 & S.2572 Department of Defense Appropriations Act, 2026. H.R.5342 & 2354 - Commerce, Justice, Science and Related Agencies Appropriations Act, 2026. H.R.4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026. H.R.7148 - Consolidated Appropriations Act, 2026. FY27 National Defense authorizations. FY27 Defense appropriations. FY27 National Security, Department of State, and Related Programs appropriations. FY27 Commerce, Justice, Science, and Related Agencies appropriations. Aerospace, weapons, missile defense, and military satellite & space programs. Communications science and technology. Manufacturing research and development. Acquisition policy, software development, and related topics. Data rights issues. Domestic sourcing. Systems modification, modernization, logistics, sustainment, and readiness. Intelligence surveillance and reconnaissance systems. DOD energy. STEM education, workforce training, and military to civilian job transition. Post-employment restrictions. Aeronautical charting and data. Critical minerals and rare earths. Defense industrial base cybersecurity, supply chain, and policy matters. Spectrum. H.R.4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026. H.R.7148 - Consolidated Appropriations Act, 2026. FY27 National Security, Department of State, and Related Programs appropriations. International sales and service (commercial and military). International supply chain. China relations. Russia sanctions. AUKUS legislation. Foreign Military Financing. H.R.1162 - Medicaid Primary Care Improvement Act. S.1944 - Employee Access to Worksite Health Services Act. H.R.2450 - Prescription Drug Transparency and Affordability Act. S.2355 & H.R.5582 - Patients Deserve Price Tags Act. Implementation of P.L. 119-21 - One Big Beautiful Bill Act. General health care and employee benefits issues; health care coverage, regulatory implementation, transparency, delivery and payment reform, cost containment, and telehealth. Proposals related to ERISA preemption. H.R.4213 - Department of Homeland Security Appropriations Act, 2026. H.R.7147 - Further Additional Continuing Appropriations Act, 2026. S.2983 - Extending Expired Cybersecurity Authorities Act. H.R.5079 - Widespread Information Management for the Welfare of Infrastructure and Government Act. Homeland security and border security. Bioterrorism. Immigration. Aviation security. Unmanned aerial vehicles. U.S. Coast Guard acquisitions. Cybersecurity policy. Artificial intelligence policy. H.R.4016 & S.2572 Department of Defense Appropriations Act, 2026. H.R.4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026. H.R.7148 - Consolidated Appropriations Act, 2026. FY27 National Defense authorization. FY27 Intelligence authorization. FY27 National Security, Department of State, and Related Programs appropriations. Employment and labor issues, including labor relations and labor law. Workforce Innovation and Opportunity Act. Workplace safety - OSHA standards. Apprenticeships for credentials and employment, including registered apprenticeships. H.R.5342 & S.2354 - Commerce, Justice, Science and Related Agencies Appropriations Act, 2026. H.R.4552 & S.2465 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026. H.R.7148 - Consolidated Appropriations Act, 2026. H.R.7273 - NASA Reauthorization Act of 2026. S.933 - NASA Transition Authorization Act of 2025. FY27 Commerce, Justice, Science and Related Agencies appropriations. FY27 Transportation, Housing and Urban Development, and Related Agencies appropriations. FY27 Financial Services and General Government appropriations. Aerospace to include space and satellite programs. Acquisition policy. Science programs. Spectrum. Cybersecurity. Advanced aviation infrastructure, air mobility, and unmanned aerial systems. Civil aviation research and development, and NASA aeronautics. STEM education and workforce development. Human spaceflight issues. S.2503 & H.R.6222 - Rotorcraft Operations Transparency and Oversight Reform Act. S.1985 - Safe Operation of Shared Airspace Act of 2025. H.R.7613 - Airspace Location and Enhanced Risk Transparency Act of 2026. H.R.6518 & S.3759 - Securing America's Fuels Act. H.R. 7553 & S.3885 - Aviation Innovation and Global Competitiveness Act. Spectrum. Certification. Commercial aviation. Aviation quality and safety. Advanced aviation infrastructure, air mobility, innovation, technology, and unmanned aerial systems. Aeronautical charting and data. Aircraft, air safety, cockpit voice recorders, radio altimeters, air traffic systems, and cybersecurity. Supply chain. Sustainable aviation fuel. Fire suppression. Civil aviation research and development, and NASA aeronautics. Air Traffic Control modernization. H.R.1062 - Growing and Preserving Innovation in America Act of 2025. S.1605 - International Competition for American Jobs Act. S.1639 - American Innovation and Jobs Act. H.R.1990 - American Innovation and R&D Competitiveness Act of 2025. H.R.6518 & S.3759 - Securing America's Fuels Act. S.3623 & H.R.7035 - Credit Card Competition Act of 2026. Implementation of P.L. 119-21 - One Big Beautiful Bill Act. Corporate and aviation industry tax issues. Research & development audit procedures, enhancements, and experimentation expenses. Tax Cut and Jobs Act implementation. Foreign derived intangible income/deduction eligible income. Innovation and research & development competitiveness. Global minimum taxes. Energy tax. Qualified production property. U.S. case at World Trade Organization regarding EU subsidies. International trade. African Growth and Opportunity Act. Financial services issues. Export-Import Bank related issues. Securities and Exchange Commission, corporate governance, business conduct and related issues & standards. Sanctions legislation. Implementation of P.L. 119-21 - One Big Beautiful Bill Act. STEM, workforce education and training. Apprenticeships for credentials and employment. Workforce innovation and opportunity issues."

You can find more data on corporate lobbying on Quiver Quantitative.

BA Congressional Stock Trading

Members of Congress have traded $BA stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BA stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 02/02.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/19 and 1 sale worth up to $15,000 on 11/12.
• REPRESENTATIVE DAVID ROUZER sold up to $15,000 on 12/09.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 12/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BA Insider Trading Activity

BA insiders have traded $BA stock on the open market 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $BA stock by insiders over the last 6 months:

• HOWARD E MCKENZIE (Chief Engineer & EVP, ET&T) sold 10,496 shares for an estimated $2,456,150
• ANN M SCHMIDT (SVP, Chief Com & Brand Officer) sold 6,281 shares for an estimated $1,528,613
• UMA M AMULURU (EVP and Chief HR Officer) has made 0 purchases and 3 sales selling 5,600 shares for an estimated $1,266,091.
• MORTIMER J BUCKLEY purchased 2,230 shares for an estimated $499,966
• DANA S DEASY (CIDO, SVP IDT&S) purchased 554 shares for an estimated $99,102

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BA Hedge Fund Activity

We have seen 1,271 institutional investors add shares of BA stock to their portfolio, and 908 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS removed 11,091,891 shares (-71.8%) from their portfolio in Q4 2025, for an estimated $2,408,271,373
• FMR LLC added 9,317,466 shares (+21.3%) to their portfolio in Q4 2025, for an estimated $2,023,008,217
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 8,669,642 shares (-74.5%) from their portfolio in Q4 2025, for an estimated $1,882,352,671
• PENTWATER CAPITAL MANAGEMENT LP added 4,115,200 shares (+165.0%) to their portfolio in Q4 2025, for an estimated $893,492,224
• WELLINGTON MANAGEMENT GROUP LLP removed 3,933,166 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $853,969,001
• VANGUARD GROUP INC added 3,460,021 shares (+5.1%) to their portfolio in Q4 2025, for an estimated $751,239,759
• BLACKROCK, INC. added 2,683,054 shares (+5.2%) to their portfolio in Q4 2025, for an estimated $582,544,684

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BA Analyst Ratings

Wall Street analysts have issued reports on $BA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 01/28/2026
• UBS issued a "Buy" rating on 01/28/2026
• JP Morgan issued a "Overweight" rating on 01/28/2026
• Bernstein issued a "Outperform" rating on 01/15/2026
• Tigress Financial issued a "Buy" rating on 12/29/2025
• Freedom Capital Markets issued a "Buy" rating on 11/03/2025

To track analyst ratings and price targets for BA, check out Quiver Quantitative's $BA forecast page.

BA Price Targets

Multiple analysts have issued price targets for $BA recently. We have seen 10 analysts offer price targets for $BA in the last 6 months, with a median target of $272.5.

Here are some recent targets:

• John Godyn from Citigroup set a target price of $256.0 on 04/02/2026
• David Strauss from Wells Fargo set a target price of $250.0 on 04/01/2026
• Ivan Feinseth from Tigress Financial set a target price of $290.0 on 03/19/2026
• Sheila Kahyaoglu from Jefferies set a target price of $295.0 on 02/02/2026
• Gavin Parsons from UBS set a target price of $285.0 on 01/28/2026
• Ken Herbert from RBC Capital set a target price of $275.0 on 01/28/2026
• Seth Seifman from JP Morgan set a target price of $270.0 on 01/28/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,670,000 of UNITEDHEALTH GROUP INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Data Privacy Paperless/Digital Healthcare Communications Value-Based Care No Surprises Act Healthcare Modernization Policies Health Care Affordability AI/Technology Prior Authorization Cyber Security Medicaid and Commercial Market Coverage Policy Medicare Advantage Program Medicare Modernization Proposals Drug Pricing PBM and Drug Pricing Reforms Veterans Health Issues Health Savings Health Equity"

You can find more data on corporate lobbying on Quiver Quantitative.

UNH Congressional Stock Trading

Members of Congress have traded $UNH stock 14 times in the past 6 months. Of those trades, 7 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:

• REPRESENTATIVE RICHARD MCCORMICK has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/19, 11/05 and 0 sales.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $65,000 on 03/13, 12/19 and 2 sales worth up to $65,000 on 02/10, 11/12.
• SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
• REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
• REPRESENTATIVE KEVIN HERN sold up to $500,000 on 12/23.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UNH Hedge Fund Activity

We have seen 1,261 institutional investors add shares of UNH stock to their portfolio, and 1,770 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 20,260,160 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $6,688,081,417
• CAPITAL RESEARCH GLOBAL INVESTORS removed 6,780,251 shares (-52.0%) from their portfolio in Q4 2025, for an estimated $2,238,228,657
• CARDANO RISK MANAGEMENT B.V. removed 2,264,606 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $608,839,323
• CITADEL ADVISORS LLC added 2,079,416 shares (+244.9%) to their portfolio in Q4 2025, for an estimated $686,436,015
• UBS GROUP AG removed 1,839,868 shares (-40.3%) from their portfolio in Q4 2025, for an estimated $607,358,825
• ROCKEFELLER CAPITAL MANAGEMENT L.P. added 1,568,099 shares (+532.9%) to their portfolio in Q4 2025, for an estimated $517,645,160
• AMUNDI added 1,544,066 shares (+26.6%) to their portfolio in Q4 2025, for an estimated $509,711,627

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UNH Analyst Ratings

Wall Street analysts have issued reports on $UNH in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 02/05/2026
• Truist Securities issued a "Buy" rating on 02/02/2026
• Barclays issued a "Overweight" rating on 01/30/2026
• Wells Fargo issued a "Overweight" rating on 01/30/2026
• Jefferies issued a "Buy" rating on 01/28/2026
• Leerink Partners issued a "Outperform" rating on 01/28/2026
• Bernstein issued a "Outperform" rating on 10/30/2025

To track analyst ratings and price targets for UNH, check out Quiver Quantitative's $UNH forecast page.

UNH Price Targets

Multiple analysts have issued price targets for $UNH recently. We have seen 16 analysts offer price targets for $UNH in the last 6 months, with a median target of $371.5.

Here are some recent targets:

• David Windley from Jefferies set a target price of $373.0 on 04/20/2026
• Lance Wilkes from Bernstein set a target price of $411.0 on 04/07/2026
• John Ransom from Raymond James set a target price of $330.0 on 04/01/2026
• Ann Hynes from Mizuho set a target price of $350.0 on 02/05/2026
• David Macdonald from Truist Securities set a target price of $370.0 on 02/02/2026
• Lisa Gill from JP Morgan set a target price of $389.0 on 02/02/2026
• Stephen Baxter from Wells Fargo set a target price of $370.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

JOHN W ALLISON, the Chairman & CEO of $HOMB, bought 100,000 shares of the company on 04-17-2026 for an estimated $2,696,210. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 1.8%. Following this trade, they now own 5,798,926 shares of this class of $HOMB stock.

$HOMB Insider Trading Activity

$HOMB insiders have traded $HOMB stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $HOMB stock by insiders over the last 6 months:

• JOHN W ALLISON (Chairman & CEO) purchased 100,000 shares for an estimated $2,696,210
• JAMES G HINKLE sold 30,000 shares for an estimated $908,157
• DONNA TOWNSELL (Director of Investor Relations) sold 5,563 shares for an estimated $157,877
• JOHN W II ALLISON sold 5,000 shares for an estimated $140,950

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$HOMB Hedge Fund Activity

We have seen 155 institutional investors add shares of $HOMB stock to their portfolio, and 174 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 5,337,329 shares (-67.2%) from their portfolio in Q4 2025, for an estimated $148,270,999
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,021,425 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $28,375,186
• FIRST TRUST ADVISORS LP added 830,823 shares (+37.3%) to their portfolio in Q4 2025, for an estimated $23,080,262
• VANGUARD GROUP INC added 621,751 shares (+3.1%) to their portfolio in Q4 2025, for an estimated $17,272,242
• CITADEL ADVISORS LLC added 496,669 shares (+297.5%) to their portfolio in Q4 2025, for an estimated $13,797,464
• WELLINGTON MANAGEMENT GROUP LLP removed 475,893 shares (-20.2%) from their portfolio in Q4 2025, for an estimated $13,220,307
• MORGAN STANLEY added 408,578 shares (+47.5%) to their portfolio in Q4 2025, for an estimated $11,350,296

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$HOMB Revenue

$HOMB had revenues of $266.7M in Q1 2026. This is an increase of 2.55% from the same period in the prior year.

You can track HOMB financials on Quiver Quantitative's HOMB stock page.

$HOMB Congressional Stock Trading

Members of Congress have traded $HOMB stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $HOMB stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$HOMB Price Targets

Multiple analysts have issued price targets for $HOMB recently. We have seen 4 analysts offer price targets for $HOMB in the last 6 months, with a median target of $31.5.

Here are some recent targets:

• Christopher Mcgratty from Keefe, Bruyette & Woods set a target price of $30.0 on 04/20/2026
• Matt Olney from Stephens & Co. set a target price of $32.0 on 04/17/2026
• Stephen Scouten from Piper Sandler set a target price of $33.0 on 04/17/2026
• Dave Rochester from Cantor Fitzgerald set a target price of $31.0 on 03/03/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$4,420,000 of PFIZER INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Intellectual Property Protections Vaccine Coverage Pediatric Immunization Schedule Vaccine Injury Compensation Program Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients H.R. 7837 - Most Favored Patient Act of 2026 Lyme Disease Issues 340B Issues Counterfeit Drugs Inflation Reduction Act (IRA) Prescription Drug User Fee Act (PDUFA) Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage H.R. 5509 - Safe Step Act S. 2903 - Safe Step Act S. 3510 - Biosimilar Inspection Modernization Act of 2025 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Prescription Drug User Fee Act (PDUFA) 340B Issues Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage PBM Reform Counterfeit Drugs P.L. 117-169 - Inflation Reduction Act (IRA) of 2022 Drug Pricing Medicare/Medicaid Issues International Supply Chain Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competiveness Issues Trade Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

PFE Congressional Stock Trading

Members of Congress have traded $PFE stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 02/10, 11/18 and 2 sales worth up to $30,000 on 03/13, 12/19.
• REPRESENTATIVE J. FRENCH HILL sold up to $250,000 on 12/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PFE Hedge Fund Activity

We have seen 1,256 institutional investors add shares of PFE stock to their portfolio, and 1,418 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 101,068,901 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $2,516,615,634
• NORGES BANK removed 20,119,761 shares (-21.5%) from their portfolio in Q4 2025, for an estimated $500,982,048
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 17,862,459 shares (-96.2%) from their portfolio in Q4 2025, for an estimated $444,775,229
• PACER ADVISORS, INC. removed 17,574,851 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $437,613,789
• MORGAN STANLEY added 14,342,946 shares (+19.2%) to their portfolio in Q4 2025, for an estimated $357,139,355
• BANK OF NEW YORK MELLON CORP added 13,581,757 shares (+38.9%) to their portfolio in Q4 2025, for an estimated $338,185,749
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 8,837,922 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $220,064,257

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PFE Analyst Ratings

Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 11/24/2025

To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.

PFE Price Targets

Multiple analysts have issued price targets for $PFE recently. We have seen 11 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.

Here are some recent targets:

• Jin Zhang from CICC set a target price of $33.0 on 04/16/2026
• Michael Yee from UBS set a target price of $27.0 on 04/13/2026
• Terence Flynn from Morgan Stanley set a target price of $28.0 on 04/10/2026
• Jason Gerberry from B of A Securities set a target price of $26.0 on 04/09/2026
• Vamil Divan from Guggenheim set a target price of $36.0 on 03/24/2026
• Rajesh Kumar from HSBC set a target price of $32.0 on 03/17/2026
• David Toung from Argus Research set a target price of $35.0 on 03/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Representative Sheri Biggs just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Sheri Biggs and other politicians.

The trades in the new disclosure included a:

• Purchase of $IBIT stock (ISHARES BITCOIN TRUST ETF)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Sheri Biggs